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ABSTRACT
Molecular Interactions of Salmonella with the Host Epithelium in Presence of
Commensals
by
Prerak T. Desai
Utah State University, 2010
Co-Major Professors: Dr. Bart C. Weimer and Dr. Marie K. Walsh
Department: Nutrition, Dietetics, and Food Sciences

Food-borne infections are a major source of mortality and morbidity. Salmonella
causes the highest number of Food-borne bacterial infections in the US. This work
contributes towards developing strategies to control Salmonella by (a) defining receptors
used by Salmonella to adhere to and invade the host epithelium; (b) developing a host
receptor based rapid detection method for the pathogen in food matrix; (C) and defining
mechanisms of how probiotics can help alleviate Salmonella-induced cell death in the
host epithelium.
We developed a cell-cell crosslinking method to discover host-microbe receptors,
and discovered three new receptor-ligand interactions. Interaction of Salmonella Ef-Tu
with Hsp90 from epithelial cells mediated adhesion, while interaction of Salmonella EfTu with two host proteins that negatively regulate membrane ruffling (myosin

iv
phosphatase and alpha catenin) mediated adhesion and invasion. We also showed the role
of host ganglioside GM1 in mediating invasion of epithelial cells by Salmonella.
Further we exploited pathogen affinity for immobilized gangliosides to
concentrate them out of solution and from complex food matrices for detection by qPCR.
A sensitivity of 4 CFU/ml (3 hours) in samples without competing microflora was
achieved. Samples with competing microflora had a sensitivity of 40,000 CFU/ml.
Next we screened several probiotic strains for pathogen exclusion potential and
found that Bifidobacterium longum subspp. infantis showed the highest potential for
Salmonella enterica subspp. enterica ser. Typhimurium exclusion in a caco-2 cell culture
model. B. infantis shared its binding specificity to ganglioside GM1 with S. ser.
Typhimurium. Further, B. infantis completely inhibited Salmonella-induced caspase 8
and caspase 9 activity in intestinal epithelial cells. B. infantis also reduced the basal
caspase 9 and caspase 3/7 activity in epithelial cells in absence of the pathogen. Western
blots and gene expression profiling of epithelial cells revealed that the decreased caspase
activation was concomitant with increased phosphorylation of pro-survival protein kinase
Akt, increased expression of caspase inhibiting protein cIAP, and decreased expression of
genes involved in mitochondrion organization, biogenesis and reactive oxygen species
metabolic processes. Hence, B. infantis exerted its protective effects by repression of
mitochondrial cell death pathway which was induced in the presence of S. ser.
Typhimurium.
(216 Pages)
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CHAPTER I
INTRODUCTION

Enteric bacterial infections cause an estimated 2 million deaths worldwide every
year (9). In the U.S. infectious food-borne illnesses cause approximately 76 million cases,
325,000 hospitalizations, and 5,000 deaths annually (8). The total economic burden
related to hospitalizations is ~$3 billion and the cost due to lost productivity is estimated
to be between $20 billion and $40 billion annually (8). The economic burden due to
Salmonella alone in the U.S. is an estimated $2.8 billion (3). Unfortunately,
implementation of regulations aimed at reduction and prevention has made little impact
in the overall occurrence of Food-borne diseases (1). This places renewed importance on
understanding host-microbe interactions to define new methods of control to reduce and
prevent the ever-increasing number of Food-borne illnesses.
In the last 12 years, due to efforts undertaken broadly to reduce the incidence of
Food-borne illnesses, the relative rates for shiga-toxin producing Escherichia coli
(H7:O157), Listeria, and Campylobacter infections declined but those due to Salmonella
remained constant (1). In combination, Salmonella, Shigella and Campylobacter cause
the vast majority of food associated infectious diseases with these three genera
accounting for ~90% of Food-borne infections in 2008 (1). In 2008 Salmonella caused
the highest morbidity for all reported bacterial Food-borne illnesses in the U.S. (1). In
fact, the health risk related to Salmonella has worsened because of the emergence of
antibiotic resistant strains in animals and humans (2, 6). Researchers are aggressively
seeking new strategies that circumvent the problem of drug resistance in bacteria with
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rejuvenation of programs to discover novel antimicrobials or by using strategies to
improve the efficacy of the antibiotics in use. Unfortunately, continued emergence of
drug resistant strains and an alarming increase in multi-drug resistant strains of infectious
Food-borne disease-causing bacteria warrants increasing effort to search for alternatives
to antimicrobial chemicals. Examples of this strategy include anti-virulence therapies (5),
anti-adhesive therapy (7, 10), and the use of probiotic bacteria as dietary supplements (4).
These approaches result in additional therapeutic options for use of multiple target
molecules to intervene at key steps of host/microbe association. An emerging concept is
blocking adhesion or providing alternate surfaces that mimic the host cell as a decoy to
block disease initiation, thereby blocking disease progression. The success of this
approach requires understanding the molecular events at the host microbe interface and
how to modulate the initial interaction between pathogens and the host. Devising
alternative therapies requires a detailed understanding of the infection process beginning
with bacterial-gut association (adhesion) to invasion (host signal transduction routes) to
spread (shedding). This study seeks to discover new adhesin molecules used by
Salmonella for adherence to human gut epithelial cells to begin development of alternate
strategies that block disease initiation.
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CHAPTER II
LITERATURE REVIEW

Salmonella causes food- and water-borne disease around the world. In the U.S. it
is transmitted by many types of food, including animal and vegetable sources and is the
highest cause of morbidity and mortality in human due to Food-borne infections (Figure
2.1). One reason for host diversity is the ability of Salmonella to adapt uniquely to
specific environments and hosts causing an invasive disease. Additionally, Salmonella
adapts to a host without causing disease so that an asymptomatic and persistent carrier
state develops. This effectively creates a mechanism to consistently spread among
populations. Shedding occurs in chickens, pigs, and humans. Consequently, much of the
food supply is contaminated with an organism that is quickly transmitted between
humans and animals, rapidly becomes multi-drug resistant, readily adapts to new
environments, mutates quickly to form new serotypes, forms an asymptomatic carrier
state, and is shed after disease symptoms disappear. Therefore, we selected Salmonella to
determine the effect of specific macromolecules and other bacteria in the food supply that
can mitigate specific host/microbe and microbe/microbe interactions to reduce infection
rates. Understanding the molecular interactions during host adherence of Salmonella will
provide new insights into an important Food-borne disease and provide many target
molecules for use in prevention and intervention of disease.
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Salmonella diversity and infection
Salmonella is a pathogen of humans and animals, but the pathogenicity of
different serotypes with different hosts is not defined well or predictable (Table 2.1).
Taxonomic classification of Salmonella has evolved continuously over the years. As new
molecular technologies are used to differentiate microbes they are being applied to
Salmonella with the goal of developing consistent and correlative predictors of
host/microbe interactions and infections. Unfortunately, even within the most commonly
isolated serotypes, many questions remain unanswered that define specific serotype
diversity and interactions with the host. Using molecular taxonomic methods, Salmonella
is divided into only two species - Salmonella enterica and Salmonella bongori. Foodborne illness is almost entirely caused by serotypes within the S. enterica species (1).
This fact motivates extensive characterization of the large number of food and human
isolates to define specific serotypes to define predictive associations. It is especially
important in outbreak investigations, which led to multiple systems of identification
beyond 16s DNA typing that include bacteriophage typing, serotyping, metabolic
fingerprints, and genetic fingerprints.
Unfortunately, strain differentiation with serotyping is limited in predictive value
in non-typhoidal serovars. Hence, there is a need to develop a more refined strategy to
characterize and classify different Salmonella isolates using more specific genomicsbased tools to give predictive information about their host range and physiology for
disease or persistence. One emerging option is to utilize comparative genomics based on
the 16 finished genome sequences, 21 draft sequences, and the 42 more genome
sequences in progress. Comparative genomic hybridizations (CGH) using S. enterica ser.
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Typhimurium LT2 and another 22 Salmonella members, including all six subspecies of S.
enterica and S. bongori, found broad concordance with phylogenomic studies using 16S
DNA (68). This research also noted specific genes that changed during the evolution of
the groups. With so much sequence information we have the opportunity to harness the
power of phylogenomics to unequivocally address the question of Salmonella
phylogenetic diversity, host adaptation, and mechanisms of survival in many different
environments. This approach promises to link the specific genes or gene clusters to
specific Salmonella serotypes and host parameters that enable establishment of a
mutualistic partnership that leads to shedding and disease spread.
Salmonella and antibiotics
In humans, Salmonella-induced gastroenteritis is usually a self-limiting disease,
but in immunocompromised individuals and infants some of the non-typhoidal serovars
can cause bacterimia, which requires use of antibiotics. Resistance to antibiotics remains
a significant problem in many of the Salmonella isolates. This can be attributed to
persistence of Salmonella under constant antibiotic pressure due to indiscriminate use of
antibiotics in animal feed coupled to a highly mutable genome (58). According to the
National Antimicrobial Resistance Monitoring System (NARMS), in 2005, S. ser.
Typhimurium was the most frequently encountered serotype, accounting for 21.3% of
Salmonella isolates in the NARMS surveillance program (16). Of all the isolates tested,
34.8% were resistance to at least one of the antibiotics used for clinical salmonellosis. A
greater cause of concern though is the prevalence of multidrug resistant isolates; 22.2%
of the isolates were resistant to five different antibiotics (ampicillin, chloramphenicol,
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streptomycin, sulfamethoxazole, and tetracycline) (16). This problem demands
investment in research to define alternative strategies for management of Salmonella and
the use antibiotics as a last resort.
Salmonella host adaptation
Out of the nearly 2,600 known serovars, ~50 serovars of S. enterica subsp.
enterica account for >99.5% of all clinical isolates of Salmonella from humans and
animals (66). In spite of the predominance of S. enterica subsp. enterica serotypes, the
correlation between serotype, host, and disease is not well established. It is common to
find that the same serovar causes different disease symptoms in different hosts. Based on
their host specificity Salmonella serovars can be loosely categorized into two groups
(44). Members of the first group colonize a narrow range of hosts (commonly known as
host-adapted serovars) to cause an acute typhoid-like disease (44). Cross-infection of
these serovars into other non-host adapted species is possible, but the disease is usually
not as invasive as in its primary host (44). Examples of host-adapted serotypes include S.
enterica ser. Dublin in cattle, S. enterica ser. Typhi in humans, S. enterica ser.
Gallinarum in chickens, and S. enterica ser. Choleraesuis in pigs (44). The second group
is comprised of S. enterica subsp. enterica that infect and persist in a broad range of hosts
(commonly known as non-host adapted serovars). These cause non-typhoidal
gastroenteritis. The most common food-associated examples are S. enterica ser.
Enteritidis and S. enterica ser. Typhimurium, which are found in many food types and
host species. S. enterica ser. Enteritidis is commonly associated with chickens while S.
ser. Typhimurium infects humans, cattle, swine, sheep, horses, rodents, chicken, turkeys,
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ducks, pigeons, and finches. They are commonly transmitted to humans via direct
interaction with the animal or consumption of the meat. Cross contamination of food
animal products to water or vegetables is also a source of animal-associated Salmonella.
An increasing problem for food safety and public health is the zoonotic
transmission of non-host adapted serovars between an animal that is an asymptomatic
carrier to food and subsequently to humans that results in an outbreak of gastroenteritis.
The carrier state may occur in humans as well as animals. In a Salmonella-infected host,
after acute salmonellosis is resolved, the organism may persist asymptomatically to be
shed in the feces for months after the disease symptoms have ceased. In humans ~3% of
the people infected with typhoid-causing serovars and ~0.1% of people infected with
gastroenteritis-causing serovars become chronic carriers (51). The existence of carrier
states in food animals is of particular concern, as Salmonella can directly enter the food
chain and cause further cross contamination. The exact molecular mechanisms of how
Salmonella persists in the carrier state are not known for animals or humans, but in some
animal models fecal shedding is positively correlated with the prophylactic use of
antibiotics (56). It may be due in part to an altered gut microflora composition caused by
antibiotic treatment.

Salmonellosis in humans
S. enterica causes two distinct diseases in humans - typhoid-fever (enteric fever)
and non-typhoidal gastroenteritis (Figure 2.2)
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Enteric fever
The disease in humans is characterized by invasion of Salmonella through the
small intestine before further spread into the liver, spleen, gall bladder, and bloodstream.
There are four host-adapted serovars in S. enterica subsp. enterica (Typhi, Paratyphi A,
Paratyphi B, Paratyphi C) that cause enteric fever in humans. They account for ~2% of
the total Salmonella isolates from human salmonellosis (17). There are no other known
hosts, except humans and higher primates, for these four serovars (61).
Untreated enteric fever has a mortality rate of 12-30% while antibiotic-treated
cases have ~1% mortality. The organism is usually transmitted through the fecal/oral
route and through poor sanitary practices. There are two commercially available vaccines
for typhoid fever in humans. The first vaccine is a live attenuated strain of serovar Typhi,
while the other is a preparation of the capsular Vi antigen. Both the vaccines have a
reported ~55% efficacy (35) at the 3-year interval. Clinical trials of a third, but
unlicensed vaccine (rEPA-Vi conjugate), have shown a comparative increase in
efficiency (~89%) and it confers immunity for a longer period (35). Since the only source
of infection is an infected person, spread of the organism is controlled with antibiotics
and good hygiene to prevent cross contamination. Enteric fever is not common in
industrialized regions like the US, but travelers to Asia, Africa, and Latin America are at
risk.
Non-typhoidal gastroenteritis
Salmonella-associated gastroenteritis is a common food safety concern. It is
characterized by nausea, cramping abdominal pain followed by diarrhea, fever, and
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sometimes vomiting. The infection is usually restricted to inflammation of the intestine,
but complications can arise in at risk populations, such as infants, the elderly and
immunocompromised patients. The infective dose for gastroenteritis causing serovars
varies from 104-106 cells (12).Various factors influencing infective dose are serovar, the
delivery matrix of the organism and various host specific factors (e.g., age and immune
status) (12). The infective dose of Salmonella in a food matrix containing high fat or
protein (e.g., cheese, meat) is significantly lower than those containing low of no fat or
protein (e.g., water, vegetables) (12, 23). Although people from all age groups are
susceptible to infection with Salmonella, the incidence of salmonellosis in children < 4
years of age is seven times higher compared to healthy adults (1) (Figure 2.1)
The overwhelming majority (roughly 98%) of human clinical isolates of
Salmonella cause non-typhoidal gastroenteritis. The range of hosts for gastroenteritiscausing Salmonella varies from warm-blooded (swine, human, cattle, poultry, rodents) to
cold-blooded (reptiles, amphibians) animals. S. ser. Typhimurium is the most dominant
serovar causing illness in humans and animals, accounting for approximately 17% of the
human clinical isolates and 20% of non-human isolates (17). One reason for the high
prevalence of S. ser. Typhimurium is that it colonizes a broad range of hosts - humans,
cattle, poultry, sheep, pigs, horses, and wild rodents (7). The second most isolated serovar
is S. ser. Enteritidis, which accounts for 16% of human clinical isolates and 3% of nonhuman isolates (17). No effective vaccine exists for humans against Salmonella-causing
gastroenteritis.
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Molecular mechanisms of Salmonella-induced gastroenteritis
Non-typhoidal salmonellosis in humans is characterized by rapid loss of fluid and
electrolytes, abdominal cramps and in few cases vomiting and fever. The main stages of
Salmonella infections are adhesion to the host mucosa, invasion of the host mucosa,
intracellular replication, and dissemination back into the environment via fecal shedding
(Figure 2.3).
The primary symptom of non-typhoidal gastroenteritis is dehydration due to
passive loss of protein-rich fluid, and a decreased ability to absorb the lost fluids because
of injury to the mucosal lining caused by acute inflammation (63). In some cases that are
untreated or in at risk populations death results from dehydration, not the outright
infection. Since adhesion and invasion of the host mucosa are the required steps for
progression of the disease, intervention at these stages is an attractive therapeutic
strategy, especially since antibiotic resistance is increasing.
Adhesion to the host
Adhesion of Salmonella, like other microbial pathogens, to a specific stucture on
the epithelial surface is the first and necessary step of host colonization (78). Several in
vivo studies have defined the importance of adhesion in the infection process of various
pathogens. For Salmonella in particular, Sugita-Konishi et al. (80) used a mouse model to
demonstrate that preventing Salmonella from adhering to the host mucosa significantly
reduced the amount of Salmonella recovered from the spleen. Clinical studies with
cranberry juice, an inhibitor of adhesion of uropathogenic E. coli to human epithelial
cells showed that the juice significantly decreased the rate of urinary tract infections in
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women (49). These and many other in vivo studies (2, 77, 78) have unequivocally
established the importance of bacterial adherence in disease progression. A detailed
understanding of bacterial adhesins and the cognate host receptors will lead to new
therapies that prevent bacterial adhesion, thereby averting disease. Since a single
bacterium utilizes many different molecules to bind the host, a thorough characterization
of all the bacterial adhesins is required to realize the full potential of anti-adhesive
therapies.
Salmonella expresses a variety of adhesins that can be categorized into fimbrial
and afimbrial adhesins. Five major types of fimbrial adhesins that mediate adhesion to
epithelial cells are defined: 1) thin aggregative fimbriae, 2) long polar fimbriae, 3)
plasmid encoded fimbriae, 4) Type I fimbriae, and 5) π-fimbriae. Each fimbrial type uses
a slightly different host molecule for adherence to the host cell (Table 2.2)
Thin aggregative fimbriae are encoded by the csg operon and are essential for
virulence of Salmonella in the mouse model (81). In vitro, thin aggregative fimbriae of S.
ser. Enteritidis bind fibronectin, but the in vivo relevance of this interaction is unknown
(21). In mice, csgA is a pathogen-associated molecular pattern (PAMP) that binds TLR-2
(82), which subsequently leads to an inflammatory response by the host.
Long polar fimbriae in Salmonella are encoded by the lpfABCDE operon and
mediate attachment of Salmonella to murine Paeyer’s patches, but not to villous
enterocytes (8). Deletion mutants of lpfC alone had minimal effect on virulence in mice,
as did single gene deletion mutants of invA (necessary for invasion). However, double
deletions led to a 150-fold increase in oral LD50 as compared to the wild type strain or the
single deletion mutants (8, 64).
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Another fimbrial operon in Salmonella’s repertoire is the pefBACD operon that is
contained on the virulence plasmid. This operon mediates adhesion to the mouse small
intestine and is also important to induce the inflammatory response in the host (6).
Plasmid-encoded fimbriae specifically bind the Lewis X blood group antigen in vitro
(18). The in vivo significance of this observation remains to be determined; however, it
suggests that human hosts are susceptible based on their blood-type, much like found in
Helicobacter pylori infections (72). Type I fimbriae modulate the adherence of
Salmonella to human colon carcinoma cells (HT-29) through mannosylated
oligosaccharides on the cell surface (48), which provides further evidence for the role of
the host glycan status for Salmonella infection. Type I fimbriae are encoded by the
fimAICDHF operon with the fimH subunit on the tip of the fimbrial shaft providing
binding specificity to the host glycan.
The π-fimbriae are encoded by the stdABC operon. The stdA gene mediates
attachment of Salmonella to α-1-2 fucosylated receptor(s) localized in the mucus layer of
the murine cecum (19). It is speculated that in vivo stdA-mediated binding to the mucus
layer gives a competitive advantage during colonization of the mouse cecum. Hence,
Salmonella fimbrial adhesins act like lectins that bind various terminal sugar residues on
the host cell surface which serves two purposes: 1) to help the organism colonize host’s
gut and 2) to bring the organism close enough to the host cell surface so that it can invade
via other proteins on the host and the microbe.
Recently a few non-fimbrial adhesins and components of the Type III secretion
system (T3SS) were implicated to mediate adhesion of Salmonella to the host mucosa
(Table 2.2). Salmonella contains two T3SS loci; T3SS-1 is associated with invasion of
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the host mucosa, while T3SS-2 is associated with survival inside host cells. Surprisingly,
three translocon components of the T3SS-SP1 (sipB, sipC, sipD) mediate intimate
attachment of the organism to epithelial cells in vitro (55). The cognate host receptors for
these T3SS molecules are unknown.
Two auto transporters (shdA and misL) bind fibronectin. Human intestinal
epithelial cell expression of both these proteins in vitro correlated with increased
adhesion and increased invasion of Salmonella (27, 47). Binding to extracellular matrix
(ECM) components by enteric pathogens is proposed to serve two functions for
pathogens. One advantage is to colonize damaged host tissue where the ECM
components are freely accessible. The second function is that binding ECM components,
like fibronectin, allows the pathogen to modulate the host cytoskeleton via integrins. This
leads to gap junction disruption that opens direct access to the basement membrane and
the circulatory system (50, 75). Salmonella uses several receptors to colonize the host via
different classes of molecules, which again demonstrates the significance of adhesion in
disease. Table 2.2 summaries the known adhesins that mediate attachment of Salmonella
to the host mucosal epithelial molecules. The list of molecules implicated as adhesins
contains Salmonella adhesins that bind sugar moieties on the host cell surface. These are
all associated with fimbrae. Another series of molecules uses other receptors. Location of
the sugar moieties it is not entirely clear and no assessment of adhesion with sugars that
are part of glycans, glycoproteins, or glycolipids is available.
While a short list of adhesins is known for Salmonella, in many cases the host
receptor is unclear. This limits our understanding of the molecular events following
adhesion. For example, the plasmid-encoded fimbrial protein (PefC) is important for
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adhesion, but the cognate host receptor is unknown. This lack of information is crucial
for deciphering the signal transduction events initiated at the host-microbe interface that
lead to the disease symptoms via membrane protein signaling. One approach is to delete
the genes needed for invasion. In this light, incubation of human epithelial cells with
adherent but non-invasive mutants of Salmonella leads to an increase in NFkB activation
via a signal transduction route initiated from an undescribed receptor (30). Hence, there
are yet unidentified T3SS-independent mechanisms that lead to modulation of
inflammatory pathways that are likely therapeutic targets. Additional research to
characterize the receptors of host Salmonella interactions is definitely warranted and will
lead to new therapeutic strategies as well as defining new mechanisms of disease
initiation.
Invasion of the host mucosa
The ability of Salmonella to induce its uptake within non-phagocytic epithelial
cells is central to its pathogenicity (60). The second step in the infection process is the
invasion of enterocytes. Internalization of Salmonella is rapid, typically occurring within
15-30 minutes of bacterial contact with the host cell (60). The whole process resembles
macropinocytosis (34, 60) and progresses with direct injection of bacterially produced
effector molecules through the T3SS into the host cytosol. This manipulates the
cytoskeleton via actin filaments causing formation of membrane ruffles among other
effects (Figure 2.4). The internalized bacteria remain enclosed within a special
membrane-bound vacuole (Salmonella-containing vacuole (SCV)). Salmonella also
interferes with the host’s intravessicular trafficking machinery via a different set of T3SS
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effectors to prevent fusion of SCVs to lysosomal compartments. This bacterially directed
maturation of SCV leads to the formation of a protected intracellular niche permissive of
bacterial replication and persistence (28).
T3SS Effectors and modulation of the host actin cytoskeleton. T3SS effectors
are eukaryotic-like bacterial proteins that interfere with a wide range of cellular
processes. These effectors are injected directly into the host cytosol by the T3SS that
resembles a molecular syringe. Table 2.3 lists the characterized T3SS effectors in
Salmonella involved in invasion and their role in the infection process. Figure 2.5
(adapted from (60)) shows the interplay of the effectors with the host molecules.
Salmonella modulates the host actin cytoskeleton by direct stimulation of actin
nucleation and polymerization, activation of small GTPases that eventually leads to actin
polymerization, and via indirect activation of GTPases via phosphoinositide metabolism
(60). Two of the injected effectors proteins, SipA and SipC, bind actin and directly
manipulate the host actin cytoskeleton. SipC mimics the actin nucleation activity of the
endogenous Arp2/3 complex and stimulates actin assembly by bundling and cross-linking
existing actin filaments (60). SipA promotes actin filament polymerization by reducing
the monomer concentration necessary for filament assembly, enhancing the filament
bundling activity of the host protein fimbrin. SipA also binds to the assembled filaments
and prevents ADF/cofiliin mediated depolymerization. Thus the synergistic activity of
SipC and SipA promotes the formation of actin filaments in proximity to the attached
bacteria (60).
The protrusive force required to drive the formation of the phagocytic vesicle
requires formation of highly branched actin filaments. The formation of such a network is
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mediated by small GTPases of the Rho family, primarily Rac and Cdc42. Two of the
Salmonella effectors, SopE and SopE2, act as guanine nucleotide exchange factors
(GEFs) that are specifically targeted towards Rac and Cdc42 to facilitate the exchange of
GDP to GTP in the GTPases stimulating Rac and Cdc42 activity. Once activated Rac and
Cdc42 stimulate downstream effectors leading to actin assembly (60).
The injected effector protein SopB (also annotated as SopD in some publications)
indirectly stimulates RhoG activity that leads to hydrolysis of phosphoinositides (28).
SopB also exerts inositol phosphatase activity on the intermediates in the phosphoinositol
conversion pathway changing the conversion of PI(3,4)P2, PI(3,4,5)P3, PI(3,5)P2, and
PI(4,5)P2 (28). The exact mechanism of how RhoG is activated is under investigation, but
it is proposed that modulation of the phosphoisositide concentration recruits endogenous
RhoG GEF, SGEF, which leads to activation of RhoG (28). RhoG activates Rac through
Rac’s GEF which eventually leads to actin polymerization (60).
The next step in invasion is phagosome closure. The PI(4,5)P2 hydrolyzing
activity of SopB leads to reduction of PI(4,5)P2 in the vicinity of the attached bacteria. It
is hypotized that the local reduction in the PI(4,5)P2 levels leads to dissociation of cortical
actin from the nascent phagosome resulting in phagosome closure (60).
Shortly after bacterial entry the host cytoskeleton is remodeled to its initial state.
This phenomenon is pronounced in polarized epithelial cells where apical microvilli are
completely reassembled after invasion. This is achieved by another injected effector SptP
that acts like an endogenous Rho GAP inactivating the previously activated Rac and
Cdc42 (by SopE and SopE2) (60).
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Once inside the SCV the bactierum prevents fusion of the SCV membrane with
the lysosomal compartment to avoid intracellular clearance by the host lytic enzymes and
the immune system. The exact mechanisms of this process are not known, but this
phenomenon is mediated by T3SS effectors from Salmonella pathogenicity island-2 (SPI2) that are secreted in the host cytoplasm across the SCV membrane.
Invasion of the host mucosa by Salmonella results in increased expression of
chemotactic factors by the host. This results in infiltration of neutrophils into the lamina
propria (74). As the inflammatory reaction progresses, neutrophils migrate through the
epithelial layer with the accumulation of inflammatory cells. Protein-rich fluid is secreted
into the intestinal lumen which manifests itself as diarrhea (74).
Novel therapeutic and prophylactic approaches for control of Salmonella
Since adhesion of bacteria to the host initiates the infection process, intervening at
that step represents an ideal strategy for disease prevention. Salmonella is capable of
binding via multiple adhesins (Table 2.2); hence, it may be difficult to develop a
universal class of anti-adherence compounds unless common interacting molecules can
be found. To fully harness the potential of this approach, extensive characterization of
adhesin/receptor affinity and specificity are needed. Various sugar moieties (mannose,
fucose, sialic acid, galactose) are important for fimbrial adhesion. Consequently, they are
immediate targets for discovery and development. The efficacy of anti-adhesive therapy
is demonstrated in animal models where administration of specific oligosaccharides
protects the animal from various enteric infections (Table 2.4). The efficacy of various
sugar moieties for pathogen blocking in animal models is summarized in Table 2.4.
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Interestingly, human breast milk contains oligosaccharides that are similar to cell surface
carbohydrates, and some in vitro studies demonstrate their efficacy in disease prevention
for some populations (52). To fully realize the potential of this approach, a more
thorough characterization of adhesins is required.
The concept of anti-adhesive compounds can be extended to non-carbohydrate
adhesion-inhibitory agents like antibodies. The efficacy of this approach is demonstrated
in an E. coli-mouse infection model to block specific receptors (54). The central concept
is that microbial adhesins make ideal vaccine candidates. Langermann et al. (54) showed
that immunization of mice with the E. coli FimH adhesin reduced in vivo colonization by
more than 99%. Furthermore, passive systemic administration of immune sera to FimH
also resulted in reduced bladder colonization by uropathogenic E. coli (54). Hence,
characterization of Salmonella adhesins could also provide viable targets for the elusive
vaccine against gastroenteritis causing serovars.
The normal gut flora forms the first line of defense against enteric infections (79).
The composition of this protective flora can be altered by dietary and environmental
influences making the host susceptible to disease. Disturbance in the normal microflora
due to pre-treatment of mice with antibiotics makes them more susceptible to Salmonella
infection (22). The same study also showed that the total number of bacteria in the gut
was not altered after pre-treatment with antibiotics, but rather the altered composition of
the gut flora was responsible for the increased susceptibility to Salmonella (22). The use
of probiotics centers on the idea that probiotic treatments re-establish the natural
condition which excised in the host before being disrupted by various stresses (36). Many
studies have linked prophylactic treatment with probiotics to reduced rate of enteric
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infections. A study in the pig model showed that feeding a five-strain probiotic mixture
that contained two strains of Lactobacillus murinus, and one strain each of Lactobacillus
salivarius, Lactobacillus pentosus and Pediococcus pentosaceous reduced pathogen
shedding and alleviated disease symptoms when animals were infected with S. ser.
Typhimurium (15). Although the specific mechanism of the pathogen reduction was not
elucidated, this study suggests that probiotics can inhibit infection and reduce symptoms.
Broadly, the mechanisms of probiotics to directly influence the pathogen include
competing for nutrients, production of antimicrobials, and pathogen exclusion at the host
surface (57).
The pathogen exclusion potential of various probiotics is dependent on the
probiotic as well as the pathogen strain. Jin et al (45) showed that in vitro L. acidophilus
inhibited adhesion of S. sv Pullorum, but failed to inhibit adhesion of S. sv Enteritidis and
S. ser. Typhimurium. A recent study in humans correlated the decreased number of
Bifidobacterium in the gut to acute salmonellosis (14). A study in the cell culture model
has also demonstrated the anti-adhesive effect of Bifidobacterium on S. ser. Typhimurium
(10). The ability of Bifidobacteria to inhibit pathogen attachment is strain dependent and
independent of Bifidobacteria’ s adhesion properties; an adherent bifidobacterial strain
does not guarantee pathogen exclusion (11). The mechanisms of adhesion of
Bifidobacteria to the host are undefined. There is only one study that implicates a solute
binding lipoprotein (BopA) (41, 42) in adhesion of Bifidobacterium to caco-2 epithelial
cells in vitro (Table 2.5). The cognate receptor on the host is unknown. The exact
mechanisms of pathogen exclusion by Bifidobacteria are not yet characterized.
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Another well documented mode of probiotic action against enteric pathogens is
the production of various antimicrobial compounds such as H2O2, lactic acid and
bacteriocins (57). For example, the strong antimicrobial activity of L. rhamnosus GG
against S. ser. Typhimurium was due to the accumulation of lactic acid (24). Pridmore et
al. (70) described an in vitro role of H2O2 in the anti-Salmonella activity of L. johnsonni.
Lievin et al. showed that two strains of Bifidobacterium isolated from infant gut produced
a yet unidentified antimicrobial substance that exerted antimicrobial effect against S. ser.
Typhimurium in vitro, inhibited cell entry, and killed intracellular S. ser. Typhimurium
using Caco-2 cells (59).
At the host mucosa there is a complex multi- way interaction between host,
pathogen and the resident gut flora that dictates the outcome of the infection. Most
studies until now have been dedicated to unravel the effect of
probiotics/commensals/pathogen on the host while the literature on the microbe-microbe
interaction is sparse at best. Recently there has been a steady increase in reports of
intraspecies communication that affect the virulence gene expression of pathogens. For
example, short chain fatty acids like acetate, propionate and butyrate induce the
expression of hilA (invasion protein transcription activator), which positively regulates
virulence gene expression in Salmonella (29). Even et al. (33) demonstrated that mixed
cultures of Lactococcus lactis negatively regulated the virulence genes of Staphylococcus
aureus. They did not investigate the in vivo relevance of the observation, but the in vitro
results open a new dimension of looking at the microbe-microbe interactions.
Among all age groups the incidence of Salmonella-induced diarrhea is highest in
infants (17). Bifidobacterium forms the most abundant genera in breast fed infants (53),
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and since they show anti-infective activity towards Salmonella, the molecular mechanism
by which they inhibit pathogen adhesion and invasion needs to be investigated. The effect
of Bifidobacterium on gene expression of Salmonella and how this influences infectivity
needs to be investigated.
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Hypothesis and objectives
B. longum subspecies. infantis reduces S. ser. Typhimurium adhesion to gut
epithelial cells by competing for the same receptors and also improves cell survival by
modulation of specific pathways in the host.
These hypotheses will be tested via the following objectives:
Objective 1. Define the pathogen exclusion potential of selected probiotic bacteria to gut
epithelium in vitro.
Objective 2. Define the binding partners of the host-bacteria interaction
Objective 3. Identify putative signal transduction and metabolic pathways modulated in
the host and the microbes using caco-2 cells in vitro with adhesion of B.
infantis and S. ser. Typhimurium.
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Table 2.1 Number of serovars present in each species of Salmonella (66).
Salmonella species
S. enterica
S. enterica subsp. enterica
S. enterica subsp. salamae
S. enterica subsp. arizonae
S. enterica subsp. diarizonae
S. enterica subsp. houtenae
S. enterica subsp. indica
S. bongori
Total (genus Salmonella)

Number of
serovars
2,557
1,531
505
99
336
73
13
22
2,579
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Table 2.2 Adhesins used by Salmonella and their cognate partners on the host for
adherence to the host mucosal epithelium.
Salmonella adhesin molecule
Fimbrial adhesins
Plasmid encoded fimbriae (pefC)
Plasmid encoded fimbriae (pefA)
Fimbrial Adhesin (stdA)
Long Polar fimbriae (lpf operon)
Thin aggregative fimbriae (agfA)
Type-1 Fimbriae (fimH)
Thin curled fimbriae (csgA)
Non-fimbrial adhesins
Non-fimbrial adhesin (siiE)
Auto-transporter like protein
(shdA)
Autotransporter (misL)
66-kDA Heat Shock Protein
Murien Lipoprotein (lppA, lppB)
Outer Membrane Protein (ratB)
Intimin-like protein (sinH)
Type III secretion system
Protein Translocase (sipB)
Protein Translocase (sipC)
Protein Translocase (sipD)
Uncharacterized
Outer membrane lipoprotein
(invH)
Unknown
Unknown
Unknown
1

Cognate Host receptor

Reference

Unknown
Galβ1–4(Fucα1–3)GlcNAc
Fucα1-2Galβ1-4GlcNAc
Unknown
Unknown
Mannose moieties on glycoconjugates
Toll-like receptor 2 (TLR2)

(6)
(18)
(19)
(8)
(81)
(43)

Unknown
Fibronectin

(37)
(47)

Fibronectin
Mucin
Unknown
Unknown
Unknown

(27)
(32)
(76)
(46)
(46)

Unknown
Unknown
Unknown

(55)
(55)
(55)

Unknown

(4)

Mixed Gangliosides
Cystic fibrosis transmembrane
conductance regulator1
Galb(1-3)GalNAc

(26)
(67)

Unknown
Integrins CR3, CR1
receptor for ser. Typhi, but not for ser. Typhimurium.

(82)

(38)
(83)
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Table 2.3 Salmonella T3SS effectors that play a role in invasion of non-phagocytic cells.
Effector protein
SipA
SipB
SipC
SipD
SopE
SopE2
SopB/SigD
SptP

Function
Enhances actin filament assembly and inhibits actin
disassembly
T3SS translocon component, acts like an adhesin
T3SS translocon component, acts like an adhesin,
promotes actin polymerization
T3SS translocon component, acts like an adhesin
Guanine nucleotide exchange factor (GEF) for Cdc42
and Rac ;promotes assembly of branched actin filaments
Guanine nucleotide exchange factor (GEF) for Cdc42
Phosphoinositide phosphatase; activates RhoG; Other
roles suspected but not characterized
Rho GAP, functions in repression of host membrane
ruffling post entry.

Reference
(60)
(55, 60)
(55, 60)
(55, 60)
(60)
(60)
(60)
(60)
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Table 2.4 Anti-adhesive compounds that prevent bacterial infection in vivo. (GITGastrointestinal tract, UT-Urinary tract)
Organism
C. jejuni
E coli

H. pylori

Site of
infection
Mice GIT
Mice UT
Mice UT
Mice GIT
Pig GIT
Monkey GIT

Anti-adhesive molecule
HMO
methyl alpha-Dmannopyranoside
Globotetraose
Mannose
Sialyl-3'-LacNAc
Sialyl-3'-Lac

Bacterial
Receptor
Unknown
Type 1 Fimbriae
Type 1 Fimbriae
P-fimbriae
Unknown
Unknown

Ref
(73)
(5)
(31)
(39)
(62)
(62)

36

Table 2.5 Known adhesins of selected probiotics
Organism

Microbe
Protein

Host receptor

Ref

Lactobacillus
acidophilus NCFM

Mub

Mucus

(13)

Lactobacillus brevis
ATCC 8287
Lactobacillus johnsonni
LA1

SlpA
Fbp
CdpA
SlpA

Unknown
Fibronectin
Unknown
Laminin, Collagen, Fibronectin

(13)
(13)
(3)
(25)

EF-tu

Mucus

(40)

GroEL
Msa

Mucus
Mucus via mannose binding

(9)
(69)

CnBP

Collagen

(71)

LspA

Collagen, Mucin

(20)

BopA

Unknown

(42)

Lactobacillus
plantarum WCFS1
Lactobacillus reuteri
NCIB 11951
Lactobacillus salivarius
UCC 118
Bifibacterium. bifidum
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Figure 2. 1 Reported cases of Food-borne illnesses by age (1)
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Figure 2. 2 The two types of diseases caused by Salmonella. Both are initiated at the
intestine but enteric fever is characterized by spread of Salmonella to deeper tissues while
gastroenteritis is limited to inflammation of the intestine (Adapted from (65)).
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Figure 2. 3 Infective cycle of gastroenteritis caused by Salmonella. Adapted from
Navaneethan et al. (63).
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Figure 2. 4 TEM showing invasion of bovine enterocytes by S. ser. Typhimurium.
Arrows 1 indicates membrane-bound bacteria after engulfment. Arrow 2 highlights
engulfment at the apical membrane while it is still open to the lumen (Adapted from
(74)).
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Figure 2. 5 Interaction of Salmonella with the host through its T3SS effectors (Adapted
from (60)).
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CHAPTER III
IDENTIFICATION AND CHARACTERIZATION OF HOST MICROBE
RECEPTORS BY WHOLE CELL CROSSLINKING

Abstract
A cell-cell crosslinking method to discover host-microbe receptors was
developed. The protocol was first applied to discover extracellular matrix (ECM) binding
proteins in Lactobacillus acidophilus, E. coli and Salmonella ser. Typhimurium. I found
new bacterial proteins crosslinked to ECM components, in addition to proteins already
reported in literature. Further, I applied the protocol to crosslink S. ser. Typhimurium to
epithelial cells, and discovered three new receptor-ligand interactions. Interaction of
Salmonella Ef-Tu with Hsp90 from epithelial cells mediated adhesion, while interaction
of Salmonella Ef-Tu with two host proteins that negatively regulate membrane ruffling
(myosin phosphatase and alpha catenin), mediated adhesion and invasion. I also showed
the role of host ganglioside GM1 in mediating invasion of epithelial cells by Salmonella.
Introduction
Bacterial association with humans is a complex evolutionary partnership the
impacts health (34) and disease (51). This co-evolution reflects complex host receptor
and bacterial adhesin partnerships (30). Unfortunately, relatively few receptor/adhesin
associations are defined (30) and many more exist than can be associated with host
response to disease Host-microbe receptor/adhesin pairings are one of the most critical
determinants that control bacterial host range (38), targets bacteria to specific tissues
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(17). Adhesion is the first step in infection. It initiates the host response by triggering
signal transduction routes, and prompts the immune system to mount a response to clear
the infection. In case of invasive bacteria, such as Listeria monocytogenes (45) and
Salmonella enterica (23), adhesion is the prelude to host cell invasion to cause
gastrointestinal infection and tissue migration that leads to systemic disease and
secondary infections or long term carrier states. Likewise, recognition of host cell surface
molecules by commensal and probiotic bacteria is also important for the observed health
benefits of bacterial association with humans (34). Probiotic bacteria initiate a proinflammatory or an anti-inflammatory response by the host based on the type of
microbial ligands bound by host receptors (58). Hence, identification and characterization
of host-microbe receptor pairs is one of the most important areas in cellular microbiology
for the discovery of mechanisms initiated by bacterial ligands during adhesion with host
cell receptors.
Control of bacterial infection is becoming increasingly challenging with rising
antimicrobial resistance (20). This situation calls for alternative compounds and strategies
to control infectious disease. Disrupting adhesion is a possible strategy to reduce
bacterial adhesion and invasion, and hence slow or stop disease progression (47);
however, to fully harness the potential of this approach discovery and extensive
characterization of receptor/adhesin specificity is needed. Alternatively, microbial
adhesins can be used as vaccine candidates that have increased immunogenicity if they
consistently bind to specific host receptors. Langermann et al. (31) successfully
demonstrated this approach using an adhesin-based vaccine to reduce in vivo colonization
of E. coli by more than 99% in a murine cystitis model. Identifying the cognate
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receptor/adhesin partnerships used by pathogenic bacteria to bind and invade host cells is
the first step in development of a series of alternative therapies that will reduce pathogen
infection, systemic disease, and bacterial shedding.
Identification of receptor/adhesin pairs is difficult. No protocols or methods are
established that define the ligand-receptor relationships. Even though reports of bacterial
adhesin are common, they host receptor is usually unknown, or at best inferred from the
possible set of host receptors. One approach to define the partnership is to screen libraries
of tagged mutants for defects in adhesion/ colonization phenotype (42). Unfortunately,
this approach does not reveal the identity of cognate host receptor. Considering the
usually high redundancy of adhesin molecules (genes) in microbial genomes, screening
mutant libraries where only a single loci is disrupted, the expected false negative rate will
be very high leading to an excruciatingly slow approach to find cognate receptors. While
the affinity pull down approach will define the cognate partnership membership, such as
the report by Cabanes et al. (9), identity of one at least one host binding partners must be
known before beginning this type of experiment. This report describes an a priori high
through put method to discover cognate receptor/adhesin partners in bacterial
associations.
To characterize host-microbe receptor partners, a whole cell cross-linking method
was developed using a cell impermeable cross-linking reagent, Sulfo-Nhydroxysuccinimidyl-2-(6-[biotinamido]-2-(p-azido benzamido)-hexanoamido) ethyl1,3'-dithioproprionate (sulfo-SBED) ( Appendix Figure A1) to covalently link cellular
proteins during host-bacterial association. Sulfo-SBED is a heterobifunctional reagent
that can be used to cross-link proteins (25). The NHS-ester moiety of sulfo-SBED
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covalently reacts preferentially, with primary amines of one protein that is followed by
photoactivation of the aryl azide moiety to nonspecifically bind interacting molecules
within 9-12 Å, thereby covalently cross-linking two protein molecules that are intimately
interacting. Additionally, the Sulfo-SBED molecule contains biotin that was used to
isolate the covalently bound complex and a reducible disulfide linkage to release both
proteins with individual pieces of Sulfo-SBED that remain on the respective proteins.
Sulfo-SBED is membrane impermeable cross-linking reagent, hence in intact cells, only
the cell surface proteins would be labeled (25) and presence of proteins from lysed cells
was prevented by repeated washing of labeled cells in osmotically balanced buffer. By
exploiting the molecular properties of Sulfo-SBED to cross-link membrane proteins
within whole cells during adhesion a new method was designed to identify cognate
receptor/adhesin partners with two-dimension gels and mass spectrometry.
I initially used the method to determine ECM binding protein in L. acidophilus, S.
ser. Typhimurium and E. coli. Later, I identified several new putative receptor ligand
interactions between S. ser. Typhimurium and epithelial cells. I functionally showed the
role of 3 of those partnerships in adhesion and invasion of S. ser. Typhimurium.
Materials and methods

Cell culture and bacterial strains
Caco-2 cells were obtained from ATCC (HTB-37, Manassas, VA) and cultured as
per ATCC’s recommendation. All the cells used in the assay were between passage
numbers 22-30. In brief, cells were plated at a density of 105 / cm2 in either a T25 or a 96
well plate. Cells were maintained in DMEM/High Modified (Thermo Scientific,
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Rockford, IL) with 16.6% fetal bovine serum (FBS) (HyClone Laboratories, Logan, UT),
non-essential amino acids (Thermo Scientific, Rockford, IL), 10mM MOPS (Sigma, St.
Louis, MO), 10 mM TES (Sigma), 15 mM HEPES (Sigma) and 2 mM NaH2PO4(Sigma).
Cells were considered to be differentiated 14 days post confluence (49), and used for the
adhesion and crosslinking assay. Bacterial cells were grown as described in Table 3.1.
Labeling bacterial cells and purified proteins
with Sulfo-SBED
The bacterial cells were labeled with Sulfo-N-hydroxysuccinimidyl-2-(6[biotinamido]-2-(p-azido benzamido)-hexanoamido) ethy-1, 3’-dithioproprionate (SulfoSBED) (Thermo Fisher Scientific, IL, USA). The total cell surface protein content on ~
109 bacteria was measured using the BCA protein assay (Thermo Fisher Scientific, IL,
USA). Assuming an average molecular weight of 60,000 Da for proteins, 10 fold molar
excess Sulfo-SBED (dissolved in DMSO at 50 µg/µl) of the determined protein
concentration, was added to 109 bacteria suspended in 1 ml of tyrode’s (140 mM NaCl,
5mM KCl, 1mM CaCl2, 1mM MgCl2, 10 mM glucose, 10mM sodium pyruvate, 10 mM
HEPES, pH 7.4) The labeling reaction was continued in dark on ice for 45 minutes with
intermittent shaking. After 45 minutes the reaction was quenched by adding two fold
molar excess glycine as compared to sulfo-SBED. The bacteria were washed twice with
tyrode’s by centrifugation at 6000 X g for 2 minutes and resuspended in 1 ml tyrode’s
buffer.
Fibronectin (Sigma-Aldrich Corp, St. Louis, MO) and fibrinogen Sigma-Aldrich
Corp, St. Louis, MO) were dissolved in tyrode’s at 1 mg/ml and were labeled with 10
fold molar excess of sulfo SBED as described earlier. After quenching the labeling
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reaction, the proteins were desalted against tyrode’s using microcon YM-30 filter
(Millipore, Billerica, MA) exactly as per manufacturer's instructions and resuspended at a
concentration of ~1 mg/ml.
Identification of microbial adhesins by label
transfer from purified proteins
About ~109 microbial cells were incubated with 1 ml of sulfo-SBED labeled
fibronectin (1mg/ml; approximately 1.4 X 105 molecules /bacterial cell) or fibrinogen
(1mg/ml; approximately 1.8 X 105 molecules/bacterial cell) for 30 minutes at 37° C. At
the end of 30 minutes the suspension was placed under a 15 watt UV lamp (302 nm) at a
distance of 5 cm for 10 minutes. The cells were washed twice with 1 ml tyrode’s by
centrifugation at 6000 X g for 2 minutes and resuspended in 500 µl lysis buffer (0.1%
triton, 150mM DTT) and 250 µl of glass beads (0.1 mm) (BioSpec Products, Inc.,
Bartlesville, OK). The samples were homogenized in a Mini-Beadbeater (BioSpec
Products, Inc., Bartlesville, OK) by giving 3 pluses at full speed for 30 s with intermittent
1 minutes incubation on ice. The free biotin in the sample from the reduced noncrosslinked proteins was removed by passing the lysate through a YM3 microcon filter
(Millipore, Billerica, MA) as per manufacturer's instructions. The retentate (volume
brought up to 800 µl with tyrode’s) from YM3 filter was incubated with ~30, 3 mm
avidin-coated glass beads (Xenopore Corp., Hawthorne, NJ) for 30 minutes on a shaking
platform to capture the biotinylated proteins. The glass beads were subsequently washed
3 times with 5 ml of wash buffer (50mM Tris, 1.5 M NaCl, pH adjusted to 7.2) to remove
nonspecifically bound proteins. The proteins on the washed beads were digested
overnight using 300 ng of proteomics grade trypsin (Sigma-Aldrich Corp, St. Louis, MO)
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in 1 ml of 100mM ammonium bicarbonate buffer. The digested proteins were
concentrated using a speedvac (Thermo Fisher Scientific, IL, USA ) to final volume of 50
µl and submitted to the Center for Integrated Biosystems, Utah State University (Logan,
UT) for protein identification by LC-MS/MS. The whole label transfer protocol was
repeated using unlabeled ECM components as negative controls.
Identification of microbial adhesins by crosslinking
with pure proteins
Microbial cells were interacted, crosslinked with labeled fibronectin/ fibrinogen
and lysed exactly as described earlier. Fifty µl of the cell lysate was diluted with 50 µl of
2X Laemmli sample buffer (52.5 mM Tri-HCL, pH 6.8, 25% glycerol, 2% SDS, 0.02%
bromophenol blue) with or without the addition of 150 mM DTT and heated at 95°C for
10 minutes. The lysate was then centrifuged at 12000 x g in a micro centrifuge and the
proteins (50 µl) in the supernatant were separated by SDS-PAGE using the MiniPROTEAN electrophoresis system (Bio-Rad Laboratories, Hercules, CA) exactly as per
manufacturer’s recommendation at a constant current of 30 mAmp per gel, using 4-20 %
precast Tris-HCL Gels (Bio-Rad Laboratories, Hercules, CA). The gels were stained
overnight with Imperial protein stain (Thermo Fisher Scientific, IL, USA) exactly as per
manufacturer’s recommendations. The gels resolved under reducing and non-reducing
conditions were imaged using the Kodak Image Station 2000R (Carestream Health,
Rochester, NY). The images for gels resolved under reducing and non-reducing
conditions were compared and bands missing in the reduced gels were identified. The gel
bands were picked, in-gel digested and the proteins identified using LC-MS/MS at the
Center for Integrated Biosystems, Utah State University (Logan, UT). The protein
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Identification of host microbe receptors
by cell-cell crosslinking
About 109 sulfo-SBED labeled bacteria were interacted with ~106 Caco-2 cells
grown in a T25 in a final volume of 3.5 ml tyrode’s buffer for 60 minutes at 37˚C. At the
end of 60 minutes the bacterial suspension was aspirated from the flask. The flask was
then placed under a 15 watt UV lamp (302 nm) at a distance of 5 cm for 10 minutes. The
cross linked Caco-2 cells and bacteria were resuspended in 500 µl of lysis buffer (8 M
urea, 6.0% ampholytes pH Range (3-10) (Bio-Rad Laboratories, Hercules, CA), 0.4 %
CHAPS, 0.25 % Triton 100, 0.15 % n-Dodecyl-B-β-D maltoside, 0.002% bromophenol
blue) and 250 µl of glass beads (0.1 mm, BioSpec Products, Inc., Bartlesville, OK). The
samples were homogenized in a Mini-Beadbeater (BioSpec Products, Inc., Bartlesville,
OK) by giving 3 pluses at full speed for 30 s with intermittent 1 minutes incubation on
ice. The samples were stored at -70° C until further use.
The cross linked samples were thawed and centrifuged at 12000 x g in a micro
centrifuge and the supernatant was used for 2D gel analysis. Isoelectric focusing (IEF)
was performed using 50 µl of sample in tube gels using the Model 175 tube cell (Bio-Rad
Laboratories, Hercules, CA) as per the manufacturer’s recommendation. In brief 4%
polyacrylamide gels were cast in 1 mm diameter tubes to a height of 11 cm. Fifty µl
samples in the lysis buffer was loaded directly on to the tubes and run at 200 V for 2
hours, 400 V for 4 hours, and finally at 800 V for 8 hours. After the IEF run, gels were
extruded from the tubes and equilibrated in transfer buffer (3 % SDS, 0.07 M Tris-HCL)
with or without 150 mM DTT for 15 minutes. The gels equilibrated in the presence of
DTT were subsequently alkylated in transfer buffer using 150 mM iodoacetamide for 15
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min. The tube gels were then resolved in the second dimension using the Criterion
electrophoresis system (Bio-Rad Laboratories, Hercules, CA) exactly as per
manufacturer’s recommendation at a constant current of 45 mAmp per gel using 4-20 %
precast Tris-HCL Gels (# 345-0104, Bio-Rad Laboratories, Hercules, CA). The gels were
stained overnight with Imperial protein stain (Thermo Fisher Scientific, IL, USA) exactly
as per manufacturer’s recommendations.
The gels resolved under reducing and non-reducing conditions were imaged using
the Kodak Image Station 2000R (Carestream Health, Rochester, NY). The images were
compared and spots missing in the reducing gels but present in the non-reduced gel were
identified. The gel spots were picked, in-gel digested and the proteins identified using
LC-MS/MS at the Center for Integrated Biosystems, Utah State University (Logan, UT).
Purification of Ef-Tu from Salmonella ser.
Typhimurium
Elongation factor Tu (Tuf) was affinity purified from S. ser. Typhimurium lysate
using a GDP-Sepharose column as described by Jacobson et al . (28) and Meide et al .
(60) with a few modifications. S. ser. Typhimurium was grown in 2 liters of brain heart
infusion broth (Thermo Fisher Scientific, IL, USA ) to early stationary phase (OD600=
~2.0). The cells were washed once with equal volume of saline and resuspended in 100
ml of TE buffer (10mM Tris, 1 mM EDTA, 0.1mM phenylmethylsulfonyl fluoride, pH 8)
containing lysozyme (Sigma-Aldrich Corp, St. Louis, MO) at 10 mg/ml. The cell
suspension was incubated at 37 °C for 30 minutes. At the end of 30 minutes sodium
deoxycholate was added to the suspension at a final concentration of 1 mg/ml and
incubated for 15 more minutes with gentle stirring. At the end of incubation period 100
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units of DNase 1 ( Promega Corp., Madison, WI) and MgCl2 at a final concentration of
10mM were added and incubated for 30 more minutes. The suspension was then
centrifuged at 25,000 X g for 30 minutes and the supernatant was used for protein
fractionation. Proteins precipitated from the 25 000 X g supernatant by (NH4)2 SO4
between saturations of 37% and 64% were dissolved in binding buffer (50mM Tris-HCl,
1mM DTT, 10mMMgCl2, 0.1mM phenylmethylsulfonyl fluoride, pH 8) at approximately
a concentration of 5 mg/ml.
Periodate oxidation and coupling of the oxidized GDP to the Sepharose were
done as follows: 0.1 mmol of GDP was dissolved in 1.3 ml of 0.1 M citrate phosphate
buffer (pH 5.0) and to this solution was added 0.11 mmol of sodium periodate dissolved
in 0.2 ml of the same buffer. The reaction mixture was incubated in the dark at room
temperature for 30 minutes. Excess periodate was eliminated by addition of 10 µl of a
40% (wt/vol) solution of ethylene glycol and incubation for an additional 10 min. One ml
of this mixture was added to 3 gm. of EAH Sepharose 4B (#17-0569-01, GE Healthcare,
Piscataway, NJ) that had been swollen in a total volume of 24 ml of 0.1 M Tricine-NaOH
(pH 8.2) containing 0.5 M NaCI. This suspension was gently rotated for 2 hour at 4°C
and was subsequently treated with 1.0 ml of 0.3 M sodium borohydrate, freshly dissolved
in 0.2 M Tricine-NaOH (pH 8.2). After 1 hour, 0.66 ml of the latter solution (again
freshly prepared) was added and incubation was continued for another hour. At the end of
incubation GDP-EAH-Sepharose was washed four times with 40 ml of 4 M NaCl.
Previously fractionated S. ser. Typhimurium lysate was adsorbed onto the washed
GDP-EAH-Sepharose by mixing equal volumes of packed resin and of (NH4)2 SO4
fractionated cell extract .The mixture was dialyzed (12 hours, 22°C) against the binding
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buffer using a 3.5K MWCO dialysis tubing (Thermo Fisher Scientific, IL, USA). The
mixture was then packed into a column (0.75 X 20 cm) and washed with the same buffer
until the absorbance at 280 nm reached baseline. One column volume of the binding
buffer containing 100µM GDP was then allowed to flow into the column and elution was
interrupted for 1 hour. Subsequent elution with GDP-containing buffer yielded Ef-Tu in
homogenous form. The purity of the eluted protein was confirmed by LC-MS/MS.
Determination of adherent and invasive bacteria
The role of specific receptors in adhesion and invasion of the host by salmonella
was assayed by determining the changes in the amount of total host (intestinal epithelial
cells, Caco-2) associated salmonella due to receptor blocking by specific antibodies. The
amount of total host associated salmonella was determined by either total viable plate
count or by qPCR as described below. The amounts of total invasive salmonella in the
host were determined by the gentamicin protection assay with a few modifications as
described below (16).
Total host associated bacteria were determined as follows. Caco-2 cells were
cultured as described earlier in a 96-well plate. The bacteria were used after two transfers
for the adhesion assays. Bacterial cells were collected from 2 ml of media after growth
for 14 hours, washed twice with an equal volume of PBS, and re-suspended at ~108
CFU/ml, in DMEM/High modified with 1X non-essential amino acids, 10mM MOPS, 10
mM TES, 15 mM HEPES and 2 mM NaH2PO4 but without the FBS. Caco-2 cells were
incubated with antibodies or specific proteins as mentioned in Table 3.2 for 60 minutes in
a final volume of 50 µl at 37˚C in 5% CO2. At the end of 60 minutes, the Caco-2 cells
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were infected with 50 µl of bacterial cell suspension (MOI 1:100) and incubated for 60
minutes at 37˚C in 5% CO2. The bacterial cell suspension was aspirated and the Caco2
monolayer was washed thrice with 200 µl of tyrode’s to remove non-adhered bacterial
cells from the monolayer. DNA extraction buffer (AEX Chemunex, France) (50 µl) was
used to lyse the monolayer and the bacteria associated with the host, and incubated at
37˚C for 15 minutes followed by 95˚C for 15 min. Resulting cell lysate was used to
determine the number of bacteria associated with the Caco-2 cells (14). Quantitative
analysis was done using qPCR with a CFX 96 Real Time System (Bio-Rad, Hercules,
CA). Reactions were performed in a final volume of 25 μl including 1 μl of cell lysate,
100 nM of PCR primers and iQ SYBR Green Supermix (Bio-Rad, Hercules CA) as per
manufacturer’s instructions. The primers used for the amplification are listed in Table
3.1. The reaction parameters consisted of denaturation step at 95°C for 5 min, followed
by 40 cycles of denaturation, annealing and extension at 95˚C for 15 s, 56˚C for 30 s,
72˚C for 30 s, respectively and a final extension at 72°C for 1 min. The product was
verified using a melt curve analysis from 50˚C to 95˚C with a transition rate of 0.2˚C/s.
The amount of bacterial cells and Caco-2 cells present in each well were estimated using
a standard curve of CT vs. Log10 CFU and amount of bacteria per Caco-2 was calculated.
The data were normalized relative to control wells which were not given any antibody
treatment. The experiment was done in four replicates.
The amount of total invaded and adhered bacteria was determined using the
gentamicin protection assay as follows. Caco-2 cells were infected exactly as described
earlier. The infected cells were incubated for 60 minutes at 37°C with 5% CO2. Upon
incubation, media was aspirated and cells were washed three times with tyrode’s buffer.
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Invaded bacteria were estimated by incubating the cells with 100 µg/ml gentamicin for 2
hours at 37°C with 5% CO2 to kill bacteria adhered or outside the Caco-2 cells. To
determine total host associated bacteria, cells were incubated with cell culture media
without any antibiotic. Cells were again washed three times with tyrode’s buffer and
lysed with 0.01% triton. The amount of bacteria in the Caco-2 lysate was determined by
plating serial dilutions on LB agar. The experiment was performed in four replicates. The
number of adhered bacteria were enumerated by subtracting mean of invaded bacteria (B)
from mean of total host associated bacteria (A) and error (ΔZ) was calculated as (ΔZ)2 =
(ΔA)2 + (ΔB)2 where, ΔA is SEM associated with the A and ΔB is SEM associated with
B. The data were normalized relative to control wells which were not given any antibody
treatment. Differences in the mean due to treatment were tested by one way ANOVA.
Post ANOVA, the means were compared to each other by Tukey-Kramer's method.
NFkB reporter assay
A reporter cell line, monitoring the activity of NFkB was generated by
transducing Caco-2 cells with lentiviral particles expressing GFP under the control of a
minimal CMV promoter and tandem repeats of NFkB transcriptional response element.
Caco-2 cells were seeded at a density of 5 X 104 / cm2 in a 96 well plate and cultured as
described before. After 2 days Caco-2 cells were transfected with ready to transduce
lentiviral particles (# CLS-013G, SABiosciences, Fredreric, MD) exactly as per
manufacturer's recommendations. In brief, cells in each well were transfected with the
viral particles at an MOI of 1:10, 0.3 µl of SureFECT transfection reagent
(SABiosciences, Fredreric, MD) in a final volume of 50 µl. Two days after transfection
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the supernatant was aspirated and the cells were maintained in the cell culture media with
12µg/ ml puromycin for 18 more days until the cells differentiated, and then they were
used for the reporter assays. The cells were serum starved for 24 hours prior to infection
with bacteria. The transfected cells were infected with different bacteria as mentioned
earlier but at an MOI of 1:1000. At the end of eight hours the amount of fluorescence in
each well was measured at an Ex/Em of 485/535 using a DTX 880 Multimode Detector
(Beckman Coulter, Brea, CA). Blank reading from non-transfected cells were subtracted
from the reported values. Differences in the mean due to treatment were tested by one
way ANOVA. Post ANOVA, the means were compared to each other by Tukey-Kramer's
method.
Western Blots
The relative abundance of target proteins due to different treatments was
quantified by densitometric analysis of western blots. Caco-2 cells were cultured as
mentioned before in a 48 well plate. The cells were serum starved for 24 hours prior to
infection with bacteria. Bacterial cells were grown as mentioned earlier, except that they
were grown in cell culture media. Caco-2 cells were incubated with either serum free cell
culture media or, Ef-Tu (2 µg/ml) dissolved in serum free cell culture media with or
without the presence of S. ser. Typhimurium LT2 ΔinvA at an MOI of 1:1000. The
experiment was repeated in 4 replicates. The cells were harvested at the end of 60
minutes by lysis in 30 µl of 1X SDS sample buffer with protease and phosphatase
inhibitors (52.5 mM Tri-HCL, pH 6.8, 25% glycerol, 2% SDS, 0.02% bromophenol blue,
50mM DTT, 50 mM Sodium pyrophosphate, 100 mM sodium fluoride, 10 mM
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orthovanadate, 1 Roche protease inhibitor cocktail tablet/50ml solvent).The samples were
heated at 95°C for 10 minutes and centrifuged at 12,000 X g for 10 minutes. 20 µl of the
sample was resolved on precast 10% Tris-HCl polyacrylimide gels (Bio-Rad
Laboratories, Hercules, CA) at a constant current of 45 mAmp per gel using the Criterion
electrophoresis system (Bio-Rad Laboratories, Hercules, CA). The resolved proteins were
then transferred to a PVDF membrane (Bio-Rad Laboratories, Hercules, CA) using the
Trans-Blot semi-dry electrophorectic cell (Bio-Rad Laboratories, Hercules, CA) as per
manufacturer's recommendation. Upon completion of the transfer, the blots were probed
for the presence of p-Akt 473 (#9271), p-AKT 308 (#9275) and p-myosin 19 (#3671), by
Pierce® Fast Western Blot Kit (Thermo Fisher Scientific, IL, USA), according to the
manufactures recommendations. Primary antibodies for all the proteins were purchased
from Cell Signaling Tech. (Boston, MA). The blots were imaged using the Kodak Image
Station 2000R (Carestream Health, Rochester, NY). Densitometric analysis of the blot
was done using Image J (1). Differences in the means due to treatment were tested by one
way ANOVA. Post ANOVA, the means were compared to each other by Tukey-Kramer's
method
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Results

Identification of fibronectin binding proteins in
Lactobacillus acidophilus NCFM
L. acidophilus binds many different extracellular matrix components (ECM) (13),
but the identity of most bacterial proteins that mediate this interaction is not known. I
used a label transfer strategy to identify bacterial proteins that mediate interactions of L.
acidophilus NCFM with fibronectin. I also wanted to check the feasibility of ultimately
using this reagent to be able to crosslink whole cells. Fibronectin was labeled with sulfoSBED and interacted with L. acidophilus NCFM, crosslinked and subsequently reduced,
which transferred the biotin label from fibronectin to any proteins within ~13 A° distance
of fibronectin. The biotinylated proteins in L. acidophilus NCFM were immobilized onto
avidin coated beads and identified by LC-MS/MS. The identified proteins are
summarized in Table 3.3. A negative control in which unlabeled fibronectin was
interacted with the bacterial cells, identified no proteins as being biotinylated. Of the six
proteins identified, functional analysis of a cdpA deletion mutant showed ~80% reduction
in adhesion to Caco-2 cells (3). InterProScan sequence analysis of cdpA predicted the
presence of two protein domains, IPR004903- bacterial surface layer protein, and
IPR011490 extracellular matrix-binding protein (41). One of the other identified protein;
LBA0222 was predicted to contain a signal peptide (41) and a transmembrane domain
(11) at its N-terminal. Since there were no annotated protein families in LBA0222, I used
Phylobuilder (21) to build neighbor joining trees based on multiple sequence alignments
of homologs of LBA0222 (Appendix Figure A2). This analysis revealed that the closest
homolog of LBA0222 in L. acidophilus NCFM was cdpA (E-Value 3.0e-22). Hence this
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method functionally identified two homologous proteins in L. acidophilus as fibronectin
binding proteins, one of which was bioiformatically predicted to contain a domain that
binds ECM components. I also identified four ribosomal proteins crosslinked to
fibronectin. Although typically found intracellularly, they have also been found expressed
on the surface of Streptococcus (55) and E. coli (54).

Identification of fibrinogen binding proteins in
E. coli and Salmonella ser. Typhimurium by
crosslinking and SDS-PAGE
The label transfer protocol is useful to identify protein interactions, if the identity
of the at least one of the interacting proteins (e.g. fibronectin in the previous case) is
known. In a cell-cell interaction model, where the identity of none of the binding partners
is known, it is possible to get a list of interacting proteins using the label transfer
approach, but it is not possible establish binding partnerships. To be able to establish
binding partnerships, I used a slightly different approach with the same crosslinking
reagent. I initially verified the feasibility of the approach by crosslinking fibrinogen to S.
ser. Typhimurium and E. coli to identify the fibrinogen interacting proteins, and later
used the approach for whole cell crosslinking. After crosslinking the protein to the
bacterial cell surface I lysed the bacteria and separated the crosslinked complex by SDSPAGE under reducing and non-reducing condition. The reducing conditions break the
disulfide bond in the crosslinker, separating the two proteins. This was visualized on a gel
due to a shift in the molecular weight of the crosslinked complex between the reducing
and non -reducing gels. Bands which showed such a shift in molecular weight were cut
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out from the gel resolved under non-reducing conditions, and the proteins were identified
using LC-MS/MS.
I identified three bands that were present in the gel resolved under non-reducing
conditions (Fig 3.1), but absent in the gels resolved under reducing conditions. Of the
three bands, two bands contained only fibrinogen, while the third band contained
fibrinogen as well as murein lipoprotein (Lpp), for S ser. Typhimurium and universal
stress protein B (UspB) for E. coli (Table 3.4). Lpp is a murein lipoprotein expressed on
the cell surface and contributes towards the virulence of the organism in the mice model
(56). Specifically, Lpp is a murein lipoprotein expressed on the cell surface and is an
established virulence factor in S. sv Typhimurium that mediates invasion (56) Persson et
al (50) reported csgA fimbriae in Salmonella to be a fibrinogen binding protein, but since
csgA is not usually expressed under normal culture conditions (26) it was not found
cross-linked to fibrinogen. Fibrinogen binding is reported in E. coli (57), but no known
fibrinogen binding proteins have been discovered. We found UspB, a membrane protein
in E. coli that is required for ethanol tolerance cross-linked with fibrinogen. Hence using
a crosslinking approach I identified a murein lipoprotein that mediates adhesion and
invasion in S. ser. Typhimurium and a cell membrane attached stress tolerance protein in
E. coli as a fibrinogen interacting protein. Given the success in the initial phase using
individual host proteins to find established bacterial adhesins, experiments moved to
cross-link whole cells.
Identification of host microbe receptors
by whole cell crosslinking
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After verifying that the crosslinking protocol worked with microbes and pure
ECM components, I used the same protocol to crosslink whole cells. I labeled the
bacteria with sulfo-SBED, crosslinked it with Caco-2 cells, lysed the cells and resolved
the samples on 2D gels (instead of SDS-PAGE) under either reducing conditions or nonreducing conditions. Protein spots that were present in the gel resolved under nonreducing condition, but absent in gels resolved under reducing conditions were picked
from the gel, and proteins identified using LC-MS/MS. Figure 3.2 shows a representative
gel resolved under non-reducing conditions The gels were resolved in two replicates and
only the spots that showed similar migration patterns in both the replicates were picked.
Forty four such spots were picked, of which 33 spots yielded protein IDs. Out of the 33
spots with protein ID, nine spots had protein IDs from the host as well as microbe in the
same spot. Of those nine spots, five spots had proteins whose sum of the molecular
weights matched the observed molecular weight of the spot on the gel. Hence those five
spots had proteins from host as well as microbes, which were crosslinked. The identified
proteins are listed in Table 3.5. Images of both the replicates resolved under reducing and
non-reducing conditions are shown in Appendix Figure A3. Based on the protein
identification results (Table 3.5), it can be concluded unambiguously, that STM2699 was
crosslinked with SPTAN1 and, STM1956 was crosslinked with HSP90AB1. STM4088
might have been crosslinked to either HSP90B1 or ACTN4, or both the proteins. Ef-Tu
from salmonella might have been crosslinked to PPP1R12A, HSP90AB1, CTNNA1,
PTPRE, PPP1R9B or MATR3. STM3286 from salmonella might have been crosslinked
with ACTB from the host, or it could have also crosslinked with Ef-Tu from salmonella
itself.
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Characterization of the protein-protein interactions
observed from crosslinking
Adhesion and invasion of the host mucosa is the first step in the pathogenesis of
salmonella. To verify the functional significance of the crosslinked proteins, I determined
their role in adhesion and invasion of S .ser. Typhimurium. Out of the five bacterial target
proteins identified from crosslinking, I investigated the role of one of those proteins and
found that, Ef-Tu was involved in adhesion as well as invasion. Out of the 11 host
proteins identified, I looked at the role of five of those proteins in adhesion and invasion.
I found that two of those proteins were involved in adhesion, one protein was involved in
invasion, while two proteins had no role in adhesion or invasion.
Since Salmonella binding with host gangliosides has been reported in the
literature (14, 37, 48), I also investigated the role of 2 gangliosides, GM1 and GD3 in
adhesion and invasion. I narrowed down on these two gangliosides as GM1 has been
reported to be a receptor for many bacterial toxins (40) and has also been shown as a coreceptor important in toll like receptor signaling (44). I investigated GD3 as it is the most
abundant ganglioside present in differentiated Caco-2 cell membranes (53). Figure 3.3
shows a dose dependent effect of blocking each receptor with antibodies, on the amount
of total host associated bacteria. Based on these data, the antibody dilution that showed
optimum pathogen blocking was subsequently used to dissect the role of individual
molecules in either adhesion or invasion. As evident from the Figure 3.3, PPP1R12A,
CTNN1A, HSP90AB1 and ganglioside GM1 were involved in association of S. ser.
Typhimurium to the epithelial cells, as blocking those molecules with antibodies
significantly reduced the amount of host associated bacteria. PPP1R9B, PTPRE and
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ganglioside GD3 on the other hand had no effect. Also blocking Ef-Tu on the bacteria
significantly reduced the amount of host associated bacteria. I further assessed the
contributions of PPP1R12A, CTNN1A, HSP90AB1, ganglioside GM1 from the host and
Ef-Tu from the bacteria on adhesion and invasion of S. ser. Typhimurium.
I investigated the role of Ef-Tu in adhesion and invasion of S. ser. Typhimurium
(Fig 3.4) by either blocking Ef-Tu with an antibody, or by adding excess native purified
Ef-Tu to compete with cell surface associated Ef-Tu, from the same bacteria. In a wild
type background (WT), blocking Ef-Tu on the bacteria with an antibody caused a
significant reduction in adhesion as well as invasion (p<0.05). The fraction of
intracellular host associated bacteria, dropped from 5.8% in unblocked control to 2.5 % in
Ef-Tu blocked cells. Adding excess Ef-Tu significantly decreased the amount of adhered
bacteria, but increased the amount of the invaded bacteria. The fraction of intracellular
host associated bacteria increased from 5.8% in untreated control to 16.6 % in cells
spiked with excess Ef-Tu, and this effect was dose dependent. The effect of receptor
blocking on a non-invasive S. ser. Typhimurium ∆invA strain was also assessed. InvA is
an inner membrane protein that is necessary for the secretion of T3SS-1 effectors, which
are required for invasion (19). Adding excess Ef-Tu to ΔinvA cells caused a decrease in
adhered bacteria, while there was no change in amount of invaded bacteria. Based on
these results it can be concluded that Ef-Tu was directly involved in adhesion and
invasion of S. ser. Typhimurium.
I also investigated the role of the crosslinked host molecules, in adhesion and
invasion by blocking specific receptors on the epithelial cells with antibodies. Initial
screening (Fig 3.3) revealed that of the seven host molecules tested, four had a role in
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either adhesion or invasion. I further tested the role of those molecules in adhesion and
invasion. Blocking HSP90AB1, CTNNA1, PPP1R12A and GM1 on the host with
antibodies significantly reduced (p<0.05) the total number of adhered wild type bacteria
to 26%, 45%, 31% ,and 56%, respectively, relative to unblocked control. Concurrently
the amount of invaded bacteria was reduced to 78%, 20%, 10%, and 7 %, respectively,
relative to control. The fraction of intracellular host associated bacteria changed from
5.8% for the control to 15.5%, 1.4%, 3.7%, and 0.68 % for HSP90AB1, CTNNA1,
PPP1R12A, and GM1 blocking respectively,. The effect of host receptor blocking on the
amount of host associated bacteria was also tested on a non-invasive S. ser.
Typhimurium. Blocking HSP90AB1, PPP1R12A and GM1 on the host reduced the
adherence of the noninvasive strain to 38%, 71%, and 49 % respectively, relative to the
non-blocked control, while blocking CTNNA1 had no effect. Total host associated WT
bacteria reduced to 22%, 20%, 19%, and 59% relative to non -blocked control after
blocking HSP90AB1, PPP1R12A, CTNNA1 and GM1 respectively. Hence it can be
concluded that HSP90AB1 was involved in adhesion of salmonella, while rest of the
tested molecules were involved in adhesion and invasion. Also based on the differences
in susceptibility to antibody blocking between WT and ΔinvA strain, the role of
PPPR12A and CTNNA1 were downstream of the effects induced in the host due to
injection of T3SS-1 effectors.
It has been speculated that, since Ef-Tu is a well conserved protein in all bacteria,
it is a MAMP (microbe associated molecular pattern) that is recognized by the host cells.
Agrobacterium Ef-Tu is recognized by EFR, a receptor kinase in Arabidopsis thaliana,
which leads to induction of genes in Arabidopsis necessary for protection from
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Agrobacterium mediated DNA transformation (65). It has also been shown that Ef-Tu
from Lactobacillus johnsonni elicits a proinflammatory response in cultured epithelial
cells (22). Since NFkB is a central regulator of inflammatory response, to test if Ef-Tu
from S ser. Typhimurium induced a proinflammatory response in cultured epithelial cells,
I quantified NFkB mediated transcription in a reporter Caco-2 cell line in response to
excess Ef-Tu. The results are summarized in Figure 3.6. S. ser. Typhimurium (WT and
ΔinvA) both induced activity in Caco-2 cells. However there was no effect of adding
excess Ef-Tu or blocking Ef-Tu with an antibody on the activity of NFkB.
Of the seven host receptors I tested for an adhesion/invasion related phenotype,
three were protein phosphatases (PPP1R12A, PTPRE, and PPP1R9B) and one was a
chaperone protein (HSP90AB1). Two of the three phosphatases (PPP1R12A, PTPRE)
and HSP90AB1 have been shown to modulate the phosphorylation status of Akt (2, 64)
at threonine 308 and serine 473. Hence I hypothesized that Ef-Tu modulates the
phosphorylation status of Akt in Caco-2 cells. Since sigD, one of the T3SS-1 effector has
been shown to induce phosphorylation of Akt; I tested the hypothesis by relative
quantification of P-AKT 473 and P-AKT 308by incubating Caco-2 cells with ΔinvA
strain of Salmonella ser. Typhimurium in presence or absence of excess Ef-Tu (2 µg/ml).
Levels of P-Akt3 08 were below detection in all the treatments. Levels of P-AKT 473 due
to different treatments are summarized in Figure 3.7. Presence of S. ser. Typhimurium
ΔinvA had no effect on levels of P-AKT 473. Presence of excess Ef-Tu with or without
the presence of the organisms significantly increased the levels of P-AKT 473. Hence EfTu from S. ser. Typhimurium induced phosphorylation of Akt in epithelial cells
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Discussion

I developed a crosslinking method to discover host microbe receptors which
doesn't require any apriori knowledge of interacting protein targets on the host or the
microbe. I used the method to discover protein-protein interactions between Salmonella
and cultured intestinal epithelial cells (Caco-2). I discovered five salmonella protein that
were crosslinked to 11 proteins from epithelial cells. One of the discovered Salmonella
proteins was translation elongation factor Tu (Ef-Tu). Ef-Tu is typically found
intracellularly and is one of the most abundant proteins in bacterial cells (18). It is a
monomeric G protein, which binds and mediates the entry of aminoacyl tRNA into the
A site of ribosomes, so as to facilitate the elongation of a protein being translated.
Correct binding of an aminoacyl tRNA into the A site of ribosomes triggers the GTPase
activity of Ef-Tu. Ef-Ts acts as a guanine nucleotide exchange factor (GEF) for Ef-Tu ,
and exchanges the hydrolyzed GDP for GTP. Hence for translation, a stoichiometric
ratio of 1:1:1 of ribosomes: Ef-Tu: Ef-Ts is sufficient (35). Yet, in a dividing cell,
ribosome, Ef-Tu and Ef-Ts exists at a stoichiometric ratio of ~ 1:10:1 (18). Hence in a
dividing cell Ef-Tu exists at ~ 10 X concentrations then what is usually required for
translation, indicating that perhaps Ef-Tu is also required in the cell for functions other
than its role in protein translation. The role of Ef-Tu as a chaperone has also been
proposed as it was shown that Ef-Tu promoted functional folding of proteins after urea
denaturation (10). Based on the fact that Ef-Tu can form filamentous structures in vitro
(7, 8, 62), it has also been proposed that Ef-Tu may be a cytoskeletal element in
prokaryotes. Soufo et al . recently showed that in Bacillus subtilis, Ef-Tu co-localizes
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with MreB, an actin like cytoskeletal element and is a major determinant of cell shape
(12).
I characterized the interaction of Salmonella Ef-Tu with host epithelial cells and
showed that, it mediates adhesion and invasion of Salmonella. Cell surface associated EfTu from Salmonella has also been shown to interact with the host tumor necrosis factor
(TNF-alpha) (52). The implications of this association in the infection process are not
clearly understood. Cell surface expression of Ef-Tu has also been confirmed in
phylogentically diverse group of bacteria including Lactobacillus johnsonii (22),
Agrobacterium tumefaciens (65), Mycobacterium tuberculosis (63), Mycobacterium
leprae (43), Francisella tularensis (6), Helicobacter pylori (39), Mycoplasma
pneumoniae (4), Mycoplasma genetelium (5), Streptococcus pyogenes (55),
Streptococcus gordonii (29), and Streptococcus oralis (61). Table 3.5 lists the interacting
partners of Ef-Tu known in different bacterial species and Figure 3.8 shows a neighbor
joining tree made by aligning Ef-Tu sequences from bacteria whose Ef-Tu is known to
interact with specific host proteins. Figure 3.8 demonstrates that there is casual
correlation between taxonomic distance of the Ef-Tu and similarity of binding partners
i.e. Ef-Tu from both the Mycoplasma tends to bind fibronectin, while Ef-Tu from both
the Lactobacillales tend to bind mucins. Data from more organisms is needed to have
more significant correlations between the phylogenetic distance and similarity of binding
partners. One to three Ef-Tu gene copies are present in the bacterial genome depending
upon the species (33), but there was no correlation between number of Ef-Tu copies
present and surface localization of Ef-Tu. I did not find any correlations between bacteria
expressing Ef-Tu on the surface and its phylogenetic position either.
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One of the host proteins found crosslinked to Ef-Tu was Hsp90. Hsp90 is a highly
conserved molecular chaperone that has a variety of roles in signal transduction, protein
folding and protein degradation. A homolog of Hsp90 is also expressed on the cell
surface and act as microbial receptors for Listeria monocytogenes (9) and Clostridium
difficile Toxin A (46). Here I show that Hsp90 can specifically mediate adherence of
Salmonella with epithelial cells.
Surprisingly two of host receptors that I found crosslinked to Salmonella, which
had a role in invasion (PPP1R12A, CTNNA1), interact with the actin cytoskeleton.
PPP1R12A is a cell surface expressed (27, 36) myosin light chain phosphatase that
regulates the interaction of actin and myosin downstream of small G protein Rho.
Increased phosphatase activity of PPP1R12A, negatively regulates formation of
membrane ruffles (59). Since binding of Ef-Tu with PPP1R12A enhanced invasion of
Salmonella, it can be speculated that Ef-Tu by a yet unknown mechanism decreased the
phosphatase activity of PPP1R12A, leading to lesser negative regulation of membrane
ruffling, which is a downstream effect of T3SS effectors (24).
Alpha catenin (CTNNA1) has recently been shown to be a molecular switch, that
either binds E-cadherin/beta catenin complex as a monomer or, it binds F-actin as a
homodimer (15). When bound to F-actin, alpha catenin negatively regulates actin
filament branching by suppressing Arp2/3 mediated actin polymerization, possibly by
competing with Arp2/3 for actin binding (15). Two of the T3SS effectors (SopE, SopB)
stimulate Arp2/3 mediated actin polymerization, which is necessary for the formation of
membrane ruffles and invasion (24). Since interaction of Ef-Tu with CTNNA1 promoted
invasion only in Salmonella that possess T3SS, it can be speculated that binding of Ef-Tu

68
with alpha catenin decreased its binding with actin by an unknown mechanism, leading to
increased Arp 2/3 mediated polymerization and hence increased invasion. Hence
interaction of Ef-Tu from Salmonella with host PPP1R12A and CTNNA1most likely
promoted invasion by inhibiting the negative regulation of membrane ruffling. This
mechanism probably acted in concert with membrane ruffling induced by the T3SS
effectors.
The role of gangliosides as receptors for bacteria, viruses and toxins is well
studied (14). For Salmonella it has been reported that gangliosides act as co receptors
with TLR5 for flagellar protein FliC, which leads to induction of NfKB activity in
epithelial cells (48). Here I have reported that ganglioside GM1 is involved in the
invasion of epithelial cells by Salmonella. Blocking host GM1 with antibody reduced
adherence ~2-fold, but reduced invasion ~15-fold, hence GM1 probably interacts with a
Salmonella factor which is very important for mediating invasion. Since a T3SS-1
deletion mutant and GM1 blocking showed similar phenotypes, it can be speculated that
GM1 interacts with components of the T3SS. Tejero et al . (32) recently showed that
three translocon components of the T3SS-1 (SipB, SipC, SipD) mediate intimate
attachment of Salmonella with epithelial cells before injection of the effectors (SopE,
SopB) that cause membrane ruffling, and this interaction is important for the successful
delivery of the SopE and SopB. The identity of the host interacting partners for SipB,
SipC and SipD is not known. It can be speculated that since GM1 plays such a crucial
role in invasion, perhaps it is the binding partner for the translocon components for the
T3SS.
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In conclusion, we developed a cell-cell crosslinking method to discover host and
microbe receptors that mediate interaction between bacterial and mammalian cells. We
initially verified the method by crosslinking pathogens and commensals with pure ECM
components and went on to use the method to crosslink Salmonella with epithelial cells.
New protein-protein interactions were discovered. We showed that interaction of Ef-Tu
on the Salmonella cell surface with Hsp90 on Caco-2 cells mediates adhesion while
interaction of Ef-Tu with PPP1R12A and CTNNA1mediates adhesion as well invasion.
We also showed that host ganglioside GM1 mediates adhesion and invasion.
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Table 3. 1. Bacteria growth conditions and primers for their quantitation by qPCR.
Bacteria
Salmonella enterica ser.
Typhimurium LT2
(ATCC 700720) Gene:
16s rDNA

Growth condition
37°C / 220 rpm in
LB (BD Difco,
France)

qPCR primers
Standard curve equation
Forward: TGT TGT GGT TAA TAA CCG CA Log10 CFU = Ct-46.52/Reverse: CAC AAA TCC ATC TCT GGA
5.034
R2 = 0.99

Caco2 (ATCC HTB-37)
Gene: G3PDH

See cell culture for
growth description

Forward: ACC ACA GTC CAT GCC ATC
AC Reverse: TCC ACC ACC CTG TTG CTG
TA

Log10 CFU = Ct-33.69/-4.13
R2 = 0.99
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Table 3. 2 Antibodies used to block host and bacterial receptors
Host
Species
HSP90AB1 Heat shock protein 90kDa alpha (cytosolic), Rabbit
class B member 1
Polyclonal
PPP1R12A Protein phosphatase 1, regulatory (inhibitor) Rabbit
subunit 12A
Polyclonal
PPP1R9A
Protein phosphatase 1, regulatory (inhibitor) Rabbit
subunit 9A
Polyclonal
CTNN1A
Catenin (cadherin-associated protein), alpha Rabbit
1
Polyclonal
PTPRE
Protein tyrosine phosphatase receptor type
Mouse
E (PTPRE)
Polyclonal
Ganglioside Ganglioside GD-3
Mouse
GD-3
Monoclonal
Ganglioside Ganglioside GM-1/ Asialo GM1
Rabbit
GM-1
Polyclonal
Ef-Tu
Elongation factor Tu
Mouse
Monoclonal
Receptor

Protein Description

Dilutions Used
1:500, 1:1000,
1:2000, 1:4000
1:50, 1:100,
1:200, 1:400
1:250, 1:500,
1:1000, 1:2000
1:50, 1:100, 1:200,
1:400
1:100, 1:200,
1:400, 1:800
1:50, 1:100, 1:200,
1:400
1:250, 1:500,
1:1000, 1:2000
1:50, 1:250, 1:500,
1:1000

Vendor
#NB110-96885, Novus
Biologicals
#NB110-38890, Novus
Biologicals
#NB120-3483,
Novus Biologicals
#NB120-2364,
Novus Biologicals
#H00005791-A01,
Novus Biologicals
#NB120-6217,
Novus Biologicals
#AB31119, Abcam
#05-235, Millipore
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Table 3. 3 Fibronectin binding proteins identified in L. acidophilus using a label transfer
approach.
Locus Tag
LBA0222
LBA0324
LBA0223
LBA0315
LBA0291
LBA0786

Protein
Hypothetical Protein
30S ribosomal protein S9
Cell separation protein, CdpA
30S ribosomal protein S13
50S ribosomal protein L3
30S ribosomal protein S4

Unique
Peptides
3
3
2
2
2
2

MASCOT
Score
141
126
141
146
137
104
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Table 3. 4 Fibrinogen binding protein identified in S. ser. Typhimurium using a
crosslinking approach.
Band Locus Tag
K1

S1

Organism

B3494

E. coli K12

FGA

H. sapiens

FGB

H. sapiens

FGG

H. sapiens

STM1377
FGA

S.
Typhimurium
H. sapiens

FGB

H. sapiens

FGG

H. sapiens

Protein
Universal stress
protein B
Fibrinogen alpha
chain
Fibrinogen beta
chain
Fibrinogen gamma
chain
Murien lipoprotein
lpp
Fibrinogen alpha
chain
Fibrinogen beta
chain
Fibrinogen gamma
chain

Unique
PLGS
Mw
Peptides
Score
2
13018 103
22

69713 424

22

55892 320

20

49464 170

3

8386

27

69713 2408

18

55892 1596

15

49464 1239

320
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Table 3. 5 Host Microbe proteins identified as binding partners by whole cell crosslinking.
Mw of
Spot on
Gel (Da)
276000
103000
94000

131000

120000

S. Typhimurium Protein

Putative Phage Tail like
protein (STM2699)
Flagellar biosynthesis
factor FliA (STM1956)
Putative cytoplasmic
protein (STM4088)
Elongation Factor Ef-Tu
(STM4146, STM3445)

Peptides

PLGS
Score

3

98.2

Bacteria
l protein
Mw
(Da)
10804

3

87.4

27456

2

80.1

9306

5

368

43256

Translation initiation factor
IF 2 (STM3286)

8

415.8

97342

Elongation Factor Ef-Tu
(STM4146, STM3445)

4

220.8

43256

Caco-2 Protein

Spectrin, alpha, nonerythrocytic 1 (SPTAN1)
Heat shock 90kDa protein
1 beta (HSP90AB1)
Tumor rejection antigen
gp96 (HSP90B1)
Actinin alpha 4 (ACTN4)
Protein phosphatase 1
regulatory subunit 12A
(PPP1R12A)
Heat shock 90kDa protein
1 beta (HSP90AB1)
Catenin alpha 1
(CTNNA1)
Protein tyrosine
phosphatase receptor type
E (PTPRE)
Protein phosphatase 1
regulatory subunit 9B
(PPP1R9B)
Matrin 3 (MATR3)
Beta actin (ACTB)

Pepti
des

PLGS
Score

Host
Protein
Mw(Da)

7

446.5

284105

13

651.7

83212

9

394.6

92411

5

133

104788

14

842.1

115210

4

160.5

83212

3

100.6

100008

2

124.8

80590

8

611.6

89396

5
4

195.5
177.7

94564
41709
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Table 3. 6 Known interacting host partners of Ef-Tu from other published studies
Order

Species

Actinomycetales
Alphaproteobacteria

Mycobacterium tuberculosis
Agrobacterium tumefaciens

Gamma
Proteobacteria
Gamma
Proteobacteria
Bacilli
Bacilli
Mollicutes
Mollicutes

Francisella tularensis

Host Binding
Partner
Plasminogen
Receptor kinaseEFR
Nucleolin

Reference

Salmonella ser. Typhimurium

TNF-Alpha

(52)

Lactobacillus johnsonii
Streptococcus gordonii
Mycoplasma genitelium
Mycoplasma pneumoniae

Mucins
Mucins
Fibronectin
Fibronectin

(22)
(29)
(5)
(4)

(63)
(65)
(6)
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Figure 3. 1 Fibrinogen binding proteins identified from E. coli and S. ser. Typhimurium
LT2 by crosslinking labeled fibrinogen with the microbes and then separating the
proteins under reducing (A4, B3) and non-reducing conditions (A2, A3, B1, B2). Proteins
identified from bands S1 and K1 are shown in Table 3.4. Bands K2, K3, S2 and S3
contained fibrinogen subunits (FGA, FGB and FGG) but no bacterial proteins

Figure 3.2

Figure 3. 2 Crosslinked proteins resolved by 2D gel electrophoresis under non reducing conditions. The circled spots were
picked and identified using LC-MS/MS
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Figure 3.3

Figure 3. 3 Effect of blocking host and microbe receptors on total host associated bacteria as determined by qPCR. Treatments
which were significantly different from cells that were given no antibody treatment (Control) (p<0.05) are marked with "*".
The actual antibody dilutions of each antibody used are in Table 3.2. Error bars indicate standard error from four replicates.
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Figure 3. 4 Effect of blocking Ef-Tu with an antibody, and adding excess Ef-Tu, on
adhesion and invasion of S. ser. Typhimurium in a wildtype (WT) background and non invasive (ΔinvA) background. Treatments that do not share a letter are significantly
different (p<0.05). The % numbers of the x axis represents the fraction of total host
associated bacteria that were intracellular (invaded). Error bars indicate standard error
from four replicates.
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Figure 3. 5 (A). Effect of blocking specific host proteins with antibodies on adhesion and
invasion of S. ser. Typhimurium. (B) Effect of blocking specific host molecules with
antibodies on total host associated S ser. Typhimurium in a wild type (WT) and a noninvasive (ΔinvA) background. . Treatments that do not share a letter are significantly
different (p<0.05). The % numbers of the x axis represents the fraction of total host
associated bacteria that were intracellular (invaded). Error bars indicate standard error
from four replicates.

Figure 3.6

Figure 3. 6 (A) Effect of adding excess Ef-Tu from S. ser. Typhimurium and anti-Ef-Tu on NFkB activity of Caco-2 cells (B)
Effect of adding excess Ef-Tu from S. ser. Typhimurium and anti-Ef-Tu on NFkB activity of Caco-2 cells in presence of S. ser.
Typhimurium (WT) or S. ser. Typhimurium ΔinvA. Treatments that do not share a letter are significantly different (p<0.05).
Cell free lysate from S. ser. Typhimurium was used as a positive control for induction of NFkB mediated transcription. Error
bars indicate standard error from four replicates.
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Figure 3.7

Figure 3. 7 Relative densitometric quantification of p-Akt 473 by western blots.
Treatments not sharing a letter are significantly different (p<0.05). Error bars indicate
standard error from four replicates.
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Figure 3. 8 Neighbor joining tree based on alignment of amino acid sequences of Ef-Tu
from bacteria that have known Ef-Tu binding partners in host cells. The Ef-Tu interacting
proteins for each organism are mentioned after the species name.
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CHAPTER IV
SOLID-PHASE CAPTURE OF PATHOGENIC BACTERIA BY USING
GANGLIOSIDES AND DETECTION WITH REAL-TIME PCR

Abstract
We developed a method for concentrating pathogens from samples without
enrichment. Immobilized gangliosides concentrated bacteria for detection with real-time
PCR. A sensitivity of 4 CFU/ml (3 h) in samples without competing microflora was
achieved. Samples with competing microflora had a sensitivity of 40,000 CFU/ml. The
variance was less than one cycle.
Introduction
The Centers for Disease Control and Prevention (CDC) estimates that food-borne
diseases cause approximately 76 million illnesses, 325,000 hospitalizations, and 5,000
deaths in the United States each year, which in 2000 led to an estimated $6.9 billion
burden to the U.S. economy for just the top five food-borne pathogens
(http://www.ers.usda.gov/briefing/FoodSafety/). This avoidable burden can be reduced if
the disease-causing organism is detected and remedial action taken quickly to control the
spread of the disease. As such, many efforts to create rapid-detection tests (i.e., <24 h)
have been undertaken in the last 10 years. The limitation in most methods is the need for
a pre-enrichment step before detection to increase the population of interest with semiselective or selective media. Methods that eliminate the need for enrichment are needed
to break this time barrier so that results are provided earlier in the disease process. This
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challenge can be addressed by creating assays that concentrate bacteria or by using
detection methods that are very sensitive. More recently, use of genetic detection methods
is widely available due to the large number of microbial genome sequences that
are available.
The AOAC-approved rapid-detection technologies rely on either antibody-based
tests or nucleic acid-based tests that claim detection limits as low as one organism, but
these assays still require 24 to 48 h to provide a result. This time is somewhat shortened
by affinity capture of the infectious agent by antibodies onto a solid matrix and then
subsequent detection by PCR or real-time PCR (RT-PCR), but these tests still require
enrichment, are still based on antibody reactions that can have false-positive results, and
require extensive development time to ensure antibody quality. The approach presented in
this work avoids the two most time-limiting steps in antibody-based assays,
development and pre-enrichment.
An alternative approach to antibodies is the use of host receptors to capture the
pathogen, which changes the paradigm of detection to finding those organisms that can
bind host cells. Gangliosides are a large class of glycolipids that are common
components of eukaryotic cells. Often, the specific classes are expressed in specific
tissues that can be exploited to find organisms that will bind cells from specific tissues. In
addition, the binding of bacteria and toxins to gangliosides has been documented in the
literature (7, 13, 16, 22). To exploit this paradigm, we used host receptors (isolated mixed
gangliosides) to mimic pathogen attachment onto the host cell to capture and
concentrate pathogens from various samples onto a solid surface. With these molecules, a
variety of pathogens can be captured onto a solid phase and subsequently be detected in a
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variety of different formats, depending on the amount of information needed during the
testing regime. Here, we demonstrated that most common food-borne pathogens bind
immobilized gangliosides onto 3-mm glass beads that are easily removed from the
sample with physical separation. We determined the lower detection limit of the assay by
using Escherichia coli O157:H7 as the model organism. After 5 minutes of binding, we
detected up to 10 cells by RT-PCR within 3 h of sample collection. Spiked E.
coli O157:H7 was detected in frozen spinach, pasteurized apple juice, and bottled water
with a detection limit of 4 CFU/g of sample.
Materials and methods

Ganglioside immobilization
Gangliosides were purified from bovine buttermilk as described by Walsh and
Nam (26). Briefly, the purification of gangliosides included ultrafiltration of fresh
buttermilk (Gosners, Logan, UT) with a 1-kDa membrane to remove the lactose, followed
by an organic extraction with chloroform-methanol-water (40:80:30). The purified
gangliosides (6 µg) were used for immobilization with 100 g of 3-mm solid glass beads
(catalog no. 11-312A; Fisher Scientific, St. Louis, MO), which produced bioactive beads
(gangliobeads) with a mixture of gangliosides on the surface.

Screening of bacteria for ganglioside
binding
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In brief, all the organisms were grown to exponential phase in media and under
conditions specific for the organism (Table 4. 1). The organisms were washed twice in
saline and diluted to an optical density at 600 nm of 0.2 in saline. This suspension (2 ml)
was exposed to 10 gangliobeads for 10 minutes at 25°C with agitation and washed thrice
with 50 mM Tris-Cl (pH 7.2) for 5 minutes each time. The presence or absence of the
particular organism on the beads was confirmed either with specific antibody detection
via a tagged tertiary antibody or by RT-PCR using universal bacterial 16S primers (IDT,
Coralville, IA). Rabbit anti-Salmonella antibody (OEM Concepts, Toms River, NJ),
goat anti-E. coli antibody (BioDesign International, Saco, ME), rabbit anti-Listeria
monocytogenes antibody (BioDesign International), rabbit anti-Erwinia antibody (Abcam,
Cambridge, MA), goat anti-Bacillus globigii spores (Dugway Proving Grounds, Dugway,
UT), rabbit anti-Lactococcus antibody (Center for Integrated BioSystems, Utah State
University, Logan, UT), and rabbit anti-Lactobacillus antibody (Biotechnology Center,
Utah State University, Logan, UT) were all immunoglobulin G-type polyclonal
antibodies. They were diluted as recommended by the manufacturer for an enzymelinked immunosorbent assay or to a micromolar concentration if they were custom
products. Tertiary anti-rabbit and anti-goat conjugated to alkaline phosphatase (Sigma,
Saint Louis, MO) were diluted as recommended by the supplier. The substrate, pnitrophenyl phosphate (Sigma, St. Louis, MO) in 0.1 M glycine buffer, 1 mM MgCl2, 1
mM ZnCl2, pH 10.4 (1 mg/ml), was added to each sample, and the plates were incubated
for 20 minutes at 37°C. Color development was measured using a BioAssay 7000 plate
reader (Perkin-Elmer, Norwalk, CT) at 405 nm. Each plate contained controls consisting
of aliquots of each concentration of the specific antibody, with the appropriate tertiary
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antibody without bacteria (negative control), the tertiary antibodies alone, and the
substrate alone. The signal-to-noise value was calculated by dividing the absorbance
readings from each sample by the negative-control value. The entire experiment was done
with three biological replicates.
Detection with RT-PCR used washed gangliobeads that were added to 100 µl
distilled water and boiled for 10 minutes to release the DNA. An aliquot of the boiled
sample (12.5 µl) was used for RT-PCR with universal bacterial 16S primers (IDT,
Coralville, IA), using a DyNAmo HS Sybr green quantitative PCR kit (MJ
Research, Waltham, MA) per the manufacturer's recommendations and a DNA Engine
Opticon 2 thermal cycler (MJ Research). The thermal cycler was run for 50 cycles of 15 s
at 95°C (melting), 30 s at 60°C (annealing), and 45 s at 72°C (extension and
plate reading). The threshold cycle (CT) number was reported using Opticon Monitor
analysis software (version 2.02; MJ Research). Appropriate negative controls for probing
for nonspecific binding (using 3-mm glass beads instead of gangliobeads) and sterility in
the beads and buffers (using gangliobeads with saline instead of bacterial suspension)
were also used along with the test samples. The experiment was done with three
biological replicates, using duplicate RT-PCRs.
Capture and detection of E. coli 0157:H7 from buffers and food. To check the
lower detection limit of this approach, we exposed 2-ml 10-fold serial dilutions of logphase E. coli O157:H7 cells (108 to 100 CFU/ml; cell population was determined using
plate counts with nutrient agar) to 10 gangliobeads. The beads were either unwashed or
washed before testing with RT-PCR. The organisms on the beads were detected using the
commercially available Genevision rapid pathogen detection system for E.
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coli O157:H7 (Warnex Diagnostics, Quebec, Canada) per the manufacturer's instructions.
Pasteurized apple juice, commercial bottled water, sterile ultrahigh-temperature milk,
salami, hamburger patties, and frozen spinach were purchased from the local grocery
store, plated on nutrient agar (as described in the Bacteriological Analytical Manual (17)),
and spiked with log-phase E. coli O157:H7 cells at the levels of 106, 104, 102, 101, 100,
and 0 CFU/25-g sample after the pure-culture population was determined by plating on
nutrient agar. Spinach, hamburger patties, and salami were diluted 1:1 (weight to volume)
with saline in a filtered stomacher bag and stomached at high speed using the Seward
stomacher laboratory system (Lab3; Bristol, England) for 15 min, and the sample
rinse was spiked with the above-mentioned E. coli O157:H7 population. Food samples
(25 g) were exposed to 30 gangliobeads on a rocking platform for 30 min. After 30 min,
the beads were removed by decanting the liquid from the sample and added to 400 µl of
lysis buffer supplied with the Genevision rapid pathogen detection kit, and PCR was
performed per the manufacturer’s instructions. The aerobic plate counts of all the foods
were estimated prior to spiking with E. coli O157:H7 by using nutrient agar at 32°C as
described in the Bacteriological Analytical Manual (17). The average of three replicate
plate counts was reported. The experiment was done with three biological
replicates, using RT-PCR in duplicate.

Results and Discussion
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We screened 20 different bacterial strains for their abilities to specifically bind
immobilized gangliosides (Table 4. 1). Ten strains of Salmonella, two strains
of Escherichia coli, Lactococcus lactis, and Bacillus globigii spores bound to the beads.
However, Lactobacillus acidophilus, Lactobacillus gasseri, Lactobacillus helveticus,
Listeria monocytogenes, and Erwinia herbicola did not bind to the immobilized
ganglioside mixture. All of the tested enterobacteriaceae bound the gangliobeads in this
study. While variability among Salmonella strains with respect to binding gangliosides is
known, we focused on Salmonella enterica serovar Enteritidis, where all the strains tested
bound. Of the firmicutes tested, only L. lactis IL-1403 bound the beads, indicating
that organisms used routinely in fermented foods will not interfere with this assay. None
of the Listeria strains tested bound the beads.
Subsequently, we focused on testing the detection limit by using E. coli O157:H7
with RT-PCR (Genevision) as a proof of concept for this system (Figure 4. 1). The lower
detection limit of the Genevision assay (i.e., without addition of gangliobeads for
concentration) using direct extraction was 1,000 CFU/ml. This detection limit was
improved with addition of the gangliobead capture step to 10 CFU/ml. Washing beads
prior to detection via RT-PCR caused a loss in detection for E. coli populations with
104 CFU/ml, but at lower populations, no significant difference (P > 0.05) was observed.
Washing the beads led to loss of organisms that were not tightly bound to the bead
surface, just as described by Blake and Weimer (3), who used a solid-phase enzymelinked immunosorbent assay for Bacillus spores from water. To further increase the
binding capacity, more beads may be added to increase the number bacteria that will be
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bound (3). Hence, gangliobeads efficiently concentrated E. coli O157:H7 from solution,
even when the organisms were present at 10 CFU/ml.
The inability of the Genevision system alone (without the use of a solid-phase
concentration) to detect organisms at <1,000 CFU/ml is due to the need for at least 1
CFU/10 µl (the volume of cell lysate used in each PCR), which equates to 1,000 CFU/ml.
This limitation was overcome by the addition of gangliobeads to the sample to
concentrate low cell numbers from a large volume. This resulted in a volume reduction
that is more compatible with sample processing requirements for PCR (i.e., microliter
volumes rather than milliliter volumes).
After ascertaining the ability of gangliobeads to concentrate E. coli O157:H7 from
solution, we tested the ability of this approach to detect spiked organisms directly from
food (Table 4. 2). We detected spiked E. coli O157:H7 in bottled water, apple juice, and
frozen spinach with a lower detection limit of 4 CFU/g. The lower detection limit for
hamburger was 400 CFU/g, while for salami and milk the limit was 40,000 CFU/g.
Except with milk, a significant correlation (r2 = 1; P < 0.0001) between the level of
background microflora and the minimum detection limit for each food was observed
(Table 4. 2). Hence, it is likely that the background microorganisms out-competed the
spiked E. coli O157:H7 for binding to gangliosides, which explains the higher detection
limits for hamburger and salami. The higher detection limit for milk with no competing
flora is likely due to the presence of milk fat globule membranes that contain
gangliosides and lactoferrin, which binds gangliosides. In either case, this would lead to
competitive binding with E. coli O157:H7 for the gangliosides (26). Weimer et al. (27)
did not observe competition for solid-phase capture when using antibodies immobilized
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onto glass beads. In light of these data, the efficiency of binding with gangliobeads is
affected by the levels of background microflora and other molecules in the foods that
bind gangliosides. Hence, ganglioside-immobilized beads would be suitable for food
systems containing low initial microbial populations and foods of non-animal origin (e.g.,
bread, fruit juices, ready-to-eat salad, water, fruits, and vegetables).
The variability of the assay was measured for each approach with buffer and
foods. The standard errors of the means (SEMs) for the decreasing concentrations of E.
coli ranged from 0.03 to 0.81 cycles in unwashed samples, while washed samples had a
range of 0.36 to 0.92 cycles (Figure 4.1, error bars). This translated into coefficients of
variation (CVs) of between 1.9 and 3.9% over the concentrations in the wash treatments.
For the food samples, the variance and % CV differed by sample, but all SEMs were less
than 1.32 and all CVs less than 6.8%. The average CV for concentrations in all foods was
3.1%.
The specificity and sensitivity of PCR-based rapid-detection systems have driven
their increased popularity in the last 2 decades (6). There are several PCR-based pathogen
detection systems available commercially, such as BAX (DuPont Qualicon, Wilmington,
DE), Probelia (Sanofi Diagnostic Pasteur, Marnes La Coquette, France), and Genevision
(Warnex Diagnostics, Quebec, Canada), but all are hindered by a detection limit ranging
from 103 to 106 CFU/ml tied to the presence of PCR inhibitors in the sample, sample
dilution prior to cell lysis, or large sample volumes that do not allow a representative
sample for PCR. To overcome these limitations, the sample is pre-enriched in laboratory
media for 6 to 48 h prior to detection in at least 2 liters of media. The enrichment
procedures are labor-intensive and do not allow quantitative or high-throughput
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automated screening procedures. In addition, all the commercially available PCR-based
systems require at least 24 to 48 h to report a result. To lower the detection times, various
researchers have used antibody-coated immunomagnetic beads (4, 8-10, 15, 20, 25, 28) to
capture a variety of pathogens, such as Salmonella, E. coli, Campylobacter, Listeria,
Yersinia, and Clostridia, for subsequent detection of them with PCR or RT-PCR. These
studies achieved sensitivities of 5 to 1,000 CFU/ml within 3 to 10 h in food systems. The
advantage of using gangliosides over using antibody-coated beads is that one can capture
a broad repertoire of pathogens by using a single reagent. The specificity of detection can
be adjusted by using PCR for each pathogen of interest with various primer designs and
combinations. Simultaneous detection of various pathogens in one PCR is also possible
by employing multiplex PCR (19). Additionally, coupling gangliobead capture with RTPCR without pre-enrichment for detection makes the assay quantitative even at a low
population of 4 CFU/g. Furthermore, the specificities of ganglioside binding to
polyomavirus, simian virus 40 (12), Newcastle disease virus (11), human
immunodeficiency virus (21), adenovirus (2), and human influenza virus (23) suggest
that this technology has potential use for viral detection when coupled with real-time
reverse transcriptase PCR (14). Ganglioside-immobilized beads could also be used for
capturing specific toxins, such as botulinum toxin (1, 24), cholera toxin (5), and E. coli
heat-labile enterotoxin (18), with subsequent detection via a solid-phase immunoassay,
such as that reported by Weimer et al. (27). Mason et al. (16) successfully used liposomes
with encapsulated DNA reporters and ganglioside receptors embedded in the bilayer to
detect botulinum toxin with a lower detection limit of 0.02 fg/ml. Coupling of
ganglioside-immobilized beads with the ImmunoFlow system (27), which uses a
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fluidized bead bed for capture, may increase the sensitivity to as low as 1 CFU
independent of the sample size, as demonstrated for E coli O157:H7 and Bacillus globigii
spores by using antibody-coated beads.
In conclusion, we demonstrated the ability of gangliosides immobilized on 3-mm
glass beads to concentrate pathogenic organisms and Bacillus spores directly from
samples without pre-enrichment. Use of gangliobeads prior to a commercial RT-PCR kit
for food pathogen detection improved the sensitivity 100-fold in samples that did not
contain competing bacteria or molecules that bind gangliosides. However, with
competing microflora and biomolecules the detection limit was 40,000 CFU/g. This
approach concentrated E. coli O157:H7 directly from foods containing low initial
bacterial counts and foods of non-animal origin with a detection limit of 4 CFU/g in 3 h.
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Table 4. 1 Growth conditions and ganglioside binding specificity of selected bacteria.
(NB = Nutrient broth, NA = not done, MRS = MRS broth, BHI = BHI broth, 1 =
organism detected via specific antibody, 2 = organism detected by RT-PCR). The
Bacillus spores were provided as a powder and no growth was needed.

Organisms
E. coli
E. coli
Salmonella enteritidis
Salmonella enteritidis
Salmonella enteritidis
Salmonella enteritidis
Salmonella enteritidis
Salmonella enteritidis
Salmonella enteritidis
Salmonella enteritidis
Salmonella enteritidis
Salmonella typhimurium
Bacillus globigii spores
Lactococcus lactis
Lactobacillus acidophilus
Lactobacillus acidophilus
Lactobacillus gasseri
Lactobacillus helveticus
Listeria monocytogenes
Listeria monocytogenes
Erwinia herbicola

Strain
K12
O157:H7
8326
13076
13314
31194
49214
49215
49217
49218
49220
700720
IL1403
4355
NCFM
33323
10386
43251
EGDe
33243

Medium
NB
NB
NB
NB
NB
NB
NB
NB
NB
NB
NB
NB
NA
MRS
MRS
MRS
MRS
MRS
BHI
BHI
NB

Temp. Growth Ganglioside Detection
(˚C) Condition Binding Method
37
37
37
37
37
37
37
37
37
37
37
37
NA
37
37
37
37
37
37
37
37

Shaking
Shaking
Shaking
Shaking
Shaking
Shaking
Shaking
Shaking
Shaking
Shaking
Shaking
Shaking
NA
Static
Static
Static
Shaking
Shaking
Shaking
Shaking
Shaking

+
+
+
+
+
+
+
+
+
+
+
+
+
+
-

1, 2
1, 2
1
1
1
1
1
1
1
1
1
1
1
1, 2
1
2
2
1
1
2
1
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Table 4. 2 Minimum detection limit of spiked E. coli O157:H7 in the food types used in
this study and the levels of food associated background microflora.

Food Type
Water
Apple juice
Spinach
Hamburger
Salami
Milk

Aerobic Plate Count before
Lower
E. coli O157:H7 spike
Detection Limit
(CFU/gm.)
(CFU/gm.)
0
8
577
24856
9350000
0

4
4
4
400
40000
40000
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Figure 4. 1 Threshold cycle numbers (CT) when gangliobeads were exposed to different
cell populations of E. coli O157:H7 with or without washing the beads. The error bar
represents the SEM of CT values from six observations. A CT of >45 was considered no
detection. Shorter CT is equal to a faster detection time, which indicates a higher
population.
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CHAPTER V
SYSTEMS LEVEL ANALYSIS OF CROSS TALK BETWEEN THE HOST
COMMENSAL AND PATHOGEN

Abstract
Bifidobacterium longum subspp. infantis showed the highest potential for
Salmonella enterica subspp. enterica ser. Typhimurium exclusion in a Caco-2 cell culture
model among the five screened probiotic strains. B. infantis and S. ser. Typhimurium
shared binding specificity to host ganglioside GM1 among the tested receptors. Further,
B. infantis completely inhibited, Salmonella-induced caspase 8 and caspase 9 activity in
intestinal epithelial cells. B. infantis also reduced the basal caspase 9 and caspase 3/7
activity in the epithelial cells in absence of pathogen. Western blots and gene expression
profiling of epithelial cells revealed that the decreased caspase activation was
concomitant with increased phosphorylation of the pro-survival protein kinase Akt,
increased expression of caspase inhibiting protein cIAP and decreased expression of
genes involved in mitochondrion organization and biogenesis and reactive oxygen
species metabolic processes. Hence B. infantis exerted it’s protective effect by repression
of mitochondrial cell death pathway which was induced in presence of S. ser.
Typhimurium. Gene expression analysis of epithelial cells also revealed that B. infantis
strongly induced expression of genes downstream of cAMP signaling, MAPK signaling
and NFkB signaling. Using both gene expression and small metabolite profiling of
bacterial and epithelial cells, I observed a three way crosstalk between the epithelial cells,
Salmonella and Bifidobacteria. In these interactions, B. infantis prevented catabolism of
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arginine (a substrate for nitric oxide (NO) production) by S. ser. Typhimurium, making it
available for increased NO production by the host. This was evidenced by the induction
of genes necessary for nitrate and nitrite respiration in the pathogen (nitrate and nitrite are
breakdown products of NO). Using a comparative and functional genomics approach I
also discovered a cluster of 50 proteins that have been acquired in the B. infantis genome
through lateral gene transfer, are found only in subspp. infantis (and absent in subspp.
longum) and are induced only in the presence of the host. Therefore these genes likely
have been maintained in the genome through selective pressure from the host.

Introduction
The normal gut flora forms the first line of defense against enteric infections (77).
The composition of this protective flora can be altered by dietary and environmental
influences making the host susceptible to disease. The use of probiotics centers on the
idea that probiotic treatments re-establishes the natural condition that exists in the host
which is disrupted by various stresses (31). Recently, there has been a renewal of interest
in the use of probiotics, due to the rise in number of multidrug resistant pathogens; and
the increased knowledge of the roles played by human microbioata in health and disease.
Renewed interest in probiotics is also reflected by the rapid increase in the numbers of
“probiotic” products being marketed.
Efficacy of probiotics in the prevention of gastrointestinal diseases has been
observed in several in vivo and in vitro models. A study in the pig model showed that
feeding a five-strain probiotic mixture (that contained two strains of Lactobacillus
murinus, and one strain each of Lactobacillus salivarius, Lactobacillus pentosus and
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Pediococcus pentosaceous) reduced pathogen shedding and alleviated disease symptoms
when infected with S. ser. Typhimurium (11). Although the specific mechanism of
pathogen reduction was not elucidated, this suggests that probiotics can inhibit infection
and reduce symptoms. The pathogen exclusion potential of various probiotics is
dependent on the probiotic as well as the pathogen strain. Jin et al. (38) showed that in
vitro L. acidophilus inhibited adhesion of S . sv Pullorum, but failed to inhibit adhesion of
S. sv Enteritidis and S. sv Typhimurium. A cell culture study has also demonstrated the
anti-adhesive effect of Bifidobacterium on S. ser. Typhimurium. The ability of
Bifidobacteria to inhibit pathogen attachment is strain-dependent and independent of
strain specific adhesion properties (6).
Le Blanc et al (17) recently showed the preventative and therapeutic efficacy of
L. casei in a mouse model of S. ser. Typhimurium infection. Administration of L. casei
not only decreased neutrophil infiltration and inflammation, but also increased the release
of Salmonella specific IgA in the intestinal lumen. Hence the protective effect of
probiotics goes beyond the commonly reported modes of action that include competing
for nutrients, production of antimicrobials, and pathogen exclusion at the host surface
(48).
Silva et al. reported the protective effect of B. longum in a mouse model of
salmonellosis, where mice fed B. longum and infected with S. ser. Typhimurium showed
higher survival than those infected without the probiotic intervention (76). Surprisingly,
pathogen levels in the animal feces were similar with or without B. longum even though
survival rate was higher in the animals supplemented with B. longum. Hence additional
mechanisms other than competitive exclusion accounted for higher survival of
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Salmonella infected animals. Among all age groups the incidence of Salmonella-induced
diarrhea is highest in the infant population (13). Bifidobacteria are one of the most
numerically abundant and among the first colonizers of the human gut (3). It is estimated
that in breast fed infants ~10% of the gut microbioata is composed of Bifidobacteria (43).
Since Bifidobacteria show anti-infective activity towards Salmonella, the molecular
mechanism by which they inhibit pathogen adhesion and protect the host needs to be
investigated.
At the host mucosa there is a complex multi- way interaction between host,
pathogen and the resident gut flora that dictates the outcome of the infection. Most
studies have been dedicated to unraveling the effect of probiotics/ commensals/ pathogen
on the host while the literature on the microbe-microbe interaction is sparse at best.
Recently there is a steady increase in literature that reports interspecies communication
that would affect the virulence gene expression of pathogens. For example, short chain
fatty acids like acetate, propionate and butyrate induce the expression of hilA (invasion
protein transcription activator), which positively regulates the virulence gene expression
in Salmonella (21). Communication between Salmonella and Yersinia through acyl
homoserine lactones (AHLs) has also been reported, which enhances Salmonella
colonization in the murine intestine (22). Hence interspecies crosstalk can lead to
different outcome of the disease
I hypothesize that B. longum spp. infantis reduces S sv. Typhimurium adhesion to
gut epithelial cells by competing for the same receptors and also improves cell survival
by modulation of specific pathways in the host as well as the pathogen. Modulation in
cellular networks was probed by determining gene-expression profile and small
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metabolite profiles of the epithelial cells, B. infantis, and S. ser. Typhimurium during coinfection.

Materials and method

Cell culture and bacterial strains
Caco-2 cells were obtained from ATCC (HTB-37, Manassas, VA) and cultured
as per ATCC’s recommendation. All the cells used in the assay were between passage
numbers 22-30. In brief, cells were plated at a density of 105 / cm2 in either a T75 or a 96
well plate. Cells were maintained in DMEM/High Modified (Thermo Scientific,
Rockford, IL) with 16.6% fetal bovine serum (FBS) (HyClone Laboratories, Logan, UT),
non-essential amino acids (Thermo Scientific, Rockford, IL), 10mM MOPS (Sigma, St.
Louis, MO), 10 mM TES (Sigma), 15 mM HEPES (Sigma) and 2 mM NaH2PO4(Sigma).
Cells were considered to be differentiated 14 days post confluence (65), and used for the
adhesion assays, caspase assays and gene expression. Bacterial cells were grown as
described in Table 5.9.

Determination of adhered and invaded
bacteria
The ability of specific bacteria to block Salmonella binding to epithelial cells was
tested by determining the changes in the amount of total host (intestinal epithelial cells,
Caco-2) associated salmonella in presence of specific bacteria. The amount of total host
associated salmonella was determined by qPCR as described below. The amounts of
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intracellular salmonella in the host were determined by the gentamicin protection assay
with a few modifications as described below (24).
Total host associated bacteria were determined as follows. Caco-2 cells were
cultured as described earlier in a 96-well plate. The bacteria were used after two transfers
for the adhesion assays. Bacterial cells were collected from 2 ml of media after growth
for 14 hours, washed twice with an equal volume of PBS, and resuspended at ~108
CFU/ml, in DMEM/High modified with 1X non-essential amino acids, 10mM MOPS, 10
mM TES, 15 mM HEPES and 2 mM NaH2PO4 but without the FBS. Caco-2 cells were
infected with either Salmonella alone or Salmonella in conjunction with other bacteria
(Fig 5.1) in a final volume of 50 µl at an MOI (multiplicity of infection) of 1: 1000. The
ratio of Salmonella with other bacteria was 1:1. Caco-2 cells were incubated with bacteria
for 60 minutes. The bacterial cell suspension was aspirated and the Caco-2 monolayer
was washed thrice with 200 µl of tyrode’s (140 mM NaCl, 5mM KCl, 1mM CaCl2, 1mM
MgCl2, 10 mM glucose, 10mM sodium pyruvate, 10 mM HEPES, pH 7.4) to remove
non-adhered bacterial cells from the monolayer. DNA extraction buffer (AEX
Chemunex, France) (50 µl) was used to lyse the monolayer and the bacteria associated
with the host, and incubated at 37˚C for 15 minutes followed by 95˚C for 15 min.
Resulting cell lysate was used to determine the number of bacteria associated with the
Caco-2 cells (19). Quantitative analysis was done using qPCR with a CFX 96 Real Time
System (Bio-Rad, Hercules, CA). Reactions were performed in a final volume of 25 μl
including 1 μl of cell lysate, 100 nM of PCR primers and iQ SYBR Green Supermix
(Bio-Rad, Hercules CA) as per manufacturer’s instructions. The primers used for the
amplification are listed in Table 5.9. The reaction parameters consisted of denaturation
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step at 95°C for 5 min, followed by 40 cycles of denaturation, annealing and extension at
95˚C for 15 s, 56˚C for 30 s, 72˚C for 30 s respectively and a final extension at 72°C for
1 min. The product was verified using a melt curve analysis from 50˚C to 95˚C with a
transition rate of 0.2˚C/s. The amount of bacterial cells and Caco-2 cells present in each
well were estimated using a standard curve of CT vs. Log10 CFU and amount of bacteria
per Caco-2 was calculated. The data were normalized relative to control wells which
were incubated with Salmonella alone. The experiment was done in four replicates.
Differences in the mean due to treatment were tested by one way ANOVA. Post
ANOVA, the means were compared to control using Dennett’s multiple comparison test
The amount of intracellular and adhered bacteria was determined using the
gentamicin protection assay as follows. Caco-2 cells were infected exactly as described
earlier. The infected cells were incubated for 60 minutes at 37°C with 5% CO2. Upon
incubation, media was aspirated and cells were washed three times with tyrode’s buffer.
Invaded bacteria were estimated by incubating the cells with 100 µg/ml gentamicin for
two hours at 37°C with 5% CO2 to kill bacteria adhered or outside the Caco-2 cells. To
determine total host associated bacteria, cells were incubated with cell culture media
without any antibiotic. Cells were again washed three times with tyrode’s buffer and
lysed with 0.01% triton. The amounts of bacteria in the Caco-2 lysate were determined by
plating serial dilutions on LB agar. The experiment was performed in four replicates. The
number of adhered bacteria were enumerated by subtracting mean of invaded bacteria (B)
from mean of total host associated bacteria (A) and error (ΔZ) was calculated as (ΔZ)2 =
(ΔA)2 + (ΔB)2 where, ΔA is SEM associated with the A and ΔB is SEM associated with
B. The data were reported as log10 colony forming units (CFU) /well. Differences in the
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mean due to treatment were tested by one-way ANOVA. Post ANOVA, the means were
compared to each other by Tukey-Kramer's method.

Caspase assays
Caco-2 cells were cultured in a 96 well plate as mentioned earlier and were
washed with phosphate buffered saline (PBS) before infection with bacteria. Caco-2 cells
were infected with either Bifidobacterium longum subspp. infantis ATCC 15697,
Salmonella ser. Typhimurium LT2 ATCC 700720, or both the organisms simultaneously.
Upon adding bacterial treatments (MOI of 1:1000) in a volume of 50 µl, cells were
incubated at 37°C with 5% CO2. After 8 hours, caspase 8, 9 and 3/7 activities was
measured using Caspase-Glo assay kits (Promega, Madison, WI) exactly as per
manufacturer’s instructions. Bioluminescence due to caspase activity was measured using
the DTX 880 Multimode Detector (Beckman Coulter, Brea, CA). Differences in the mean
due to treatments were tested by one way ANOVA. Post ANOVA, the means were
compared to each other by Tukey-Kramer's method.
Infection of epithelial cells for gene expression
Caco-2 cells were cultured in T75 as mentioned earlier, and were serum starved
for 24 hours prior to infection with bacteria. Caco-2 cells were infected with either
Bifidobacterium longum subspp. infantis ATCC 15697, Salmonella ser. Typhimurium
LT2 ATCC 700720, or both the organisms simultaneously at an MOI of 1:1000 in a final
volume of 10 ml. All the three bacterial treatments were also incubated in absence of the
Caco-2 cells in the exact same conditions. All the infected cells were incubated at 37°C
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with 5% CO2. At 30, 60, and 120 minutes after infection, media with non-adherent
bacteria was aspirated and 10 ml TRIzol LS reagent (Invitrogen, Carlsbad, CA) was
added to the cells. This was gently mixed with pipette followed by centrifugation at 7200
× g for 5 minutes to pellet the bacteria. TRIzol LS supernatant was stored in a clean tube
and further processed for RNA extraction from Caco-2 cells. The bacterial pellet was resuspended in 2 ml of fresh TRIzol LS, gently mixed and further processed for RNA
extraction from host associated bacteria
Bacterial RNA extraction and gene
expression
The TRIzol LS suspension containing host associated bacteria was centrifuged at
7200 × g for 5 minutes. The TRIzol LS supernatant was stored in a clean tube for later
use. 1 ml of lysis enzyme cocktail containing 50 mg/ml of lysozyme (Sigma) and 200
U/ml mutanolysin (Sigma) in TE buffer (10mM Tris and 1mM EDTA, pH 8) was added
to bacterial pellet obtained by centrifugation. The solution was mixed gently and
incubated at 37°C for 1 hour followed by centrifugation at 7200 × g for 5 minutes. The
supernatant was discarded and pellet was re-suspended in 250 μl of proteinase K buffer
(100 mM Tris-HCl, 5 mM EDTA, 200 mM NaCl, and 0.2 % SDS, pH 8) containing 8
U/ml of proteinase K (Fermentas, Glen Burnie, MD). This was incubated at 55°C for 1
hour with intermittent mixing. To this, previously stored TRIzol LS was added and gently
mixed. RNA was isolated from TRIzol LS exactly as per manufacturer's
recommendations. RNA concentration, A260/280 and A260/230 were measured on
NanoDrop (Thermo scientific, Waltham, MA) and samples were processed further only if
the RNA concentration was at least 0.5 µg/µl and ratios were ≥ 1.8. The RNA samples
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were analyzed for integrity on 2100 Bioanalyzer (Agilent Technologies, Santa Clara,
CA).
Total RNA (10 µg in 20 μl) was reverse transcribed into cDNA with random
hexamers and Superscriptase II (Invitrogen, Carlsbad, CA) exactly as per manufacturer’s
recommendations by using 400 U of Superscriptase II/ 10 µg RNA. Upon cDNA
synthesis, the enzyme was heat inactivated and the RNA templates were degraded with
80 U of RNaseH (Epicentre, Madison, WI) at 37°C for 20 minutes. The reaction mixture
was cleaned using the Qiaquick-PCR purification kit (Qiagen, Valencia, CA) exactly as
per manufacturer’s instructions. Purified cDNA was eluted from the column twice with a
total of 100 μl of nuclease free water (Ambion, Austin, TX).
cDNA was fragmented using DNaseI (Promega, Madison, WI) according to
manufacturer's recommendations by using 0.6 U of DNaseI/ µg cDNA at 37 °C for 20
minutes. The fragmented cDNA was labeled using GeneChip DNA Labeling reagent
(Affymetrix, Santa Clara, CA) and Terminal Transferase enzyme (TdT) (New England
Biolabs, Ipswich, MA) as per manufacturers' recommendation by using 2µl GeneChip
labeling reagent and 3µl TdT / µg cDNA at 37 °C for 60 minutes. The samples were
denatured prior to hybridization, at 98°C for 10 minutes followed by snap cooling at 4°C
for 5 minutes.
Labeled cDNA was hybridized onto two different custom made Affymetrix
GeneChip designed against all the annotated coding sequences of Bifidobacterium
longum subspp. infantis ATCC 15697 (50) and Salmonella enterica subsp. enterica
ser.Typhimurium LT2 ATCC 700720. Briefly the Salmonella array contained 9852 probe
sets, of which 4735 probe sets were designed against S. ser. Typhimurium. Each probe
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set contained 11 probes, each 25 nucleotides long. The Bifidobacteria chip has been
described by Locascio et al (50). 500 ng of labeled cDNA for samples extracted from
pure culture of B. infantis and S. ser. Typhimurium; 1000 ng labeled cDNA for samples
extracted from co culture of B. infantis and S. ser Typhimurium; 2000 ng of labeled
cDNA for samples extracted from co-culture of B. infantis/ S. ser. Typhimurium and
Caco-2; and 2500 ng of labeled cDNA for samples extracted from co-culture of B.
infantis , S. ser. Typhimurium and Caco-2 was hybridized onto the respective chips. In
total, 24 chips Salmonella chips were processed (2 replicates X 3 Time points (30
minutes, 60 minutes, 120 minutes) X 4 Treatments ) and 8 Bifidobacteria chips were
processed (2 reps X 1 Time point (120 mins) X 4 Treatments).
Microarray data normalization and
statistical analysis of microbial chips
Raw data (.cel files) was back ground corrected, quantile normalized and
summarized using RMA-MS (78).The resultant normalized log2 transformed intensity
matrix was used for further statistical analysis. To detect differentially regulated genes,
the Salmonella chip data was analyzed as unpaired time course analysis with “signed
area” as the time summary method, while for Bifidobacteria chips the data was analyzed
as two class unpaired data, with T statistic, using Significance Analysis of Microarrays
(SAM) (84). All the genes were ranked based on the score(d) from SAM output. This pre
ordered ranked gene list was then used in Gene Set Enrichment Analysis software
(GSEA) (60, 79) to detect the coordinate changes in the expression of groups of
functionally related genes, upon respective treatments. Gene sets for Bifidobacteria were
defined based on annotations from KEGG (41), Cluster of Orthologous Groups of
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proteins (COGs) (81), Carbohydrate Active Enzyme Database CAZY (66) and genes
identified from Locasio et al (50). Putative horizontally transferred genes in B. infantis
were identified using Integrated microbial genomes system (IMG) (55). Genes sets based
on protein localization were created based on annotations from CoBaltDB (34). Gene sets
for Salmonella were defined based the annotations from Comprehensive Microbial
Resource (CMR) (68), Cluster of Orthologous Groups of proteins (COGs) (81),
Virulence Factors of pathogenic bacteria Database (VFDB) (14, 89), Carbohydrate
Active Enzyme Database (CAZY) (66), and Biocyc (12). Gene sets based on putative
horizontally transferred genes in Salmonella were defined using predictions from the
Horizontal Gene Transfer Database (HGT-DB) (32). Genes sets based on protein
localization were created using predictions from CoBaltDB (34).
Caco-2 RNA extraction and gene expression
The TRIzol LS supernatant obtained after pelleting the bacteria was freeze thawed
twice in liquid nitrogen. Two hundred fifty μl water was added to 750 μl of TRIzol LS
sample. This was further processed for RNA extraction exactly as per manufacturer’s
instructions. RNA concentration, A260/280 and A260/230 were measured on NanoDrop
(Thermo scientific, Waltham, MA) and samples were processed further only if the RNA
concentration was at least 0.5 µg/µl and ratios were ≥ 1.8. The RNA samples were
analyzed for integrity on 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA).
Synthesis of cDNA, biotin labeled cRNA, fragmentation and purification of cRNA were
carried out using one-cycle cDNA synthesis kit (Affymetrix, Santa Clara, CA) exactly as
per manufacturer's instructions. 10 µg of labeled and fragmented cRNA was hybridized
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onto the Affymetrix HGU133Plus2 GeneChips as per manufacturer's recommendations at
the Center for Integrated BioSystems (Utah State University, Logan, UT).
Microarray data normalization and
statistical analysis of the HGU133 Plus2
chips
Raw data (.cel files) was back ground corrected, quantile normalized and
summarized using RMA (37). RMA normalized data was then filtered through the PANP
algorithm (86) to make presence-absence calls for each probe set. Probe sets that were
called present in at least one of the samples were included in further statistical analysis
while rests were excluded. The resultant normalized, filtered, log2 transformed intensity
matrix was analyzed as two class unpaired time course data with “signed-area” as the
time summary method, using Significance Analysis of Microarrays (SAM) (84). All the
genes were ranked based on the score(d) obtained from SAM. This pre ordered ranked
gene list was used as an input for Gene Set Enrichment Analysis software (GSEA) (79) to
detect the coordinate changes in the expression of groups of functionally related genes,
upon respective treatments. The gene sets were based on Gene Ontology annotations,
KEGG annotations, Biocarta annotations and TRANSFAC annotations and were
downloaded from the molecular signatures database (79) . Ingenuity pathway analysis
(IPA) was used to map expression data onto pathways. Hierarchical clustering with
multiscale bootstrapping (1000 times) of all the samples based on normalized data was
performed using PVCLUST (80).
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Western Blots
Relative abundance of target proteins due to different treatments was quantified
by densitometric analysis of western blots. Caco-2 cells were cultured and infected
exactly as those infected for the gene expression. The cells from the T75 were removed
from the flask by scraping; suspended in 1 ml protease/phosphatase inhibitor cocktail (30
mM HEPES, 1 mM EDTA, 50 mM Sodium pyrophosphate, 100 mM sodium fluoride, 10
mM orthovanadate, 1 Roche protease inhibitor cocktail tablet/50ml solvent) and lysed
using a bead beater at full speed with three pulses of 30 s each with intermittent
incubation on ice for 1 min. The cell lysates were stored at -70˚C for further analysis.
50µg protein was diluted in 1X SDS sample buffer and the samples were heated at 95°C
for 10 minutes and centrifuged at 12,000 X g for 10 minutes. The sample was resolved on
precast 10% Tris-HCl polyacrylimide gels (Bio-Rad Laboratories, Hercules, CA) at a
constant current of 45 mAmp per gel using the Criterion electrophoresis system (Bio-Rad
Laboratories, Hercules, CA). The resolved proteins were then transferred to a PVDF
membrane (Bio-Rad Laboratories, Hercules, CA) using the Trans-Blot semi-dry
electrophorectic cell (Bio-Rad Laboratories, Hercules, CA) as per manufacturer's
recommendation. Upon completion of the transfer, the blots were probed for the presence
of p-Akt 473 (#9271) and p-AKT 308 (#9275) by Pierce® Fast Western Blot Kit
(Thermo Fisher Scientific, IL, USA ), according to the manufactures recommendations.
Primary antibodies for all the proteins were purchased from Cell Signaling Tech.
(Boston, MA). The blots were imaged using the Kodak Image Station 2000R (Carestream
Health, Rochester, NY). Densitometric analysis of the blot was done using Image J (2).
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Differences in the means due to treatment were tested by two way ANOVA with repeated
measures.
Small metabolite profiling
Fifty µl of extracellular supernatant and intracellular cell lysate collected from
the infection experiments were extracted with equal volume of ice cold methanol and
incubated at -20°C for 60 minutes. The resultant precipitates were separated from the
sample by centrifugation at 20,000 X g for 10 minutes. The supernatant was evaporated
to dryness using a speed-vac at room temperature. Metabolite profiles for all the samples
were determined using GC-MS at the Genome Center, UC Davis (Davis, CA) exactly as
described by Fiehn et al (28). In brief, the dried sample was derivatized using N-methylN-(trimethylsilyl)-trifluoroacetamide (Sigma, St. Louis, MO) and spiked with retention
index markers (RI) exactly as described by Fiehn et al (28). The samples were analyzed
on Agilent 6890 gas chromatograph controlled using Leco ChromaTOF software version
2.32. as described by Fiehn et al (28). GC/MS peaks were annotated based on the mass
spectra and retention index using the BinBase database (27). Peak areas were normalized
by calculating the sum area of all identified compounds for each and subsequently
dividing all data associated with a sample by the corresponding metabolite sum. The
resulting data were multiplied by a constant factor in order to obtain values without
decimal places and, the peak intensities were log2 transformed to remove the
heteroscedasticity (28). Hierarchical clustering with multiscale bootstrapping (1000
times) of all the samples based on normalized data was performed using PVCLUST (80)
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Results
The pathogen exclusion potential of different probiotics is strain dependent. Since
intestinal epithelial cells are the primary host target during the initial phase of Salmonella
infection, I screened five different probiotic strains for their ability to block host
association of Salmonella sv. Typhimurium (Figure 5.1) in cultured gut epithelial cells
(Caco-2). Of the 5 strains tested B. infantis showed the highest potential for Salmonella
exclusion. Hence I further characterized the effect of B. infantis on adhesion and invasion
of S. ser. Typhimurium of intestinal epithelial cells.
Effect of B. infantis on adhesion and
invasion of S. ser. Typhimurium
I first tested if B. infantis could displace already adhered S. sv. Typhimurium
from the epithelial cells, by incubating Caco-2 cells with Salmonella for 30 minutes prior
to adding B. infantis into the co-culture. As evident from Figure 5.2, adding B. infantis
had no effect on adhesion and invasion of S. ser. Typhimurium, if the pathogen was
allowed to interact with the epithelial cells first. However if B. infantis was added to the
Caco-2 cells 30 minutes prior to Salmonella, it significantly reduced adhesion and
invasion of Salmonella. A similar effect was observed when both the organisms were
added together. The degree of reduction of adhered and invaded Salmonella was similar
to when the Caco-2 cells were incubated with B. infantis first. Interestingly, incubation of
Salmonella with B. infantis for 120 minutes prior to infection of Caco-2 cells
significantly caused more adhesion and invasion as compared to when Caco-2 cells were
infected without the interaction (Figure 5.2). However it should be noted that when
compared to the control (i.e. adhesion of S. ser. Typhimurium alone) there was still
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significantly less adhesion and invasion. Hence pre-incubation of S. ser. Typhimurium
with B. infantis primed Salmonella to be more invasive, and this effect was most likely
due to gene regulation in Salmonella. To the test the hypothesis, gene expression of S.
ser. Typhimurium in co-culture with B. infantis (30, 60, and 120 minutes) was
determined and compared to gene expression profile of S. ser. Typhimurium cultured
alone.
Differentially expressed genes between the two treatments were determined using
SAM as an unpaired time course analysis using “signed area” as the time summary
method (84). All the genes were ranked based on the (d) score obtained from SAM (84),
and the pre-ranked gene list was analyzed using GSEA (79) to make inferences about
regulation of pre-defined functionally related gene-sets. Table B1 (Appendix B) lists all
the enriched gene sets in Salmonella when they were incubated with B. infantis for up to
120 minutes. Genes coding for both the type 3 secretion systems (SPI1 T3SS (q≤0) and
SPI2 T3SS (q≤0.04) as well the effectors for both the T3SS (q<0.05) were significantly
induced (Figure 5.3). Hence the increased adhesion and invasion of S. ser. Typhimurium
due to incubation with B. infantis was concomitant with increased expression of genes
coding for the T3SS structural proteins and effectors required for adhesion (47) and
invasion (52).
Next I tested if B. infantis excluded the pathogen from the epithelial cells by
competing for similar receptors. I blocked the same receptors which I had previously
shown to be important for Salmonella adhesion and invasion, and looked at the effect of
receptor blocking on adhesion of B. infantis to the host. Blocking HSP90, PPP1R12A,
CTNN1A and ganglioside GD3 on the host and blocking Ef-Tu on the bacteria had no
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effect on B. infantis binding (Appendix Figure B1). Blocking ganglioside GM1 on the
host reduced the adhesion of B. infantis to 75% as compared to unblocked control
(p=0.054). Hence Salmonella shared its binding specificity for GM1 with B. infantis.
Effect of B. infantis on caspase activation
and AKT phosphorylation in epithelial cells
Since Salmonella mediated cell death of host cells is important for disease
progression (15) , I probed the potential of B. infantis to block Salmonella mediated cell
death by measuring the activity of caspase 8, caspase 9 and caspase 3/7. Hence I
measured the activity of the effector caspases (caspase 3/7), and I measured the activity
of the initiator caspases of the extrinsic cell death pathways (caspase 8) and the intrinsic
cell death pathway (caspase9). Figure 5.4 shows the level of caspase activity after 8 hours
in epithelial cells alone or in presence of different bacteria. Epithelial cells incubated with
B. infantis showed a significant reduction in activity of caspase 9 and caspase 3/7
(p<0.05), but not caspase 8 as compared to control. Epithelial cells incubated with S. ser.
Typhimurium showed a significant increase in activity of caspase 8 and caspase 9
(p<0.05) but not caspase 3/7. Epithelial cells incubated with S. ser. typhimurium and B.
infantis both showed a caspase activity profile similar to that of cells incubated with B.
infantis alone, where activity of caspase 9 and caspase 3/7 was significantly lower than
that of control cells (p<0.05) while there was no effect on the activity of caspase 8. Hence
B. infantis not only blocked the increase in Salmonella mediated caspase activity, but also
lowered the basal caspase activity in epithelial cells.
Since B. infantis lowered the basal caspase activity, I probed the activation
(phosphorylation) status of pro survival kinase Akt in epithelial cells. Akt is protein
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kinase which regulates cell survival through two separate pathways. Akt inhibits
apoptosis by phosphorylating the Bcl-2 family member Bad, which then interacts with
14-3-3 and dissociates from Bcl-xL, which prevents downstream activation of caspase 9
and caspase 3/7 (16). Alternatively, Akt activates IKKα that ultimately leads to NFkB
activation. This leads to transcription and translation of proteins that directly inhibit
caspase 9 and caspase 3/7 activity (25). Figure 5.5 shows the phosphorylation status of
Akt at ser-473 and thr-308 at 30, 60, and 120 minutes after infection with different
microbes. Incubation of B. infantis with the epithelial cells increased the phosphorylation
of Akt at ser-473 and thr-308 in a time dependent manner (Figure 5.5) as compared to the
control, while incubation with Salmonella decreased the phosphorylation at ser 473 and
thr-308 as compared to the control. Phosphorylation levels of Akt at ser-473 and thr-308
when both the microbes were present together was similar to those of cells treated with B.
infantis at 30 and 60 minutes. However by 120 minutes, Akt ser-473 and thr-308
phosphorylation levels were similar to cells infected with S. ser. Typhimurium. Hence,
the decrease in caspase activity in epithelial cells due to B. infantis was concomitant with
increased Akt phosphorylation at ser-473 and thr-308. To further characterize the
interaction of B. infantis with epithelial cells I determined gene expression profile of
Caco-2 cells alone, Caco-2 cells with B. infantis, Caco-2 cells with S. ser. Typhimurium
and Caco-2 cells with both the bacteria after 30, 60, and 120 minutes.
Gene expression profile and small
metabolite profile of Caco-2
I determined the global gene expression profiles and small metabolite profiles
(intracellular and extracellular) of Caco-2 cells alone, and in presence of different

126
bacteria (B. infantis alone, S. ser. Typhimurium alone and B. infantis and S. ser.
Typhimurium together) at 30, 60, and 120 minutes in two biological replicates. Figure 5.6
shows the dendogram based on hierarchical clustering of averaged global gene
expression profile for each treatment at different time points. Hierarchical clustering of
all samples indicated that the global transcriptome of epithelial cells infected with S. ser.
Typhimurium and B. infantis simultaneously was more similar to that of epithelial cells
infected with B. infantis than to the transcriptome of epithelial cells infected with S. ser.
Typhimurium alone (p<0.01). Figure 5.7 shows the dendogram based on hierarchical
clustering of intracellular and extracellular small metabolite profiles under different
infection conditions. Metabolite profiling using GC/MS identified 294 compound peaks
using the BinBase database (27), out of which 110 GC/MS peaks could be assigned
positive identification. Hierarchical clustering based on log2 peak areas of all compound
peaks, revealed that the small metabolite profile formed two big clusters, i.e. a cluster of
samples with extracellular metabolites and the other with intracellular metabolites
(p<0.01) (Figure 5.7). Within the extracellular metabolite cluster, Caco-2 cells coinfected with Salmonella and Bifidobacteria together clustered with Caco-2 cells treated
with Bifidobacteria alone (p<0.12), while Caco-2 cells infected with Salmonella (60
minute and 120 minute samples) formed their own cluster (p<0.01). Hence the gene
expression profile as well as the extracellular metabolite profile of cells co-infected with
Salmonella and Bifidobacteria together was more similar to those of cells infected with
Bifidobacteria alone.
To gain insight into the functional changes in the epithelial cells due to presence
of the microbes, I compared the gene expression profile of epithelial cells when they
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were incubated alone (control) to when they were incubated with either B. infantis
(treatment) or B. infantis and S. ser. Typhimurium co-culture (treatment). Gene
expression profile of epithelial cells with microbes was compared to gene expression
profile of cells without any microbes using SAM (84) as an unpaired time course analysis
using “signed area” as the time summary method. All the genes were ranked based on the
(d) score obtained from SAM, and this pre-ranked gene list was analyzed using GSEA
(79) to make inferences about pre-defined functionally related gene-sets. The gene sets
consisted of genes annotated by the same Gene Ontology (GO) terms, KEGG pathways,
Biocarta Pathways and genes that share same transcription factor binding sites defined in
the TRANSFAC and were downloaded from the molecular signatures database (79).
Table 5.1 and Table 5.2 show enriched gene sets (based on GO annotations) that
were differentially regulated in epithelial cells when incubated with either B. infantis
alone or with B. infantis and S. ser. Typhimurium co-culture, as compared to epithelial
cells without any microbial treatment. At an FDR≤0.21; 82 gene sets were enriched in
epithelial cells treated with B. infantis (12 were induced while 70 were repressed) alone
(Table 5.1) while 61 gene sets were enriched (all repressed) in epithelial cells treated with
B. infantis and S. ser. Typhimurium co-culture. There were 36 gene sets (all repressed)
that were commonly regulated between both the microbial treatments.
Incubation of B. infantis with epithelial cells significantly induced expression of
proteins localized at cell junctions (q≤0.05), particularly adherens junctions (q≤0.11), cell
matrix junction (q≤0.13) and intercellular junction (q≤0.11). Although tight junctions as a
gene set was not induced significantly, two proteins important for maintenance of the
tight junctions; zona occludens 2 ( TJP2) (q≤0.01) and occludin (OCLN) (q≤0.14) were
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induced. None of the above mentioned gene sets were differentially regulated in presence
of both B. infantis and S. ser. Typhimurium. Hence incubation of epithelial cells with B.
infantis induced expression of proteins important for maintenance of cellular junctions,
but the effect was negated in presence of the pathogen.
Incubation of B. infantis with the epithelial cells significantly repressed genes
required for the functioning of the proteasome (q≤0.01) and the peroxisome (q≤0.02) and
they remained repressed even in presence of the pathogen.
Incubation of B. infantis with the epithelial cells caused repression of the genes
involved in biogenesis of the mitochondrial matrix (q≤0), mitochondrial membrane
(q≤0), mitochondrial respiratory chain (q≤0) as well as mitochondrial ribosomes (q≤0).
All these gene sets were also repressed (q≤0.01) when the epithelial cells were incubated
with B. infantis and S. ser. Typhimurium co-culture. Subsequently genes involved in
aerobic respiration (q≤0.21), electron transport (q≤0.20) and oxygen and reactive oxygen
species metabolic processes (q<0.18) were also repressed. Hence irrespective of the
presence of pathogen, B. infantis repressed genes related to the biogenesis of
mitochondria and genes necessary for respiration and reactive oxygen species metabolic
processes.
Figure 5.8 represents expression of genes related to apoptosis signaling in
epithelial cells after 120 minutes of exposure to B. infantis. Caspase activity data (Figure
5.4) and phosphorylation of Akt (Figure 5.5) have also been overlaid on the same
pathway. Multiple anti-apoptotic pathway signaling leading to BAD phosphorylation was
induced (q≤0.04) (Table 5.3). Hence it is evident from Figure 5.4, that repression of
caspase 3/7 and caspase 9 activity in epithelial cells by B. infantis was concomitant with

129
increase in expression of cIAP (cIAP directly represses the activity of the effector
caspases (71)), as well as increase in phosphorylation of Akt and repression of proapoptotic proteins BAD (20) and BID (51). The expression profile of the pathway was
similar in presence of the pathogen (Appendix Figure B2). Also, since B. infantis
repressed the basal caspase 9 and 3/7 activity, but not that of caspase 8, it can be
concluded that B. infantis down regulated the intrinsic death pathway which is initiated
by non-receptor-mediated intracellular signals that cause changes in the inner
mitochondrial membrane.
To gain further insights into signaling pathways and transcriptional networks
regulated in the epithelial cells due to B. infantis, enrichment analysis was performed
based on gene-sets from pathway databases (KEGG and Biocarta), and gene sets that
contained genes which share similar transcription factor binding sites as defined in the
TRANSFAC database (Table 5.3, Table 5.4, Table 5.5). Some of the enriched pathways
(Oxidative phosphorylation, mitochondrial biogenesis, proteasome, peroxisome, cell
junctions) were redundant with GO gene sets because of overlapping annotations.
Presence of B. infantis significantly induced genes necessary for functioning of four
receptor tyrosine kinase (RTK) mediated signaling pathways (i.e. hepatocyte growth
factor signaling (q≤0.05), platelet derived growth factor signaling (q≤0.04), epidermal
growth factor signaling (q≤0.05) and insulin signaling pathway (p≤0.05)). Expression of
epiregulin (EREG),which is a ligand for epidermal growth factor receptor (44) was also
strongly induced (q≤0)(~12-fold) after 120 minutes of incubation with B. infantis.
Presence of B. infantis significantly induced expression of genes in the canonical Gprotein coupled receptor pathway (GPCR) (q≤ 0.04). Expression of four GCPR ligands
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((CXCL1, CXCL2. CXCL3 and CCL20) was also significantly induced (q≤0).
Presence/absence calls based on PANP (86) revealed that, of the four induced GPCR
ligands, receptor for CXCL3 ( CXCR4 (82)) was expressed in the epithelial cells, while
receptors for the other three ligands were not expressed. Expression of CXCR4 in Caco-2
cells has also been reported by other groups (30). Subsequently, genes under regulation
of transcriptional factors, whose activity is modulated downstream of RTK and GPCR
pathways by phosphorylation through the MAPK pathway i.e. CEBPA, CREB1, NFkB,
and SRF (Table 5.6) were also significantly induced (q≤0). IL6 along with four other
chemokines (CXCL1, CXCL2, CXCL3 and CCL20) which are under the transcriptional
regulation of NFkB (83) were strongly induced (q≤0) (16-32-fold) after 120 minutes in
presence of B. infantis. Eight more genes associated with IL6 signaling pathway were
also induced (q≤0.04). Furthermore genes downstream of the IL6 signaling, which are
under the positive transcriptional control of phosphorylated STAT3 were also induced
(Table 5.6) (q≤0). Hence B. infantis induced expression of genes downstream of RTK,
GPCR and JAK-STAT signaling pathways. Also expression of agonists of the three
signaling pathways (IL6 for JAK-STAT (35), EREG for RTKs (36) and CXCL3 for
GPCR (88)) were also significantly induced, which likely induced an autocrine signaling
loop in the epithelial cells.
Expression profile of the epithelial cells exposed to B. infantis alone and those
exposed to B. infantis and S. ser. Typhimurium were directly compared, to look at the
effect of S. ser. Typhimurium on the epithelial cells in presence of B. infantis. Addition of
S. ser. Typhimurium blocked B. infantis mediated induction of the IL6 pathway (q≤0.02)
(Appendix Table B2) in the epithelial cells. Genes annotated under GO category cell
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junctions induced by B. infantis were also significantly repressed (q≤0.13) in presence of
the pathogen as compared to when only B. infantis was present. Transcription of genes
having a cAMP responsive element (CRE) in their promoter which is mediated through
CREB1 binding was also significantly repressed (q≤0) (Appendix Table B2). CREB1 is
activated by a variety of stimuli leading to phosphorylation of CREB1 (39). Repression
of genes under the transcriptional control of CREB1 was concomitant with repression of
four chemokines (CXCL1, CXCL2, CXCL3 and CCL20)(q≤0.01) which are GPCR
ligands (88). Induction of epiregulin (EREG), which is a ligand for epidermal growth
factor receptor (44) was also blocked in presence of the pathogen. Hence presence of the
pathogen blocked B. infantis induced CREB1 mediated gene expression, which was
likely a downstream effect of repression of ligands for the GCPR (CXCL3), RTK
(EREG) and JAK-STAT (IL6) pathways.
Gene expression profile of S. ser.
Typhimurium
To gain insights into how S. ser. Typhimurium adapts to the presence of B.
infantis in the host environment, I determined the gene expression profile of S. ser.
Typhimurium interacting with Caco-2 cells with or without the presence of B. infantis at
30 minutes, 60 minutes, and 120 minutes after interaction. Gene expression profile of
Salmonella between the two treatments was compared using SAM (84) as an unpaired
time course experiment with “signed area” as the time summary method. All the genes
were ranked based on the score(d) from SAM output and this pre-ranked gene list was
used with Gene Set Enrichment Analysis software (GSEA) (79) to detect the coordinate
changes in the expression of groups of functionally related genes, upon respective
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treatments. Table 5.6 lists differentially regulated gene sets in Salmonella interacting with
the host, with or without the presence of B. infantis. Presence of B. infantis induced genes
down-stream of the Qse two component system in Salmonella (57) irrespective of the
presence of host (q≤0.09) (Table 5.6 and Appendix Table B1). Hence most likely the
cross-talk between B. infantis and S. sv. Typhimurium was mediated through soluble
factors sensed by the Qse two component system. The known ligands that trigger Qse
two component system are epinephrine/norepinephrine (4) and autoinducer 3 (AI-3) (61).
Epinephrine /norepinephrine are host stress hormones and have been shown to induce
increased colonization and systemic spread of Salmonella (58). The exact biochemical
pathway or the genetic basis for production of AI-3 is not characterized, however AI-3
production has been shown to occur in variety of Enterobacteriaceae (85) including
Salmonella, while AI-3 production in Bifidobacteria has not been tested yet.
Interestingly addition of B. infantis to the host/ Salmonella co-culture repressed
genes related to arginine catabolism in Salmonella (Figure 5.9). This was reflected in the
small metabolite profile, where addition of the B. infantis lead to accumulation of
arginine and ornithine (the substrates), and depletion of putrescine (product). Catabolism
of arginine is important from a virulence perspective for two reasons. First, catabolism of
arginine is important for resistance to acid stress (29) and is required for full virulence.
Secondly, arginine is a source of production of nitric oxide (NO) via nitric oxide synthase
(iNOS) which is an important inflammatory mediator and necessary for protection of the
host cell against the invading pathogen (46). Though the exact source of arginine, for NO
production is not known, it is clear that in addition to intracellular sources of arginine,
luminal sources of arginine are also required for optimal production of NO by the host
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(67). Giardia lamblia uses depletion of arginine as a strategy to prevent NO production in
the intestinal epithelium as shown by Eckmann et al. (23). I observed a depletion of
arginine in absence of B. infantis (from Salmonella/Caco-2 co-culture), while arginine
accumulated in B. infantis presence. Hence in presence of B. infantis there was an
increased pool of arginine available for NO production. The major pathway for NO
metabolism is the stepwise oxidation to nitrite (NO2-)and nitrate (NO3- ) (91). In presence
of B. infantis, 9 genes related to nitrate and nitrite reduction were strongly induced (q≤0)
in Salmonella (Figure 5.9, Anaerobic Metabolism).Genes required for synthesis of
cofactors necessary for functioning of nitrate and nitrite reductases were also
significantly induced (q≤0) (Table 5.9, Biosynthesis of cofactors- Prosthetic Groups- and
Carriers- Molybdopterin). This Bifidobacteria mediated induction of nitrate and nitrite
reductases in Salmonella did not happen in absence of the epithelial cells. Hence
induction of nitrate and nitrite reductases in Salmonella was most likely a down-stream
effect production of NO from the host. Hence our data suggests an elegant cross talk
between the host, commensal and the pathogen, where the commensal prevented
catabolism of arginine by the pathogen, which probably lead to increased NO production
by the host as evidenced by induction of genes necessary form nitrate and nitrite in the
pathogen.
Addition of B. infantis to the host/ Salmonella co-culture also repressed genes in
Salmonella necessary for the TCA cycle (q≤0.09) and induced genes necessary for
anaerobic metabolism (q≤0) (Table 5.6, Figure 5.9). Surprisingly genes necessary for
functioning of the mitochondrial respiratory chain were also repressed in the epithelial
cells as mentioned earlier by the addition of B. infantis into the co-culture (Table 5.1,
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Table 5.2). Hence addition of B. infantis repressed genes necessary for respiration in
Caco-2 as well as Salmonella. This was reflected in the small metabolite profile of the coculture where (Figure 5.9), addition of B. infantis in the Caco-2/ Salmonella co-culture
caused a significant accumulation of glucose, fructose, trehalose and maltose (q<0.05)
extracellularly as well as intracellularly. Glucose 6P, pyruvate and citrate also
accumulated significantly while rest of the detected TCA metabolites (α ketoglutarate,
malate, fumarate and succinate) though not statistically significant, showed a depleting
trend. Hence based on the gene expression and small metabolite profile it can be
concluded that addition of B. infantis to the co-culture of the host and pathogen, reduced
the carbon flux through glycolysis and the TCA cycle, while presence of Salmonella
alone with the host induced genes related to glycolysis (q≤0.01). Induction of glucose
metabolism in the host epithelium due to Salmonella infection was also reported in vivo
by Rodenburg et al .(70). The increased glucose catabolism perhaps leads to increased
mitochondrial ETC function to regenerate the spent reducing equivalent (NAD+), which
is the main source of reactive oxygen species (ROS) generation in the cell (33).
Uncontrolled production of ROS directly activates caspase 9 (42) (intrinsic pathway), and
indirectly activates caspase 8 (extrinsic pathway) via induction of Fas and Fas ligand
expression (18), which further amplifies caspase 9 pathway. Hence, Bifidobacteria
mediated blocking of Salmonella-induced caspase 8 and caspase 9 was concomitant with
decreased carbohydrate metabolism in the host, as evidenced by gene expression in the
host as well the small metabolite profile.
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Gene expression profile of B. infantis
To gain insights into how B. infantis responds to the presence of the epithelial
cells and Salmonella, gene expression profiles of B. infantis were determined in cell
culture media alone; in presence of Caco-2 cells and in presence of Caco-2 /S. ser.
Typhimurium co-culture after 120 minutes of exposure. Expression profile of the treated
B. infantis was compared to those of B. infantis incubated alone using SAM (84) as two
class unpaired data, with t statistic. All the genes were ranked based on the score (d) from
SAM output. This pre ordered ranked gene list was used in Gene Set Enrichment
Analysis software (GSEA) (79) to detect the coordinate changes in the expression of
groups of functionally related genes, upon respective treatments. Table 5.7 lists
differentially regulated gene sets (q≤0.15) in B. infantis when they were incubated with
epithelial cells (treatment) as compared to when they were incubated in the same
conditions without the epithelial cells (control) for 120 minutes. Table 5.8 lists
differentially regulated gene sets (q≤0.15) in B. infantis when they were incubated with
Caco-2 /S. ser. Typhimurium co-culture (treatment) as compared to when they were
incubated in the same conditions alone (control) for 120 minutes.
Presence of epithelial cells significantly induced transcription of genes with %GC
content greater than 70 (q≤0) and less than 40(q≤0), irrespective of the presence of
Salmonella. Hence these genes were important for the interaction of B. infantis with the
host. Also since average %GC content of B. infantis is 60% (74) those genes were
putative horizontally transferred genes (55). Protein translation as a gene set was induced
(q≤0.01) when B. infantis was incubated with epithelial cells alone while the same gene
set was significantly repressed (q≤0) when B. infantis was incubated in presence of
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epithelial cells and S. ser. Typhimurium. Along with translation, oxidative
phosphorylation was also significantly repressed (q≤0) in presence of epithelial cells and
S. ser. Typhimurium. Hence presence of Salmonella along with epithelial cells reduced
translation and energy metabolism in B. infantis. This effect was not observed when B.
infantis was in presence of Salmonella alone (Appendix Table B4). Hence interaction of
the pathogen and epithelial cells reduced the fitness of B. infantis. This was surprising as
presence of B. infantis and Salmonella did not lead to increased expression of enzymes
needed for reactive species generation (ROS) or increased expression of defensins in the
epithelial cells which could reduce the fitness of Bifidobacteria. On the contrary in
presence of both the bacteria, mitochondrial biogenesis and genes needed for generation
of ROS were repressed in epithelial cells. Hence the fitness of B. infantis in presence of
the pathogen and epithelial cells was reduced by a yet uncharacterized mechanism.
Recently, a comparative genomic hybridization (CGH) study with 15 different
Bifidobacteria strains revealed that B. longum spp. has at least two distinct subspecies,
subsp. infantis, specialized to utilize human milk oligosaccharides, and subsp. longum,
specialized for plant-derived oligosaccharides (50). I reanalyzed the CGH data using
GSEA and determined what functionally related gene sets were conserved in the infantis
lineage but divergent in the longum lineage. The results are summarized in Appendix
Table B5. As reported by Locascio et al. gene enrichment analysis revealed that the genes
divergent between infantis and longum strains were enriched in functions related to
human milk oligosaccharide (HMO) metabolism, urease metabolism and solute binding
proteins of ABC transporters. Furthermore I also discovered clusters of putative
horizontally transferred genes that were only present in the infantis lineage and absent or
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highly divergent in the longum lineage. Surprisingly three of the gene sets related to
horizontally transferred genes (genes with % GC >70, genes with % GC<40 and
horizontally transferred genes from Firmicutes) were induced in B.infantis in presence of
the host and pathogen. Hence these genes were most likely acquired through horizontal
gene transfer in the infantis lineage and conserved in the genome under selective pressure
from the host. Of the cluster of 50 genes that were putatively acquired through lateral
gene transfer and also induced in presence of the host (Appendix Figure B3) 28 were
hypothetical proteins with no known functions.

Discussion
Many studies have linked prophylactic use of probiotics to reduced rate of enteric
infections (6, 8, 11, 48). The pathogen exclusion potential of various probiotics is
dependent on the probiotic as well as the pathogen strain (38). Hence I screened 5
different probiotic strains and found that B. infantis excluded S. ser. Typhimurium most
effectively among the tested strains. B. infantis blocked pathogen adhesion and invasion
only if it was added before or with the pathogen. This indicates that it was not able to
displace already adhered pathogen from the host cells. Among the tested host receptors B.
infantis shared its binding specificity for ganglioside GM1 with Salmonella. Further I
also showed that B. infantis blocked Salmonella mediated caspase 8 and caspase 9
activation. It also reduced the basal caspase 9 and 3/7 activity in the epithelial cells. The
reduction in caspase activity was concomitant with increased Akt phosphorylation and
increased expression of the caspase-inhibiting cIAP protein family. Hence, B. infantis
prevented the activation of the mitochondria-mediated intrinsic cell death pathway.
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Most pathogens have evolved mechanisms to subvert host signal transduction
cascades to influence host cell death decisions (72). Mitochondria integrates a variety of
signals and mitochondrial membrane permeabilization is the decisive event between cell
survival and death (72). A variety of pathogen induce cell death by causing mitochondrial
dysfunction (10, 53, 62) which is mediated through cytochrome c release in the
cytoplasm leading to caspase 9 activation. During Salmonella infection the antioxidant
defense system in the host is impaired due to excessive production of reactive oxygen
species (ROS) (56).This has been shown to increase caspase 9 and caspase 8 activity and
also observed in this study. A recent study (Shah et al, unpublished data) correlated the
induction of genes involved in production of ROS , respiration, and mitochondrial
biogenesis to increased caspase 9 and caspase 3/7 activation during Salmonella infection.
Surprisingly, B. infantis repressed the same gene categories irrespective of presence of
Salmonella and also repressed caspase 9 activity irrespective of the presence of pathogen.
Hence apart from competitive exclusion, B. infantis also mitigated Salmonella mediated
mitochondrial dysfunction in epithelial cells. It was recently shown that production of
ROS in the gut gives Salmonella a selective advantage, as the ROS can react with luminal
sulfur compounds to form tetrathionate which can be used by Salmonella to respire,
giving it a competitive edge over fermenting gut microbes (87). Our data suggests that B.
infantis could possibly block ROS production in the gut by down regulation of genes
needed for aerobic respiration and functioning of the electron transport chain. This
mechanism could contribute to the Bifidobacteria mediated resistance to Salmonella as
observed in vivo in mice (75).
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B. infantis also induced NFkB mediated transcription of four cytokines IL6,
CXCL1, CXCL2, CXCL3, and CCL20. Significantly all these genes were repressed in
presence of Salmonella. Salmonella interferes with the host signal transduction by
secreting a vast array of effector molecules directly into the host cytosol. One of the
secreted effectors AvrA blocks NFkB activation by deubiquitination of IkBα (90) which
leads to down regulation of target genes in the NFkB pathway s IL6, as observed in this
study as well as by Ye et al (90). Hence presence of Salmonella blocked B. infantis
mediated induction of NFkB , most likely through AvrA activity, which was induced in
presence of B. infantis (q≤0). Immunostimulatory effects of Bifidobacteria have also
been reported by other groups. Ruiz et al. (73) reported that in a mouse model, B. lactis
triggers IL6 secretion from intestinal epithelial cells which was concomitant with
activation of MAPK and NFkB signaling (73). In mouse embryogenic fibroblasts, B.
lactis mediated induction of IL6 was completely dependent on TLR2 signaling (73). Li et
al . have also reported the immunostimulatory properties of TLR9 dependent CpG motifs
in Bifidobacteria DNA in macrophages (49).
Patients suffering from inflammatory bowel syndrome (IBS) typically report
increased gut permeability and increased apoptotic rates of intestinal epithelial cells (40).
In this study, I observed that B. infantis treated epithelial cells showed increased
expression of tight junction and adherens junction proteins. This was also observed by
Ewaschuk et al. where soluble factors in B. infantis conditioned media lead to increased
transepithelial resistance (TER) in epithelial cells and concomitant increased expression
of tight junction proteins. Hence B. infantis was functionally shown to improve the
barrier function of epithelial cells. I also observed a B. infantis mediated decrease in
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activation of caspase 9 and caspase 3/7 concomitant with increased phosphorylation of
Akt in colonic epithelial cells. Two recent clinical trials showed that B. infantis
intervention significantly reduced IBD related symptoms (7). The probiotic mixture
VSL#3 has also been shown effective in management of IBS symptoms. Incidentally B.
infantis is one of the eight strains present in the mixture (5). These observations suggest
that B. infantis may be involved in maintaining the barrier functions of the gut epithelium
in vivo by increased expression of tight junction proteins and by modulating the cell
turnover rate.
To summarize, B. infantis competitively excluded Salmonella from binding to
epithelial cells. It prevented Salmonella mediated caspase 8 and caspase 9 activation in
epithelial cells and in absence of the pathogen B. infantis lowered the basal caspase
activity of epithelial cells. The lowered caspase activity was concomitant with increased
Akt phosphorylation, increased expression of caspase inhibiting protein (cIAP) and
repression of genes involved in mitochondrion organization and biogenesis and reactive
oxygen species metabolic processes. Using gene expression and small metabolite profile I
also observed a three way cross talk between the epithelial cells, Salmonella and
Bifidobacteria; where B. infantis prevented catabolism of arginine (a substrate for nitric
oxide (NO) production) by S. ser. Typhimurium, making it available for increased NO
production by the host as evidenced by induction of genes necessary for nitrate and nitrite
(break down products of NO) respiration in the pathogen. Using comparative and
functional genomics approach, I also discovered clusters of mostly hypothetical proteins
which have been acquired in the genome of B. infantis through lateral gene transfer and
are important for the interaction of B. infantis with epithelial cells.
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Table 5.1 GO gene sets that were differentially regulated (q≤0.21) in Caco-2 cells when
exposed to B. infantis. NES= Normalized enrichment score. A positive score indicates
that the gene set was induced in Caco-2 cells when exposed to B. infantis, while a
negative score indicates that the gene set was repressed.
Size of
Gene Set

Genes
Regulated

NES

FDR qval

Biological process
15

9

-1.72

0.21

Apoptotic mitochondrial changes

10

5

-1.78

0.21

Base excision repair

13

6

-1.77

0.21

Cellular component disassembly

22

9

-1.74

0.21

Cellular protein complex disassembly

10

4

-1.70

0.20

Coagulation

20

8

-1.72

0.20

DNA catabolic process

16

10

-1.97

0.13

Electron transport

34

14

-1.83

0.20

Embryonic development

34

18

1.99

0.12

Embryonic morphogenesis

10

8

1.90

0.19

Mitochondrion organization and biogenesis

43

19

-2.35

0.00

Negative regulation of cell differentiation

15

9

1.81

0.16

Oxygen and reactive oxygen species metabolic
process
Pattern specification process

12

8

-1.87

0.18

19

10

1.84

0.18

Protein amino acid autophosphorylation

22

13

1.83

0.15

Protein folding

50

26

-1.69

0.20

Regulation of body fluid levels

26

10

-1.81

0.20

Response to toxin

7

4

-1.96

0.10

Ribosome biogenesis and assembly

12

8

-1.67

0.21

rRNA processing

9

3

-1.77

0.20

Transcription from RNA polymerase iii promoter

17

7

-1.68

0.20

6

1.76

0.13

Name
Aerobic respiration

Adherens junction

Cellular component
12

Basolateral plasma membrane

22

9

1.78

0.16

Cell junction

48

19

1.93

0.05

Cell matrix junction

10

5

1.70

0.13

Envelope

145

64

-1.92

0.01

Intercellular junction

39

14

1.75

0.11

Kinesin complex

11

7

1.64

0.18

Mediator complex

8

5

-1.71

0.03

Membrane enclosed lumen

341

133

-1.84

0.01

Microbody

39

18

-1.78

0.02

Mitochondrial envelope

85

46

-2.30

0.00

Mitochondrial inner membrane

60

41

-2.67

0.00

152

Mitochondrial lumen

Size of
Gene Set
44

Genes
Regulated
24

-2.63

FDR qval
0.00

Mitochondrial matrix

44

24

-2.55

0.00

Mitochondrial membrane

77

44

-2.33

0.00

Mitochondrial membrane part

50

25

-2.64

0.00

Mitochondrial part

128

72

-2.72

0.00

Mitochondrial respiratory chain

23

16

-2.26

0.00

Mitochondrial respiratory chain complex i

14

10

-2.34

0.00

Mitochondrial ribosome

22

19

-2.78

0.00

Mitochondrial small ribosomal subunit

11

10

-2.17

0.00

Mitochondrion

283

161

-2.60

0.00

NADH dehydrogenase complex

14

10

-2.33

0.00

Nucleolar part

12

9

-2.09

0.00

Nucleolus

91

31

-1.93

0.01

Organellar ribosome

22

19

-2.79

0.00

Organellar small ribosomal subunit

11

10

-2.19

0.00

Organelle envelope

145

64

-1.96

0.00

Organelle inner membrane

67

39

-2.67

0.00

Organelle lumen

341

106

-1.86

0.01

Organelle membrane

243

75

-1.84

0.01

Peroxisome

39

18

-1.79

0.02

Proteasome complex

22

16

-1.83

0.01

Proton transporting two sector atpase complex

15

8

-1.71

0.04

Respiratory chain complex i

14

10

-2.35

0.00

Ribonucleoprotein complex

111

46

-2.41

0.00

Ribosomal subunit

20

16

-2.70

0.00

Ribosome

37

22

-2.70

0.00

Small ribosomal subunit

11

10

-2.15

0.00

6

-1.68

0.12

Name

Aldo keto reductase activity

Molecular function
7

NES

Antioxidant activity

14

12

-1.64

0.15

Cytochrome c oxidase activity

12

8

-1.71

0.12

Damaged DNA binding

18

6

-1.74

0.10

Deoxyribonuclease activity

16

9

-1.69

0.13

Electron carrier activity

58

28

-1.99

0.01

Endonuclease activity

20

10

-1.78

0.08

Endonuclease activity GO 0016893

10

6

-1.82

0.06

Endoribonuclease activity

11

7

-1.92

0.03

Exonuclease activity

14

9

-1.82

0.06

Hormone activity

10

4

-1.71

0.13

Methyltransferase activity

29

13

-1.67

0.13

Nuclease activity

37

22

-2.05

0.01
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Size of
Gene Set
189

Genes
Regulated
91

-2.05

FDR qval
0.01

Oxidoreductase activity acting on NADH or
NADPH
Ribonuclease activity

21

13

-2.13

0.00

17

10

-2.15

0.00

RNA polymerase activity

13

7

-1.93

0.02

Serine type endopeptidase activity

22

9

-1.71

0.11

Serine type endopeptidase inhibitor activity

15

6

-1.68

0.12

Structural constituent of ribosome

73

41

-2.05

0.01

Transferase activity transferring alkyl or aryl
other than methyl groups
RNA polymerase ii transcription factor activity
enhancer binding

25

16

-1.88

0.03

9

5

1.92

0.14

Name
Oxidoreductase activity

NES
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Table 5.2 Differentially regulated GO gene sets (q≤0.21) in Caco-2 cells when exposed to
B. infantis and S. ser.Typhimurium. NES= Normalized enrichment score. A positive
score indicates that the gene set was induced in Caco-2 cells when exposed to B. infantis
and S. ser. Typhimurium, while a negative score indicates that the gene set was repressed.
Size of
Gene Set

Name

Biological process
10

Apoptotic mitochondrial changes

Genes
Regulated

NES

FDR
q-val

7

-2.15

0.02

Mitochondrion organization and biogenesis

43

20

-2.43

0.00

Oxygen and reactive oxygen species metabolic
process

12

7

-2.05

0.05

Cellular component
Coated vesicle membrane

13

3

-1.69

0.07

Contractile fiber

15

8

-1.70

0.07

Contractile fiber part

15

8

-1.71

0.07

Envelope

145

57

-1.70

0.07

Extracellular region

160

70

-1.68

0.07

Extracellular space

80

33

-1.85

0.02

Microbody

39

15

-1.67

0.07

Microbody membrane

12

8

-1.64

0.08

Microbody part

13

8

-1.68

0.07

Mitochondrial envelope

85

36

-1.96

0.01

Mitochondrial inner membrane

60

32

-2.33

0.00

Mitochondrial lumen

44

27

-2.26

0.00

Mitochondrial matrix

44

27

-2.17

0.00

Mitochondrial membrane

77

34

-1.96

0.01

Mitochondrial membrane part

50

36

-2.21

0.00

Mitochondrial part

128

59

-2.27

0.00

Mitochondrial respiratory chain

23

17

-1.90

0.01

Mitochondrial respiratory chain complex i

14

9

-2.01

0.01

Mitochondrial ribosome

22

18

-2.34

0.00

Mitochondrial small ribosomal subunit

11

9

-1.95

0.01

Mitochondrion

283

133

-2.22

0.00

Nadh dehydrogenase complex

14

9

-1.98

0.00

Nucleolar part

12

9

-1.92

0.01

Nucleolus

91

39

-1.90

0.01

Organellar ribosome

22

18

-2.36

0.00

Organellar small ribosomal subunit

11

9

-1.97

0.01

Organelle envelope

145

57

-1.73

0.06

Organelle inner membrane

67

36

-2.43

0.00

Organelle lumen

341

95

-1.57

0.02
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Size of
Gene Set
243

Genes
Regulated
85

-1.64

FDR
q-val
0.08

Peroxisomal membrane

12

8

-1.62

0.09

Peroxisomal part

13

8

-1.66

0.07

Peroxisome

39

15

-1.61

0.09

Proteasome complex

22

16

-1.62

0.09

Name
Organelle membrane

NES

Respiratory chain complex i

14

9

-2.02

0.01

Ribonucleoprotein complex

111

59

-1.92

0.01

Ribosomal subunit

20

16

-2.18

0.00

Ribosome

37

25

-2.36

0.00

Sarcomere

7

5

-1.65

0.08

Small ribosomal subunit

11

9

-1.95

0.01

Vesicle coat

13

3

-1.64

0.08

Molecular function
21

9

-1.77

0.09

Carbon carbon lyase activity

16

8

-1.88

0.05

Carboxy lyase activity

12

7

-1.97

0.07

Cytokine activity

26

11

-1.72

0.11

Glycosaminoglycan binding

12

7

-1.71

0.11

Gtp binding

33

15

-1.93

0.08

Gtpase activity

67

15

-1.89

0.05

Guanyl nucleotide binding

33

15

-1.90

0.07

Heparin binding

10

7

-1.92

0.07

Hormone activity

10

5

-1.71

0.10

Oxidoreductase activity acting on NADH or
NADPH
Oxygen binding

21

9

-1.85

0.06

9

4

-1.84

0.06

Pattern binding

13

8

-1.77

0.10

Ribonuclease activity

17

12

-1.78

0.10

Serine type endopeptidase inhibitor activity

15

8

-1.89

0.06

Transferase activity transferring alkyl or aryl other
than methyl groups

25

11

-1.79

0.10

Carbohydrate binding
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Table 5.3 Differentially regulated pathways (q≤0.05) in Caco-2 cells when exposed to B.
infantis. NES= Normalized enrichment score. A positive score indicates that the gene set
was induced in Caco-2 cells when exposed to B. infantis, while a negative score indicates
that the gene set was repressed.
Size of
Gene Set

Genes
Regulated

NES

FDR qval

Parkinsons Disease

92

59

-2.78

0

Oxidative Phosphorylation

96

63

-2.75

0

Proteasome

39

27

-2.55

0

Alzheimers Disease

118

58

-2.3

0

Glutathione Metabolism

38

25

-2.16

0

Huntingtons Disease

140

76

-2.14

0

Spliceosome

104

54

-2.03

0

Drug Metabolism Other Enzymes

24

11

-1.89

0.02

Pyrimidine Metabolism

72

26

-1.88

0.02

Ribosome

75

42

-1.86

0.02

Peroxisome

60

29

-1.85

0.02

RNA Polymerase

27

17

-1.82

0.03

Metabolism Of Xenobiotics By Cytochrome P450

32

20

-1.82

0.03

DNAReplication

32

18

-1.82

0.03

Antigen Processing And Presentation

37

20

-1.82

0.03

Type I Diabetes Mellitus

12

9

-1.77

0.04

Arachidonic Acid Metabolism

21

14

-1.71

0.05

Autoimmune Thyroid Disease

11

8

-1.71

0.05

Notch Signaling Pathway

35

18

1.83

0.05

Phosphatidylinositol Signaling System

45

22

1.89

0.04

Hedgehog Signaling Pathway

27

7

1.9

0.04

Adherens Junction

63

38

1.93

0.04

Focal Adhesion

126

57

1.94

0.05

Proteasome Complex

18

13

-1.97

0.01

Intrinsic Prothrombin Activation Pathway

14

9

-1.74

0.04

Phospholipids as signaling intermediaries

20

8

1.86

0.04

Multiple antiapoptotic pathways from IGF-1R signaling lead to
BAD phosphorylation
GPCR Pathway

19

8

1.89

0.04

25

10

1.89

0.04

IL 6 signaling pathway

19

8

1.91

0.04

PDGF Signaling Pathway

27

10

1.92

0.04

Thrombopoietin (TPO) Signaling Pathway

18

9

1.93

0.04

EGF Signaling Pathway

27

10

1.94

0.05

Insulin Signaling Pathway

18

8

1.96

0.05

Gene Set
KEGG Pathway

Biocarta Pathway
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Table 5.4 Differentially regulated Pathways (q≤0.05) in Caco-2 cells when they were
exposed to B. infantis and S. ser. Typhimurium. NES= Normalized enrichment score. A
positive score indicates that the gene set was induced in Caco-2 cells when exposed to B.
infantis, while a negative score indicates that the gene set was repressed.
Size of Gene
Set

Genes
Regulated

NES

FDR qval

KEGG Pathway
Proteasome

39

25

-2.35

0.00

Parkinson’s Disease
Oxidative Phosphorylation

92
96

50
56

-2.23
-2.22

0.00
0.00

Antigen Processing And Presentation

37

24

-1.91

0.03

Complement And Coagulation Cascades

32

17

-1.86

0.05

Melanogenesis

64

25

1.92

0.03

Basal Cell Carcinoma

30

16

2.02

0.01

Notch Signaling Pathway

35

20

2.04

0.02

Biocarta Pathway
Proteasome Complex

18

11

-1.91

0.03

Gene Set

Table 5.5 Top ten differentially regulated (q≤0) transcriptional regulons in Caco-2 cells when exposed to B. infantis. NES=
Normalized enrichment score. A positive score indicates that the gene set was induced in Caco-2 cells when exposed to B. infantis,
while a negative score indicates that the gene set was repressed.
Remarks

Size of
Gene
Set

Genes
Regul
ated

NES

FDR
q-val

Positive regulation by activated STAT3 (63), positive
regulation by activity of Erk 1/2 (69)

128

59

2.17

0.00

Negatively regulates transcription of genes; repression
is relieved by phosphorylation of CULTL1 by PKA
(59) and PKC

53

19

2.04

0.00

CREB1: cAMP responsive
element binding protein 1

Activated by a variety of stimuli leading to
phosphorylation of CREB1 mediated by PKA
principally through GPCR signaling (39)

140

69

1.96

0.00

YNNNTAAT
CYCMN

CRX: cone-rod homeobox

SNPs in CRX are correlated to Crohn's disease (1)

104

50

2.05

0.00

V$NFKAPP
AB_01

GGGAMTT
YCC

NFKB RELA: v-rel
reticuloendotheliosis viral
oncogene homolog A

Activated by a diverse group of receptors which
include cytokine receptors, T cell receptors, growth
factor receptors and Toll like receptors (54)

95

46

1.97

0.00

V$PAX8_01

NNNTNNNG
NGTGANN

PAX8: paired box gene 8

Activity is negatively regulated by glutathionylation
of PAX8 (9)

16

11

1.94

0.00

V$OCT1_01

NNNNWTA
TGCAAATN
TNNN

POU2F1: POU domain,
class 2, transcription factor
1

103

54

2.27

0.00

V$OCT1_03

NNNRTAAT
NANNN

POU2F1: POU domain,
class 2, transcription factor
1

Activity positively regulated by BRCA (26) and
negatively regulated by Glucocorticoid-GCR complex
(45)

93

40

2.05

0.00

SRF: serum response factor
(c-fos serum response
element-binding
transcription factor)

This gene is the downstream target of many pathways;
for example, the mitogen-activated protein kinase
pathway (MAPK)

124

45

2.10

0.00

Gene Set

Binding
Motif

V$CEBP_Q
2_01

NTTRCNNA
ANNN

V$CDPCR1
_01

NATCGATC
GS

V$CREB_Q
2

NSTGACGT
AANN

V$CRX_Q4

V$SRF_Q4

SCCAWATA
WGGMNMN
NNN

Transcription Factor
CEBPA: CCAAT/enhancer
binding protein (C/EBP),
alpha
CUTL1: cut-like 1,
CCAAT displacement
protein (Drosophila)

Activity positively regulated by BRCA (26) and
negatively regulated by Glucocorticoid-GCR complex
(45)

158

V$STAT3_0
2

NNNTTCCN

STAT3: signal transducer
and activator of
transcription 3 (acute-phase
response factor)

This protein is activated through phosphorylation in
response to various cytokines and growth factors
including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2
(64)

75

25

2.08

0.00

159

160
Table 5.6 Differentially regulated gene sets (q≤0.09) in S. ser. Typhimurium when
incubated with epithelial cells as compared to when incubated with epithelial cells and B.
infantis for 120 minutes. NES= Normalized enrichment score. A positive score indicates
that the gene set was induced in S. ser. Typhimurium when incubated with Caco-2 cells
and B. infantis together, while a negative score indicates that the gene set was repressed.
Gene Set
Biosynthesis Of Cofactors- Prosthetic Groups- And
Carriers- Molybdopterin
Cog J-Translation
Cog K-Transcription
DNA Metabolism- DNA Replication- RecombinationAnd Repair
Energy Metabolism- Anaerobic
Genes Induced By QSE Two Component System
Glycan Biosynthesis-Lps Biosynthesis
Membrane Transport-Protein Export
Protein Fate- Protein Folding And Stabilization
Protein Fate- Protein Modification And Repair
Protein Synthesis- Ribosomal Proteins- Synthesis And
Modification
Protein Synthesis- Translation Factors
Protein Synthesis- tRNA And rRNA Base
Modification
Purines- Pyrimidines- Nucleosides- And Nucleotides2-Deoxyribonucleotide Metabolism
SPI-3
Transcription-RNAProcessing
Mobile And Extrachromosomal Element FunctionsProphage Functions
Mobile And Extrachromosomal Element FunctionsPlasmid Functions
Membrane Transport-ABC Transporters
HGT-High %GC
Genes With %GC Greater Than 60
Energy Metabolism- TCA Cycle
Cellular Processes- DNA Transformation
Biosynthesis Of Cofactors- Prosthetic Groups- And
Carriers- Biotin

Size of Genes
Gene Set Regulated

NES

FDR qval

9

6

1.60

0.08

170
246

107
96

2.51
1.76

0.00
0.04

119

54

1.61

0.09

66
44
27
16
34
20

26
29
13
11
11
11

2.21
1.63
1.74
1.80
1.60
1.64

0.00
0.09
0.05
0.03
0.09
0.09

61

46

1.94

0.01

28

19

1.88

0.01

28

17

2.27

0.00

10

4

1.58

0.09

9
7

4
6

1.60
1.60

0.09
0.08

143

64

-2.41

0.00

28

24

-2.01

0.00

174
70
196
35
30

57
46
100
8
26

-1.99
-2.60
-2.54
-1.65
-1.99

0.00
0.00
0.00
0.09
0.00

8

4

-1.89

0.01
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Table 5.7 Differentially regulated gene sets (q≤0.15) in B. infantis when incubated with
epithelial cells as compared to when incubated in the same conditions without the
epithelial cells for 120 minutes. NES= Normalized enrichment score. A positive score
indicates that the gene set was induced in B. infantis when incubated with Caco-2 cells,
while a negative score indicates that the gene set was repressed.

Gene Set
Genes with %GC >70
Genes with %GC< 40
Translation
Pyrimidine Metabolism
Purine Metabolism
Cog J Translation
Cog F Nucleotide Transport And Metabolism
CHO-Binding Module Family (Cazy)
Glycosyl Hydrolases (Cazy)

Size of
Genes
Gene
Regulated
Set

NES

FDR
q-val

48

26

2.53

0.00

34

17

2.05

0.00

57

24

1.93

0.01

35

15

1.93

0.01

43

17

1.60

0.11

137

41

1.89

0.01

61

29

1.82

0.01

5

2

-1.79

0.13

41

14

-1.78

0.07
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Table 5.8 Differentially regulated gene sets (q≤0.15) in B. infantis when incubated with
epithelial cells and S. ser. Typhimurium as compared to when incubated alone for 120
minutes. NES= Normalized enrichment score. A positive score indicates that the gene set
is induced in B. infantis when incubated with Caco-2 cells, while a negative score
indicates that the gene set was repressed.

Gene Set
Genes with %GC >70
Genes with %GC< 40
Unclassified
Genes with %GC Content Between 40 and 50
HGT from Firmicutes
Translation
Oxidative Phosphorylation
Cog C Energy Production and Conversion
Cog J Translation

Size of
Genes
Gene
Regulated
Set

NES

FDR
q-val

48

24

2.44

0.00

34

17

2.02

0.00

683

232

1.85

0.02

108

24

1.60

0.14

114

36

1.54

0.15

57

30

-2.31

0.00

11

8

-2.12

0.00

42

17

-2.01

0.00

137

40

-1.81

0.02

Table 5.9 Bacteria with their growth conditions and primers for their quantitation by qPCR
Bacteria

Growth condition

qPCR primers

Salmonella enterica
ser. Typhimurium
LT2
(ATCC 700720)
Gene: 16s rDNA

37°C / 220 rpm in serum
free cell culture media.
Cells were washed and
suspended in fresh serum
free cell culture media
before interaction with
Caco-2 cells

Caco2 (ATCC HTB37) Gene: G3PDH

Forward: ACC ACA GTC CAT GCC ATC
See cell culture for growth
AC
description
Reverse: TCC ACC ACC CTG TTG CTG TA

Bifidobacterium
longum subspp.
infantis (ATCC
15697)

37°C/ Anaerobic in MRS
broth + 0.05% Cys. Cells
were washed and
suspended in fresh serum
free cell culture media
before interaction with
Caco-2 cells

Forward: TGT TGT GGT TAA TAA CCG CA
Reverse: CAC AAA TCC ATC TCT GGA

Forward: ACT ACC CCT GGC CTG AAC TT
Reverse: GAC AGA GCG TAA CCC AGC
TC

Standard curve
equation
Log10 CFU = Ct-46.52/5.034
R2 = 0.99
Log10 CFU = Ct-33.69/4.13 R2 = 0.99

Log10 CFU = Ct-36.31/2.624 R2 = 0.97
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Figure 5.1 Efficacy of different strains to block Salmonella host association. Treatments
with "*" are significantly different (p≤0.5) as compared to control (Caco-2 cells
incubated with Salmonella alone). Error bars indicate standard error from 4 replicates.
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Figure 5.2 Effect of presence of B. infantis on the relative adhesion and invasion of S. ser.
Typhimurium to Caco-2 cells. Control (Caco-2 cells incubated with S. ser.
Typhimurium); Sal-Pre + Bif(Caco-2 cells pre-incubated for 30 minutes with S. ser.
Typhimurium and then with B. infantis for 30 more minutes); Bif-Pre+ Sal (Caco-2 cells
pre-incubated with B. infantis for 30 minutes and then with S. ser. Typhimurium for 60
more minutes); Sal+Bif (Caco-2 cells incubated with S. ser. Typhimurium and B. infantis
together for 60 minutes); Sal+Bif Incubated(S. ser. Typhimurium and B. infantis were
first incubated together for 60 minutes and then incubated with Caco-2 cells for 120
minutes). Treatments that do not share an alphabet are significantly different (p<0.05).
The % numbers of the x axis represents the fraction of total host associated bacteria that
were intracellular (invaded). Error bars indicate standard error from three replicates.

sprB
hilC
orgC
orgB
orgA
prgK
prgJ
prgI
prgH
hilD
hilA
iagB
sicP
iacP
sipD
sicA
spaS
spaR
spaQ
spaP
spaO
invJ
invI
invC
invB
invA
invE
invG
invF
invH
ssrB
sptP
sipA
sipC
sipB
sopA
sopB
sopD
sopE2
avrA

SPI1-T3SS
30 min
transcriptional regulator
invasion regulatory protein
putative cytoplasmic protein
needle complex export protein
needle complex assembly protein
needle complex inner membrane lipoprotein
needle complex minor subunit
needle complex major subunit
needle complex inner membrane protein
invasion protein regulatory protein
invasion protein transcriptional activator
invasion protein precursor
secretion chaparone
acyl carrier protein
translocation machinery component
secretion chaperone
type III secretion protein
needle complex export protein
needle complex export protein
needle complex export protein
type III secretion protein
needle length control protein
needle complex assembly protein
type III secretion system ATPase
secretion chaperone
needle complex export protein
invasion protein
outer membrane secretin precursor
invasion regulatory protein
needle complex outer membrane lipoprotein
transcriptional activator
T3SS1-effectors
30 min
protein tyrosine phosphatase/GTPase activat
secreted effector protein
translocation machinery component
translocation machinery component
secreted effector protein
secreted effector protein
secreted effector protein
type III-secreted effector protein
secreted effector protein

2

-3

1

0

2

2

0

2

3

0

0

0

0

0

0

2

1

4

2

4

3

5

1

1

1

4

1

2

0

0

0

1

2

0

0

2

0

2

4

0

0

3

0

1

0

0

-1

1

0

0

1

0
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1

0

0

2

0

2

2

0

1

3

0

1

1

0

2

3

0

0

1

0

-1

1

0

1

2

0

1

2

-1

2

4

0

0

0

0

0

0

0

0

-2

-1

2

60 min
3

1

2

1

0

-1

-1

0

-1

3

4

5

4

1

2

0

2

0

q
0.00
0.10
0.00
0.00
0.00
0.00
0.00
0.00
0.10
0.00
0.01
0.08
0.00
0.00
0.00
0.00
0.25
0.06
0.03
0.01
0.00
0.01
0.00
0.00
0.00
0.12
0.01
0.00
0.00
0.00
0.00
120 min q
0.00
0.00
0.00
0.00
0.01
0.00
0.23
0.01
0.00

SPI2-T3SS
30 min
sensor kinase
outer membrane secretin precursor
virulence protein
secretion system effector
secretion system chaperone protein
translocation machinery component
secretion system chaparone
translocation machinery component
translocation machinery component
secreted effector protein
secretion system chaparone
type III secretion system apparatus protein
type III secretion system apparatus protein
type III secretion system apparatus protein
needle complex inner membrane lipoprotein
type III secretion system apparatus protein
type III secretion system apparatus protein
type III secretion system apparatus protein
type III secretion system apparatus protein
type III secretion system ATPase
type III secretion system apparatus protein
type III secretion system apparatus protein
type III secretion protein
needle complex export protein
type III secretion system apparatus protein
type III secretion system apparatus protein
type III secretion system apparatus protein
leucine-rich repeat protein
T3SS2-effectors
30 min
ssaB
secreted effector protein
sseF
secreted effector protein
sseG
secreted effector protein
sseI
secreted effector protein
sseJ
secreted effector protein
STM2287 putative cytoplasmic protein
STM2137 putative cytoplasmic protein
sifA
secreted effector protein
sifB
secreted effector protein
pipB
secreted effector protein
pipB2
secreted effector protein
gogB
leucine-rich repeat protein
sspH2
leucine-rich repeat protein
STM4157 putative cytoplasmic protein

ssrA
ssaC
ssaD
ssaE
sseA
sseB
sscA
sseC
sseD
sseE
sscB
ssaG
ssaH
ssaI
ssaJ
ssaK
ssaL
ssaM
ssaV
ssaN
ssaO
ssaP
ssaQ
ssaR
ssaS
ssaT
ssaU
slrP

60 min

0

0

1

0

0

1

0

2

2

0

0

3

0

-2

1

0

-1

1

0

-1

1

0

-1

2

0

2

3

0

1

1

0

1

2

0

0

2

0

0

3

0

1

3

-1

0

1

0

0

2

-1

1

1

-1

0

1

0

1

0

0

0

1

1

0

2

0

1

1

0

-1

0

0

-2

1

0

0

-1

0

0

-1

0

0

1

0

0

1

0

0

1

0

-1

0

0

-1

-2

0

0

1

0

-2

1

0

1

4

0

-1

-1

0

0

1

-1

0

-1

0

1

2

0

-1

0

0

-1

-1

0

0

1

0

-1

0

60 min

120 min q
0.00
0.02
0.00
0.00
0.10
0.23
0.14
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.23
0.01
0.00
0.02
0.25
0.01
0.23
0.23
0.12
0.10
120 min
0.01
0.23
0.23
0.00
0.19
0.00
0.23
0.00
0.23
0.00
0.23
0.25
0.06
0.25
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4.6

1

-1

0

0

120 min

-1

-1

0

-2.13

60 min

-1

Figure 5.3 Log2 ratios of genes involved in biogenesis of T3SS and its effectors in S. ser. Typhimurium grown in co culture
with B. infantis or grown alone. A positive log2 ratio represent induction of genes in presence of B. infantis while a negative
log2 ratio represents repression of genes. The q value was obtained from SAM.
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Figure 5.4 Activity of caspase 8, caspase 9 and caspase 3/7 after 8 hours of incubation
with either no microbe (control), or with B. infantis alone, or S. ser. Typhimurium alone,
or B. infantis and S. ser. Typhimurium together. Means significantly different from
control (p≤0.05) for each caspases are marked with "*". Error bars indicate standard error
from 3 replicates.
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Figure 5.5 Relative levels of phosphorylated Akt at ser-473 and thr-308 in epithelial cells
upon infection with different microbes. Error bars indicate standard error from 2
replicates.

Figure 5.6 Dendogram visualizing similarity between global gene expression profiles of Caco-2 cells. The number at each
cluster edge represents Approximately Unbiased % p value estimated by multiscale bootstrap resampling 1000 times.
(Host=Caco-2 cells incubated with no microbes, Host+Bif= Caco-2 cells incubated with B. infantis, Host+Sal= Caco-2 cells
incubated with S. ser. Typhimurium, Host+Bif+Sal= Caco-2 cells simultaneously incubated with 1:1 ratio of B. infantis and S.
ser. Typhimurium. The time in minutes represent the time after infection at which the gene expression was determined
170

.

Figure 5.7 Dendogram constructed by hierarchical clustering of small metabolite profile of all the host microbe interaction
samples. The number at each cluster edge represents Approximately Unbiased % p value estimated by multiscale bootstrap
resampling 1000 times (Host= Caco-2, Bif= B. infantis, Sal= S. ser. Typhimurium. The time in minutes represent the time after
infection at which the metabolite profile was determined. "E" represents the extracellular metabolite profile from culture
supernatant, while "I" represent the intracellular metabolite profile of all the cells in co-culture.
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Figure 5.8 Log2 ratios of differentially expressed genes (q≤0.1); caspase 8,9, 3/7 activity
and phosphorylation status of Akt in epithelial cells when they are exposed to B. infantis.
Data for Akt and caspase activity are same as Fig 5.2 and 5.3. For gene expression data,
red represents induction while blue represents repression of genes when epithelial cells
were exposed to B. infantis.
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-1.64

-1.61

0

2.69

0

5.84

Figure 5.9 Log2 ratios of gene expression intensities of S. ser. Typhimurium and selected
small metabolite peak areas when Caco-2 cells were treated with either S. ser.
Typhimurium alone or with a co-culture of S. ser. Typhimurium and B. infantis.
Induction of genes represent that the gene was induced in Salmonella in presence of B.
infantis as compared to its absence.
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CHAPTER VI
SUMMARY

Food-borne bacterial infections are a substantial source of morbidity and mortality
in humans (3). In 2008 Salmonella caused the highest morbidity for all reported bacterial
Food-borne illnesses in the U.S. (1). The economic burden due to Salmonella alone in the
U.S. is an estimated $2.8 billion (2). Salmonella is a big problem for food safety and
public health. Broadly, this is because of zoonotic transmission of non-host adapted
serovars between an animal, that is an asymptomatic carrier to food and subsequently to
humans, that results in food related out breaks. While it is not possible to completely get
rid of Salmonella from the livestock, efforts can be still be undertaken to reduce the load
of the organism from the food chain. The number of pathogen outbreaks can also be
reduced if the disease causing organism is detected earlier, so that remedial action can be
taken quickly to control the spread of the disease. This work focused on developing
strategies to block Salmonella infection and allow for rapid pathogen detection.
I hypothesized that B. longum subspecies. infantis reduces S ser. Typhimurium
adhesion to gut epithelial cells by competing for the same receptors and also improves
cell survival by modulation of specific pathways in the host. These hypotheses were
tested via the following objectives.
Objective 1. Define the pathogen exclusion potential of selected probiotic bacteria in
vitro to gut epithelium.
Objective 2. Define the binding partners of the host-bacteria interaction.
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Objective 3. Identify signal transduction and metabolic pathways modulated in the host
(Caco-2 cells) and the microbes in vitro due to adhesion of B. infantis and S.
ser. Typhimurium over time.
Efficacy of probiotics in the prevention of gastrointestinal diseases has been
observed in several in vivo and in vitro models, but this effect is strain dependent and
there is limited knowledge about the mode of action of probiotics against enteric
pathogens. I screened several probiotic strains for pathogen exclusion potential and found
that Bifidobacterium longum subspp. infantis showed the highest potential for Salmonella
exclusion in a cell culture model.
To identify new protein binding partnerships, I developed a cell-cell cross-linking
protocol, in which bacterial cells were chemically cross-linked to host epithelial cells
during infection using a cleavable crosslinker. The crosslinked proteins were identified
by resolving the cross-linked complexes on 2D-gels. This approach identified several
new receptor pairs in Salmonella and epithelial cells. Interaction of Salmonella Ef-Tu
with Hsp90 from epithelial cells mediated adhesion, while interaction of Salmonella EfTu with myosin phosphatase and alpha catenin; two host proteins that negatively regulate
membrane ruffling , mediated adhesion and invasion. Ef-Tu from Salmonella also
induced phosphorylation of pro-survival kinase Akt. Ef-Tu is one of the most abundant
protein on the cell, and this work proved that a sub population of the protein is membrane
associated. Also Ef-Tu is a highly conserved protein across all Salmonella serovars,
hence maybe an ideal vaccine candidate effective against all Salmonella serotypes.
I also identified host ganglioside GM1 as a receptor that mediated adhesion and
invasion of Salmonella. Based on the fact that host glycosphigolipids can mediate
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pathogen attachment, I screened a variety of enteric pathogens, commensals and
probiotics for ganglioside binding. All the screened Salmonella, E. coli, Bifidobacteria
and Bacillus bound a mixed population of gangliosides isolated from bovine buttermilk.
Armed with this knowledge I developed a method for concentrating pathogens from
samples without pre-enrichment. Immobilized gangliosides concentrated bacteria for
detection with real-time PCR. A sensitivity of 4 CFU/ml (3 h) in samples without
competing microflora was achieved. Samples with competing microflora had a sensitivity
of 40,000 CFU/ml. In conclusion, I demonstrated the ability of gangliosides
immobilized on 3-mm glass beads to concentrate pathogenic organisms and
Bacillus spores directly from samples without pre-enrichment. Use of gangliobeads prior
to a commercial RT-PCR kit for food pathogen detection improved the sensitivity 100fold.
Next I tested, if B. infantis blocked Salmonella adhesion and invasion by
competing for the same epithelial cell receptors. I found that B. infantis shared its binding
specificity to ganglioside GM1 with S. ser. Typhimurium, while it did not use 90KD heat
shock protein, alpha catenin or myosin phosphatase for binding to the host. Furthermore,
B. infantis completely inhibited, Salmonella-induced caspase 8 and caspase 9 activity in
intestinal epithelial cells. B. infantis also reduced the basal caspase 9 and caspase 3/7
activity in epithelial cells in absence of the pathogen. Western blots and gene expression
profiling of epithelial cells revealed that the decreased caspase activation was
concomitant with increased phosphorylation of the pro-survival protein kinase Akt,
increased expression of caspase inhibiting protein cIAP and decreased expression of
genes involved in mitochondrion organization and biogenesis and reactive oxygen
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species metabolic processes. Hence B.infantis exerted it protective effects by repression
of mitochondrial cell death pathways which was induced in presence of S. ser.
Typhimurium. Gene expression analysis also revealed that B. infantis strongly induced
expression of genes downstream of cAMP signaling, MAPK signaling and NFkB
signaling. Using gene expression and small metabolite profiles I also observed a three
way cross talk between the epithelial cells, Salmonella and Bifidobacteria. In these
interactions B. infantis prevented catabolism of arginine (a substrate for nitric oxide (NO)
production) by S. sv. Typhimurium, making it available for increased NO production by
the host (Figure 6. 1). This was evidenced by induction of genes necessary for nitrate and
nitrite (break down products of NO) respiration in the pathogen. Using a comparative and
functional genomics approach I also discovered a cluster of 50 proteins that have been
acquired in the B. infantis genome through lateral gene transfer. These gene clusters are
highly conserved in only subspp. infantis and are induced only in presence of the host.
Hence they have likely been conserved in the genome through selective pressure from the
host.
In conclusion this work identified novel receptors in Salmonella that mediate
adhesion and invasion, and therefore are candidates for vaccine development against
Salmonella. Further, using immobilized host receptors I developed a method for
concentrating pathogens from samples without pre-enrichment. Mechanisms for pathogen
blocking by B. infantis included competition for GM1 binding, and inhibition of
mitochondrial cell death pathway in the host as well as the catabolism of arginine in
Salmonella. Therefore, I accept the hypothesis that B. infantis reduces S sv. Typhimurium
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adhesion to gut epithelial cells by competing for the same receptors and improves cell
survival by modulation of specific pathways in the host.
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Figure 6.1Proposed three way interactions between host epithelial cells, S. ser. Typhimurium and B. infantis
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Figure A 1 Molecular structure of Sulfo-SBED as provided by the manufacturer.

Figure A 2 Neighbor joining tree made by using Phylobuilder based on multiple sequence alignments of homologs of
LBA0222. The blue box indicates the homologous proteins in L. acidophilus NCFM.
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Figure A 3 Cross-linked proteins resolved under non reducing conditions (1,2) and under reducing conditions (3,4)
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Table B 1 Two way ANOVA with repeated measures of relative levels of phosphorylated
AKT at ser-473 and thr-308 in epithelial cells upon infection with different microbes at
30, 60 and 120 minutes post infection.
Source of
Variation

Df

Interaction
Time
Microbe
Residual

6
2
3
8

Interaction
Time
Microbe
Residual

6
2
3
8

SumMean
ofsquare
squares
pAKT-473
1512
252
608
304
5419
1806
84
10
pAKT-308
1213
202.2
311
155.5
4244
1415
358.4
44.8

F

% of
total
P value
variation

24
29
26

19.13
7.69
68.54

0.0001
0.0002
0.0045

4.514
3.471
15.44

18.69
4.79
65.36

0.0272
0.0822
0.0115
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Table B 2 Differentially regulated pathways (q≤0.05) in S. sv. Typhimurium when
exposed to B. infantis as compared to normal growth. NES= Normalized enrichment
score. A positive score indicates that the gene set was induced when exposed to B.
infantis, while a negative score indicated that the gene set was repressed.
Size of
Gene
Set
19
21
6

Genes
Regulat
ed
8
5
5

82

NES

FDR
q-val

1.57
1.55
1.55

0.05
0.05
0.05

29

1.86

0.00

40
28
80
170

22
16
56
94

1.68
1.56
1.87
2.27

0.02
0.05
0.00
0.00

Cog M-Cell Wall Membrane Biogenesis
Cog O-Posttranslational Modification Protein Turnover Chaperones
Energy Metabolism- ATP-Proton Motive Force Interconversion
Energy Metabolism- Pyruvate Dehydrogenase
Fatty Acid And Phospholipid Metabolism- Biosynthesis
Fur Regulon
Genes Induced By Qse Two Component System
Genes Regulated By HilA
Genes Regulated By SsrA-SsrB Two Component System
Glycan Biosynthesis-Lps Biosynthesis

237
142
15
8
44
66
44
17
117
27

85
70
7
6
24
33
15
11
55
23

1.70
1.57
1.62
1.73
1.55
1.87
1.65
1.68
1.55
1.85

0.01
0.05
0.03
0.01
0.05
0.00
0.02
0.02
0.05
0.00

Membrane Transport-Pores Ion Channels
Membrane Transport-Protein Export
Membrane Transport-Secretion System
Protein Synthesis- Translation Factors
Purines- Pyrimidines- Nucleosides- And Nucleotides- 2Deoxyribonucleotide Metabolism
Purines- Pyrimidines- Nucleosides- And Nucleotides- Purine
Ribonucleotide Biosynthesis
SPI-1
SPI1-T3SS
SPI2-T3SS
T3SS
T3SS Effectors
Adherence Factors-Fimbrial
Cellular Processes- DNA Transformation
Genes With% GC Greater Than 60
Membrane Transport-Electron Transfer Carriers
Mobile And Extra chromosomal Element Functions- Plasmid
Functions
SPV Locus

35
16
43
28
10

15
14
27
19
6

1.86
1.64
1.66
1.80
1.70

0.00
0.02
0.02
0.00
0.02

18

16

1.77

0.01

40
30
27
58
22
66
30
196
31
28

25
21
18
42
12
29
29
102
20
26

2.04
1.79
1.58
1.90
1.56
-2.61
-3.82
-2.04
-2.20
-3.68

0.00
0.00
0.04
0.00
0.05
0.00
0.00
0.00
0.00
0.00

4

3

-1.87

0.02

Gene Set
Amino Acid Biosynthesis- Glutamate Family
Amino Acid Biosynthesis- Serine Family
Biosynthesis Of Cofactors- Prosthetic Groups- And CarriersGlutathione And Analogs
Cell Envelope- Biosynthesis And Degradation Of Surface
Polysaccharides And Lipopolysaccharides
Cellular Processes- Chemotaxis And Motility
Cellular Processes- Detoxification
Cog F-Nucleotide Transport And Metabolism
Cog J-Translation
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Table B 3 Differentially regulated pathways (q≤0.20) in caco-2 cells when exposed to B.
infantis and S. sv. Typhimurium as compared to when exposed to only B. infantis. NES=
Normalized enrichment score. A positive score indicates that the gene set was induced in
Caco-2 cells when exposed to B. infantis and S. sv. Typhimurium, while a negative score
indicated that the gene set was repressed.
Size of
Gene
Set
Kegg Pathway
Nod Like Receptor Signaling Pathway
33
Steroid Hormone Biosynthesis
23
Biocarta Pathway
Ataxia Telangiectasia-mutated gene
18
Pathway
Il6 Pathway
19
GO Annotations
Cell Junction
48
Regulation Of Cell Migration
14
Basolateral Plasma Membrane
22
Chemokine Receptor Binding
10
Chemokine Activity
10
Cell Matrix Junction
10
Gene Set

Genes
Regulated

NES

FDR qval

7
3

-2.17
-2.10

0.01
0.01

10

-2.12

0.01

9

-2.00

0.02

22
8
9
4
4
6

-2
-1.97
-1.93
-1.94
-1.95
-2.02

0.13
0.13
0.14
0.15
0.16
0.20

Table B 4 Transcriptional regulons that are differentially regulated (q≤0) in Caco-2 cells when they were exposed to B. infantis
and S. sv. Typhimurium as compared to when they were exposed to only B. infantis. NES= Normalized enrichment score. A
positive score indicates that the gene set was induced in Caco-2 cells when exposed to B. infantis and S. sv. Typhimurium,
while a negative score indicated that the gene set was repressed.
Gene Set

Binding
Motif

Transcription Factor

V$CREB_
Q2

NSTGAC
GTAANN

CREB1: cAMP responsive
element binding protein 1

V$CREB_
Q4_01

CNNTGA
CGTMA

CREB1: cAMP responsive
element binding protein 1

V$CREB_
Q4

NSTGAC
GTMAN
N

CREB1: cAMP responsive
element binding protein 1

V$CREBP
1_Q2

VGTGAC
GTMAC
N

ATF2: activating
transcription factor 2

Remarks

Activated by a variety of stimuli leading to
phosphorylation of CREB1 mediated by PKA
principally through GPCR signaling

This protein binds to the cAMP-responsive
element (CRE),The protein forms a
homodimer or heterodimer with c-Jun and
stimulates CRE-dependent transcription.

Size

Genes
Regul
ated

NES

FDR
q-val

140

29

-2.17

0

129

40

-2.25

0

109

25

-1.99

0

134

31

-1.99

0
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Table B 5 Differentially regulated genesets in B. infantis after 120 minutes of incubation
with S. sv. Typhimurium as compared to B. infantis incubated alone. NES= Normalized
enrichment score. A positive score indicates that the gene set was induced in B. infantis
when exposed to S. sv. Typhimurium, while a negative score indicated that the gene set
was repressed
Gene Set
Genes with%GC >70
Cog J Translation
Sec System
Translation
Other Transcription Related Proteins
Purine Metabolism
Drug Metabolism
Histidine Metabolism
Multi Transmembrane
Cog G Carbohydrate Transport and Metabolism
Glycosyl Hydrolases
Cog P-Inorganic Ion Transport and Metabolism
Sec Pi Substrate
Cog V Defense Mechanism

Size of
Gene Set

Genes
Regulated

NES

FDR
q-val

48

24

2.64

0.00

137

66

1.97

0.01

9

7

1.96

0.01

57

28

1.78

0.04

4

4

1.75

0.05

43

17

1.66

0.09

5

4

1.65

0.08

9

8

1.62

0.10

460
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-1.91

0.02

191

84

-1.90

0.01

41

17

-1.86

0.02

77

19

-1.78

0.03

574

235

-1.70

0.06

69

39

-1.68

0.06
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Table B 6 Gene sets that are conserved in B. infantis but divergent in B. longum based on
comparative genomic hybridization of 15 Bifidobacteria strains (q≤0.07).
Gene Set
ABC Transporters
Cog G Carbohydrate Transport And Metabolism
Cog V Defense Mechanism
Genes%GC Less Than 40
Genes with%GC Between 40 And 50
HGT from Actinomycetales
HGT from Firmicutes
Human Milk Oligosaccharide Utilization Cluster
Lipid Anchored
Multi Transmembrane
Protein Folding And Associated Processing
Sec PII Substrate

Size of
Gene Set
76
191
69
34
108
109
114
61
61
460
13
69

Divergent
Genes
50
82
35
32
81
50
81
50
31
161
4
34

NES
-1.93
-1.68
-1.64
-1.79
-1.82
-1.81
-1.98
-2.32
-1.58
-1.5
-1.63
-1.61

FDR qval
0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.03
0.07
0.01
0.02
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Figure B 1 Effect of blocking selected Salmonella receptors with antibodies in Caco-2
cells on the adhesion of B. infantis. Control represents the adhesion of B. infantis to
unblocked caco-2 cells. Error bars represent standard error from 4 replicates.
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Figure B 2 Log2 ratios of differentially expressed genes (q≤0.1) in epithelial cells when
exposed to B. infantis and S. sv. Typhimurium. For gene expression data, red represents
induction while blue represents repression of genes when epithelial cells were exposed to
B. infantis and S. sv. Typhimurium.
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Figure B 3 Genes in B. infantis that were putatively acquired by lateral gene transfer;
were only conserved in the subspp. infantis and divergent in subspp. longum; and were
induced in presence of epithelial cells and S. sv. Typhimurium (q<0.15). The heat maps
represent averaged relative expression level of the genes under specific conditions from
two replicates.
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